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CHAPTER I. Introduction 
1.1 Chemoselective ligations 
 Nucleic acids, carbohydrates, proteins and lipids1-2 are the four major 
classes of biological macromolecules. Among them carbohydrates and proteins 
play vital role and are critical components of living organisms. They mediate a 
vast number of fundamental biological pathways ranging from cellular operations 
to recognition events.3-7 Therefore methods need to be developed for the 
conjugation of these molecules to each other and to other small molecules. The 
search for highly selective chemical reactions capable of proceeding within a 
physiological atmosphere led chemists to discover a set of technique called 
chemoselective ligation.8 With the concept called “bioorthogonality”, 
chemoselective ligation is labeld as the selective covalent coupling of two 
mutually and uniquely reactive functional groups in an aqueous environment 
(Scheme 1).9-11  
 
Scheme 1. Chemoselective ligation 
Chemoselective ligations for the modification of macromolecules such as 
proteins and carbohydrates can be approached in two ways 1) acyl-transfer 
ligations and 2) non-native ligations. 
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1.1.1 Acyl-transfer ligations 
In acyl-transfer ligations, a native amide bond is formed through a 
capture/rearrangement technique. In 1953 Wieland and co-workers were the first 
to synthesize amides by the intermolecular aminolysis of C-terminal thioesters 
with amines.12 This capture/rearrangement technique was cleverly utilized to the 
synthesis of a dipeptide as shown in Scheme 2. 
 
 
Scheme 2. Aminolysis of thioesters 
Subsequent acyl transfer ligations, as described below, include prior thiol 
capture, pseudo proline ligation, native chemical ligation, and Staudinger ligation. 
1.1.2 Prior thiol capture 
Prior thiol capture, is one of the earliest ligation developed by Kemp et 
al.13-15 Initially an auxiliary is attached to the N peptide through an ester linkage. 
The capture is mediated by the disulfide exchange between a Cys residue 
located at the N terminus of the C peptide and the free thiol of the auxiliary.16 The 
intramolecular O→N transfer produces a native peptide bond as shown in 
Scheme 3.  
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Scheme 3. Prior thiol capture 
The prior thiol capture has been applied in the ligation of various 
unprotected peptides to yield polypeptides with up to 39 residues.17 
1.1.3 Pseudo proline ligation 
In pseudo proline ligation the capture step is the initial formation of an 
imine which transforms to an oxazolidine/thiazolidine in a reversible step. The 
irreversible O→N rearrangement delivers a pseudo proline at the ligation junction 
as shown in Scheme 4. This imine ligation reaction was successfully utilized in 
the assembly of proline rich peptide bactenecin 7 by Tom and Miao.18-20 
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Scheme 4. Pseudo proline ligation 
1.1.4 Native chemical ligation 
Native chemical ligation is one of the techniques in which a 
chemoselective transthioesterification of a peptide C-terminal thioester with an N-
terminal Cys of another peptide forms a new thioester which spontaneously 
undergoes an S→N acyl transfer to form a native peptide bond (Scheme 5). 
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Scheme 5. Native chemical ligation 
This capture/rearrangement strategy was elegantly used by Kent and 
coworkers in the synthesis of human interleukin 8 (IL-8) from two synthetic 
peptide fragments.21 More recently native chemical ligation has been widely used 
in the synthesis of posttranslationally modified and unmodified proteins and in the 
conjugation of peptides with other macromolecules.22-24 
1.1.5 Staundinger ligation 
The reaction of phosphine with azide is known as the Staudinger reaction. 
Raines and Bertozzi independently developed this reaction to the formation of 
amide bonds. This chemoselective ligation technique for the site specific 
functionalization of biopolymers was introduced by Bertozzi and coworkers.25-26 
In its original variant, an iminophosphorane 24 undergoes an intramolecular 
nucleophilic attack with an ortho-substituted ester to form an amide 25 (Scheme 
6). 
 
Scheme 6. Staudinger ligation 
The Staundinger ligation was applied to the selective labeling of sialic acid 
residues demonstrating the potential of its bioorthogonality.25,27 Additionally this 
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ligation has been employed for site selective functionalization of proteins or their 
modifications and the immobilization of peptides and proteins.10-11 More recently, 
Crich et al applied the traceless Staundinger ligation to synthesize a new class of 
glycoconjugates called amidomethyl glycosides by treating the azidothiomethyl 
glycosides with borane-protected phosphinothioesters as shown in Scheme 7.28 
 
Scheme 7. Synthesis of amidomethyl glycosides through traceless 
Staudinger ligation 
1.2 Non-native ligations  
In non-native ligations linkage is achieved via the formation of bond not 
native to the naturally occurring biopolymers. For example, a bond is formed 
between two peptides through the reaction of a pair of mutually reactive 
functional groups. Typical non-native ligation methods include cycloadditions, 
oxime formation, thioesterification and thioetherification.  
1.2.1 Cycloadditions 
A number of cycloaddition reactions, including 1,3-dipolar cycloadditions 
and Diels-Alder reactions have been used as ideal chemoselective ligations 
since the reactants fuse together without generating any byproducts (Scheme 8). 
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Scheme 8. Cycloadditions as chemoselective ligations 
Recently Waldmann and co workers identified the [4+2] cycloaddition 
involving a maleimido group as a chemoselective reaction for the conjugation of 
peptides and functionalization of proteins as shown in scheme 9.29 However, the 
determination of the stereoselectivity for this ligation product was not conclusive. 
 
Scheme 9. Diels-Alder conjugation of peptides 
The Huisgen dipolar cycloaddition of azides and alkynes is of great 
interest because azides are tolerant towards water, oxygen and the nucleophilic 
functional groups present in the living systems.30-31 However, this cycloaddition is 
not highly bioorthogonal because higher temperatures are required to drive the 
reaction into the forward direction. Moreover it is not regioselective. These 
problems were independently addressed by Sharpless and Meldal groups.32-33 It 
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is believed that the addition of Cu-(I) salts allow the reaction to proceed at room 
temperature with improved regioselectivity involving a Cu-(I) acetylidene species 
via a stepwise process. This modification is known as the “click reaction”. It has 
found various applications in material and polymer science,34 specific labeling of 
bioconjugates,35 in monitoring enzyme activities and also in peptidomimetics.36 
The copper catalyzed cyclization has been applied to a range of carbohydrate 
modifications.35 A representative example is shown in Scheme 10.  
 
Scheme 10. Copper mediated Click reaction 
The 1,4-disubstituted 1,2,3-triazole units have been widely used to hold 
separate units together in complex glycosylated structures such as 
glycoconjugates, peptides and densely glycosylated molecular architectures 
including glycoclusters and  glycodendrimers.37-41 One of the major drawbacks of 
the Cu-(I)-catalyzed click coupling is the toxicity of copper, which limits its use in 
in-vivo applications. The toxicity issue was solved by Bertozzi et al who 
developed a strain-promoted cycloaddition in which the ring strain of the cyclic 
alkyne was used as a driving force to synthesize azido-functionalized 
glycoproteins (Scheme 11).42 However the slow rate of this reaction limits its 
potential use and more recently, Boons et al developed an another version of this 
9 
  
strain promoted cycloaddition for visualizing metabolically labeled 
glycoconjugates of living cells.43  
 
Scheme 11. Strain promoted cycloaddition of azido proteins 
In 2004 Schmidt and coworkers reported a facile synthesis of 
glycosylthiomethyl-1,2,3-triazoles using the click approach (Scheme 12).44 
 
Scheme 12. Synthesis of glycosylthiomethyl triazoles 
 
Complementary to the copper catalyzed click reaction the Ru-catalyzed 
azide-alkyne 1,3-dipolar cycloaddition has provided ready access to the 1,5-
disubstituted 1,2,3-triazoles.45-47 More recently Crich and Yang have utilized the 
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click approach to synthesize 1,2,3-triazole bridged dimeric oligosaccharides as 
shown in scheme 13.28 
 
 Scheme 13. 1,5-di substituted triazole bridged disaccharide  
1.2.2 Oxime formation 
Apart from the intramolecular electrophilic capture, several electrophile-
nucleophile pairs can be coupled selectively with one another under more 
feasible conditions. For example, aldehydes and ketones react with aminooxy 
groups, hydrazides and thiosemicarbazides to form oximes, hydrazones and 
thiosemicarbazones respectively as shown in Scheme 14.  
 
  Scheme 14. Chemoselective ligations involving carbonyl electrophiles 
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The enhanced nucleophilicity of the nitrogen atoms of the nucleophiles 
facilitate the reactions more favorable. The products are stable in pH 5-7 and 
have been extensively used in the formation of peptide conjugates,48-52 in vivo 
protein labeling53 and also in the generation of enzyme inhibitors.54-55  
1.3 Thiol nucleophiles 
The sulfhydryl group in cysteine has been used in reactions with a variety 
of electrophiles such as haloacetyl groups, maleimides, disulfides, sulfamidates 
and α,β-unsaturated esters because of its increased nucleophilicity. These 
reactions can be performed in water at neutral pH because these conditions are 
basic enough to supply a great amount of reactive thiolate species. More over, 
excellent selectivity can be reached in thiol-based ligations since thiolates are 
better nucleophiles compared to amines which are protonated at neutral pH. 
However the formation of thioether and disulfide bonds are not completely 
bioorthogonal chemoselective ligation reactions since many free thiol groups are 
present in the biological system and generally can only be used when competing 
sulfhydryl groups are not present. 
1.3.1 Thioesterification based chemoselective ligations 
In 1980 Hosein Hakimelahi and Just described a reaction involving the 
formation of an amide bond between azides and thioacids.56 The reaction 
proceeds via the formation of a thiatriazoline derivative through a [3+2] 
cycloaddition. Williams and coworkers applied this chemoselective ligation 
concept in the synthesis of β-glycosylamides as shown in scheme 15.57-60 
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Scheme 15. Mechanism of thioacid/azide amidation and its application   
In 2004 Schmidt et al applied this thioacid/azide amidation sequence in 
the synthesis of S-neoglycopeptides as shown in scheme 16.61  
 
Scheme 16. Synthesis of S-neoglycopeptides 
 
Furthermore, new chemoselective ligation reactions based on sulfonamide 
derivatives were developed utilizing the concept of the thioacid/azide reaction.59-
60 One of the recent reports which use the sulfonamide chemistry is the 
successful synthesis of glycosylated peptides by Crich et al (Scheme 17). 
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Scheme 17. Synthesis of a glycodipeptide through sulfonamide 
The thioesterification ligation has also been used in the functionalization of 
proteins.62 The 99-residue protein was synthesized by the ligation of C-terminal 
thiocarboxylic acid residue 72 with an N-terminal α-bromoacetamide residue 73 
(Scheme 18).  
 
Scheme 18. Synthesis of a 99-residue protein, a modified HIV-1 protease 
1.3.2 Thioetherification based chemoselective ligations 
Thioetherification is extensively used in the lipidation of proteins where a 
lipid group is covalently attached to the peptide chain. Lipidated proteins play 
numerous roles in biological processes including signal transduction, cell 
adhesion and membrane localization.63-65 N-Myristoylation, S-palmitoylation and 
S-isoprenylation are the three common types of lipid modifications in proteins.66  
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1.3.3 Synthesis of S-lipidated peptides 
  The synthesis of prenylated peptides in SPPS and in solution phase was 
successfully developed by different research groups. In 2005 Schmidt and 
coworkers have shown the efficient attachment of lipid groups to small peptides. 
This S-farnesylation and S-palmitoylation was accomplished by the SN2 
substitution of a bromide in bromoalanine containing peptide 75 with farnesyl 
thiol 76 (Scheme 19).67  
 
Scheme 19. Lipidation of small peptides 
Another elegant approach to introduce the farnesyl groups into peptides 
was developed by van der Donk et al.68 The conjugate addition of farnesyl thiol 
76 to the dehydroalanine 79 resulted in the formation of farnesylated peptide 80 
as shown in Scheme 20.  
 
Scheme 20. Farnesylation of small peptides 
The stereo control issue in the conjugate addition was addressed by using 
peptide containing aziridine-2-carboxylic acid by the same group on their 
subsequent work (Scheme 21)69. 
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Scheme 21. Farnesylation without racemization 
1.3.4 Synthesis of S-linked glycosyl amino acids and glycopeptides  
1.3.4.1 Alkylation of anomeric thiol 
Several methods have been developed for the synthesis of S-linked 
glycopeptides since after the first identification of a natural S-glycosidic linkage 
on a peptide. S-linked glycopeptides show enhanced chemical and enzymatic 
stability compared to their native congeners. 1-Thio sugars have been alkylated 
with halo amino acids to afford the corresponding S-linked glycosylpeptides 
(Scheme 22).70-75  
 
Scheme 22. Alkylation of anomeric thiol 
The direct alkylation strategy is complicated by the competing elimination 
to form dehydroalanine derivatives. However, Halcomb et al have addressed this 
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problem by using cyclic sulfamidate containing amino acid incorporated into 
peptides. The chemeoselective ligation of 1-thiosugar affords the desired S-
linked glycopeptides after the treatment with aqueous acid (Scheme 23). The 
acidic cleavage of the N-sulfate group limits its application for the synthesis of S-
linked glycoconjugates containing oligosaccharides and peptides. 
 
Scheme 23. Synthesis of S-linked glycopeptides 
Mitsunobu conditions 
Mitsunobu condensation has been applied in the synthesis of glycosylthio 
amino acids and peptides. The hydroxyl groups of N-Boc-serine methyl ester or 
N-Boc-threonine methyl ester were displaced by 1-thio glucosetetraacetate to 
provide the glycosylthio amino acids76 (Scheme 24). 
 
Scheme 24. Synthesis of glycosylthio amino acids by Mitsunobu 
condensation 
1.3.5 Michael Additions 
In 2001 van der Donk et al reported a convergent approach to the 
synthesis of S-linked glycopeptides by Michael addition of 1-thio sugars to Dha 
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containing peptides on both solution and solid phase (Scheme 25).68 The 
synthesis of four tumor assisted carbohydrate antigens Tn, T, STn and 2,6-ST 
was successfully achieved by this methodology.77  
 
Scheme 25. S-linked glycopeptides by Michael addition 
Recently, Davis and co-workers used mesitylenesulfonylhydroxylamine as 
a reagent for the oxidative elimination of Cys to Dha. Furthermore, the selective 
functionalization of proteins and peptides were achieved by utilizing this 
methodology (Scheme 26).78   
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Scheme 26. Modification of proteins by transformation of Cys to Dha 
1.4 Radical addition to form thioethers 
The radical initiated addition of thiols to alkenes to form thioethers is a 
common bioconjugation technique, particularly applied in the conjugation of 
glycans. The reactions can be induced photochemically or by the addition of a 
radical initiator. This method tolerates various functioanal groups present in 
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proteins and peptides and can be applied to their functionalization. Kunz et al 
have applied this method for the synthesis of synthetic vaccines by conjugation 
of glycopeptides to bovine serum albumin (BSA) which has been previously 
functionalized with alkene end groups as shown in Scheme 27.79 
 
Scheme 27. Radical induced thioether formation 
1.5 Synthesis of S-linked glycoprotein mimics 
1.5.1 Ligation via disulfide linkage 
The formation of a mixed disulfide is also an established ligation method 
and its application has been successful in different disciples.80-83 Disulfides, alkyl 
thiolsulfonates and thiopyridine mixed disulfides are the three types of available 
thiol modification reagents for protein mixed disulfides. A fundamental reaction 
involving protein thiol and alkyl alkanethiolsulfonates to form a mixed disulfide is 
shown in scheme 28.  
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Scheme 28. Protein mixed disulfide via alkyl alkanethiosulfonates 
 
Alkyl alkanethiolsulfonates had been used previously for the chemical 
synthesis of mixed disulfides84-86 of simple organic compounds by Boldyrev et 
al87 and Dunbar and Rogers.88 A closely related aryl arenethiolsulfonate had 
been used by Field and Giles to block a sulfhydryl group of creatine kinase.89  
Boons and Davis reported a highly facile method for synthesizing disulfide 
linked glycoproteins and glycopeptides with thioglycoside precursors by means of 
sulfenyl transfer reagents such as 5-nitropyridine-2-sulfenyl thioglycosides,83 
glycosyl methanethiosulfonates and glycosyl penylthiosulfonates (Schemes 29-
31).90-92 
 
 
Scheme 29. Disulfide linked glycoprotein 
 
 
Scheme 30. Disulfide linked glycoproteins through methanethiosulfonates 
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 Scheme 31. Disulfide linked glycoproteins through phenylthiosulfonates 
In an alternative approach to the disulfide ligation, selenylsulfide mediated 
protein glycoconjugation was approached by Davis et al.93 In two different 
approaches this method allowed glycoconjugation with mono and 
oligosaccharides of upto seven saccharide units in size at single and multiple 
sites in a variety of proteins (Scheme 32).  
 
 
Scheme 32. Selenylsulfide mediated protein glycoconjugation  
The oxidative coupling of thiosugars to cysteine containing peptides and 
proteins for the synthesis of glycopeptides and glycoproteins was developed by 
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Boons et al (Scheme 33).94 The homodimerization of the proteins is prevented by 
the use of excess thiosugars is the drawback to this method.  
 
Scheme 33. Glycoproteins synthesis through cysteine oxidation 
1.6 From Disulfides to thioether linked chemoselective ligations 
1.6.1 Allylic disulfide rearrangement 
Previous work by Moore and others showed that dialkyl or diaryl disulfides 
are unreactive with triphenylphosphine even under thermal conditions. However, 
the treatment of diallyl disulfide with triphenylphosphine in benzene at 80 °C gave 
diallylsulfide and triphenylphosphine sulfide.95 A similar reaction was observed 
when diallyl disulfide was treated with cyclic phosphoramidites under the same 
conditions.96 
Hofle and Baldwin reported that α-substituted allylic disulfides 124 and 
125 smoothly rearranged to the more stable isomer with double allylic inversion 
in benzene at room temperature (Scheme 34).97 
 
Scheme 34. Rearrangement of diallyl disulfides 
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The diallyl disulfide rearrangement occurs through a double [2,3]-
sigmatropic rearrangement proceeding via a thiosulfoxide intermediate which is 
closely related to the interconversion of allylic sulfoxides and sulfenates reported 
by Mislow.98-99 Pseudo first order rate constants measured by Höfle and Baldwin 
for different substituted allylic disulfides were consistent with the earlier work of 
Moore and Trego. The rate constant values and the negative entropy of 
activation are consistent with a cyclic transition state which favors two 
consecutive [2,3]-sigmatropic processes and are also similar in magnitude with 
allylic sulfenate to sulfoxide rearrangement .  
When no thiophile was involved, the mixed alkyl allyl disulfides were found 
to be stable at room temperature and even could be purified by distillation 
techniques. The disulfide and thiosulfoxide equilibrium strongly favors the allylic 
disulfides and is driven forward only by the addition of a thiophilic reagent 
(Scheme 35).  
 
 
Scheme 35. Pseudo first-order rate constants for phosphine mediated 
allylic rearrangement 
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The rate constant values for the phosphine promoted rearrangement 
measured by Baldwin et al led to the conclusion that increasing the bulk of R3, R4 
and R5 reduces the amount of thiosulfoxide whereas increasing the size of R1 
and R2 favor this intermediate and enhance the rate of formation of allylic sulfide. 
It was also observed that increasing the polarity of the medium favors the 
formation of the thiosulfoxide intermediate. The rate dependency with the 
substitution pattern was also observed by Moore and Trego in their earlier work. 
The disulfides 133 and 134 spontaneously excised the sulfur atom from the 
thiosulfoxide intermediate even at room temperature.    
The reverse direction of the reaction was described when allyl methyl 
sulfide (135a) or diallyl sulfide (135b) was heated with S8 gave the corresponding 
disulfides 139a and 139b with complete allylic rearrangement (Scheme 36). 
However, dialkyl sulfides were apparently inert toward the reaction with 
elemental sulfur even at 90 °C for several days under identical conditions. It was 
believed that the reaction occurs through a series of equilibria involving dipolar 
polysulfides and thiosulfoxide intermediates as shown in scheme 36. 
 
24 
  
Scheme 36. Reaction of allyl methyl sulfide and diallyl sulfide with S8 
1.7 Allylic selenosulfide rearrangement 
In 1972 Sharpless and Lauer reported that di(geranyl) diselenide (140), a 
diallyl diselenide transformed to geranyl linalyl selenide (141) on treatment with 
excess triphenylphosphine in chloroform indicating the selenium version of the 
disulfide reaction was faster than the original sulfur protocol (Scheme 37).100 The 
reaction proceeded with a half life of 2.5 h. Subsequently, Guillemin et al 
successfully characterized a range of allylic diselenides and studied their 
reactions with tributylstannane, indicating such diselenides have moderate 
stability at room temperature.101 
 
Scheme 37.  Rearrangement of digeranyl diselenide to geranyl linalyl 
selenide 
Taking these facts into account and also considering the practical 
advantages of the disulfide ligation and the disadvantages of its impermanence 
Crich et al developed a new chemical ligation technique in which one of the sulfur 
atoms in the allylic disulfide was replaced with a selenium atom.102 In the allylic 
disulfide rearrangement reported by Hofle and Baldwin the equilibrium favors the 
allylic disulfide and the reaction is driven in the forward direction either by 
another rearrangement or a thiophilic reagent under heating. Crich et al 
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hypothesized that the allylic selenosulfide rearrangement might proceed through 
a selenosulfoxide intermediate in which the weaker Se–S bond would result in 
the formation of the rearranged sulfide at room temperature with or without the 
help of triphenylphosphine (Scheme 38). 
 
 
 
Scheme 38. Chemical ligation via Se-allyl selenosulfide 
 This hypothesis was validated and led to the development of new 
permanent chemical ligation method for thiols.102 However, the tedious procedure 
for the synthesis of Se-allyl seleno Bunte salts and the slow addition of thiols to 
them required to obtain selenosulfides in the original proof of concept needed to 
be addressed. The further development of this novel selenosulfide ligation was 
as one of the outset of the work leading to this thesis. The results obtained in this 
area are described in Chapter II.  
1.8 Thioether linked glycoproteins from disulfide bonds 
 The seminal work by Moore and Trego95 and Baldwin97 followed by the 
studies directed by Harpp et al103 on the contraction of disulfide and peroxide 
linkages with P(III) reagents proved that a process for desulfurization from 
disulfide linkage to thioether derived anologues is possible. More recently, Davis 
and coworkers have applied this concept to practice by synthesizing thioether 
linked glycoconjugate from disulfide linked glycosyl peptides and proteins. This 
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strategy is compatible with uprotected sugar residues involving elimination-
conjugate addition of thiol similar to Michael addition (Scheme 39). 
 
Scheme 39. Conversion of disulfide to thioether linked glycopeptides 
1.9 Transition metal based chemoselective ligations  
 Transition metal mediated reactions have the potential for selective 
bioconjugation techniques. Many transition metal catalyzed reactions can be 
optimized to proceed under mild reaction conditions with high chemeoselectivity 
and excellent functional group tolerance. An early example of transition metal 
catalyzed protein modification was developed by Kodadek et al.104 This oxidative 
cross-linking method utilizes a high valent transition metal complex that initiates 
the reaction by abstraction of an electron from a tyrosine residue. The resulting 
tyrosyl radical then couples to nearby functional groups, joining the two residues 
through covalent linkages. In many cases the second reactive partner is also 
believed to be a tyrosine residue (Scheme 40). 
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Scheme 40. Transition metal catalyzed oxidative cross-linking 
 A number of catalytic systems have been developed to promote the 
oxidative cross-linking process. One of the first examples of using transition 
metals to covalently attach small molecules to natural amino acids was 
developed by Antos and Francis.105-106 This method uses in situ generated 
rhodium carbenoids to selectively modify tryptophan side chains in aqueous 
medium (Scheme 41). 
 
Scheme 41. Tryptophan modification with rhodium carbenoids 
 However, Crich and co-workers have later demonstrated that the rhodium 
carbenoid insertion reaction is not fully compatible with S-allylated peptides.107 
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Apart from the copper and ruthenium catalyzed formation of triazoles, palladium 
mediated cross coupling reactions such as Sonogashira, Stille, Heck and Suzuki-
Miyuara have been broadly used to provide a wide regime of potential 
chemoselective ligation reactions. In 2006 Francis and co-workers have shown 
new tyrosine modification using π-allyl palladium complexes where hydrophobic 
moieties such as farnesyl groups were attached to a tyrosine residue of a protein 
as shown in Scheme 42.108  
 
 
Scheme 42. Tyrosine modification with π-allyl palladium complexes   
1.9.1 Metal mediated glycoconjugation 
 Transition metal mediated reactions have found wide applications in 
carbohydrate chemistry. Palladium mediated cross couplings and their 
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applications toward chemoselective ligations in carbohydrate chemistry were 
developed by various research groups. In 1998 Lowary et al developed carbon-
linked glycopeptides through Sonogashira coupling of glycosyl acetylenes with 
aromatic iodides.109 Palladium or nickel mediated synthesis of unsaturated aryl 
C-glycosides through a π-allyl methodology was reported by Sinou and co-
workers.110-111 More recently, Davis and co-workers have demonstrated the Pd-
mediated Suzuki-Miyaura cross coupling for protein bioconjugation in aqueous 
media. An illustrative example showing the synthesis of a synthetic glycoprotein 
is shown in scheme 43.112 
 
Scheme 43. Palladium mediated protein bio-conjugation 
 Metals like chromium, molybdenum, tungsten, cobalt and rhodium have 
also been utilized in glycoconjugation. The rhodium catalyzed cyclotrimerization 
reaction to synthesize an aryl C-glycoside which is structurally related to the 
papulacandin natural product was reported by McDonald et al.113 Recently, Crich 
and coworkers have reported the rhodium catalyzed reaction for the ligation of 
diversely functionalized residues through a modified Kirmse-Doyle reaction.107 
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This methodology was further extended to the synthesis of thioether linked 
neoglycopeptides as shown in scheme 44. 
 
Scheme 44. Kirmse-Doyle reaction mediated formation of thioether linked 
synthesis of neoglycopeptides 
2.0 Goal of this thesis 
 The work described in this thesis was undertaken with a distinct goal in 
mind namely the development of new chemical ligation techniques for the 
permanent modification of thiols. Thus, as described in Chapter II, investigations 
were carried out on the further development of the selenosulfide ligation for the 
modification of cysteine thiols and cysteine containing small peptides. Chapter III 
deals with the investigations conducted while revisiting the allylic disulfide 
rearrangement for the primary thiol modifications with a view to designing 
phosphine free reagents to promote this rearrangement. Continuing this theme, 
Chapter IV describes the application of the newly invented silver mediated allylic 
desulfurative rearrangement to the chemoselective ligation of mono and 
disaccharides in the synthesis of β-(1,3)-glucan mimics.  
 
31 
  
CHAPTER II. Dechalcogenative Allylic Selenosulfide Rearrangement; 
Modification to Cysteine Thiols 
2.1 Selenosulfides via selenocyanates 
 Despite the mild nature of the disulfide ligation and its established 
chemoselectivity for thiols the method finds only limited use because the disulfide 
linkage is susceptible to attack by thiols and reducing agents. Taking these 
problems into consideration recently, Crich and coworkers developed a new 
modification designed to provide a stable and permanent ligation as set out in 
Scheme 38.102 This ligation proceeds with the formation of Se-allyl selenosulfides 
which on rearrangement lose the selenium atom to form the rearranged allyl 
sulfide. However, this chemistry has its own drawbacks, the most pertinent of 
which is the need to synthesize the Se-allyl seleno Bunte salts as precursors to 
the intermediate selenosulfides. The synthesis involves heating potassium sulfite 
to reflux with selenium powder in an ethanol/water mixture to give the potassium 
selenosulfite as shown in Scheme 45.  
 
Scheme 45. Synthesis of Se-allyl seleno Bunte salt 
 The potassium selenosulfite was then heated with allyl halides to give the 
corresponding Se-allyl seleno Bunte salts as orange solids which are not stable 
and should immediately be converted to Se-allyl selenosulfides. The attempted 
purification of these Bunte salts led to rapid decomposition with selenium 
extrusion. The low yields observed for the selenosulfides indicate the 
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experimental difficulties and the stability associated with the intermediates, Se-
allyl seleno Bunte salts. Moreover, selenosulfide formation could be achieved 
only by the slow addition of thiols to 10-15 equivalents of Bunte salts. 
 This inefficient protocol with the Se-allyl seleno Bunte salts prompted the 
search for an easier way to prepare the selenosulfides. The preparation and 
handling of allyl selenols is difficult, hence the idea of forming allyl selenosulfides 
from the reaction of allyl selenols with disulfides was not investigated.101 
However, it was anticipated that Se-allyl selenosulfides can be obtained in a 
simple way by the treatment of allyl selenocyanates with thiols. Earlier, Riague 
and Guillemin prepared several allylic selenocyanates and reported their 
purification.101 Simple diaryl selenosulfides and diselenides also had been 
prepared by the reaction of phenyl selenocyanates and ary thiols as reported by 
Clark et al.114 Thus, following the literature procedure, allyl selenocyanate and 
methallyl selenocyanate were prepared as shown in Scheme 46.101  
 
Scheme 46. Synthesis of allyl and methallyl selenocyanates 
 Allylic thiocyanates undergo [2,3]-sigmatropic rearrangement to the 
corresponding allylic isothiocyanates within hours at room temperature, but it was 
found that these allylic selenocyanates could be stored for a long period.115-116 
Accordingly, various substituted allyl selenocyantes were prepared by treating 
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the corresponding allyl halides with potassium selenocyanate in acetone under 
N2 atmosphere at ambient temperature (Scheme 47).  
 
 
Scheme 47. Synthesis of various selenocyanates 
 The evaporation of acetone and work-up with ethylacetate and water 
leaves the selenocyanates in organic portion. Evaporation of the solvent leaves 
the crude selenocyanates. Unlike the Se-allyl seleno Bunte salts, the 
selenocyanates were very stable and did not excise selenium on storage. The 
allyl selenocyanates were obtained in higher yields compared to the Se-allyl 
seleno Bunte salts. A comparison of yields for the formation of Se-allyl seleno 
Bunte salts and selenocyantes is presented in Table 1. 
Entry 
 
         Allyl 
halide 
 
Se-allyl seleno 
Bunte salts 
 
Yield 
 
Selenocyanates 
 
Yield 
1 
 
 
 
 
171 
 
 
 
 
 
170 
 
 
 
56 
 
 
 
 
176 
 
70 
 
34 
  
2 
 
 
 
 
172 
 
 
 
177b 
 
 
58 
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70 
 
 
3 
 
 
 
173 
 
 
 
178b 
 
 
40 
 
 
 
 
178 
 
80 
 
4 
 
Cl
  
174 
 
 
179b 
 
 
35 
 
 
 
                                179 
85  
5 
 
 
 
175 
 
 
 
 
180b 
 
 
        
      28 
 
 
 
 
 
180 
 
 
75 
 
 
Table 1. Comparison of yields for the formation of Se-allyl seleno Bunte 
salts and selenocyanates 
2.2 Selenosulfide ligation via allylic selenocyanates 
2.2.1 Application to simple thiols cysteine thiols  
A schematic representation of the reaction between allyl selenocyanates 
and thiols and the subsequent ligation is shown below.  
 
Scheme 48. Chemical ligation via Se-allyl selenosulfides obtained from 
selenocyanates 
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The reaction of allyl selenocyanates with simple thiols was chosen for 
initial study. The reaction of allyl selenocyanate with primary aliphatic thiols 
produced the allylic selenosulfides which rearranged smoothly to allylic sulfides 
in methanol at room temperature without the help of triphenylphosphine, thereby 
establishing that the rearrangement and the subsequent loss of selenium could 
be performed at room temperature (Entries 1 and 2, Table 2). However the 
reaction of hexadecane-1-thiol (201) with geranyl selenocyanate required 
triphenylphosphine to give the rearranged linalyl sulfide 205 (Entry 3, Table 2).  
Entry 
 
           Thiol                   
 
    Selenocyanate 
 
                  Product 
 
Yield 
1 
 
 
              181 
 
 
176 
 
 
184 
 
70 
 
2 
 
 
             182 
 
 
176 
 
 
185 
 
 
70 
 
 
3 
 
 
183 
 
 
178 
 
186 
 
70 
 
 
Table 2. Allylation of simple thiols with allyl selenocyanates 
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2.2.2 Application to cysteine thiols 
Subsequently, the attachment of allyl and substituted allyl groups to cysteine 
derivatives was examined. Unlike the large quantity of Se-allyl seleno Bunte salts 
needed in the first generation method, equimolar amount of simple allyl and 
methallyl selenocyanates (Entries 1 and 2, Table 3) were sufficient to complete 
the reaction, proving the selenocyanate methodology could be a convenient way 
to introduce lipid units to cysteine and cysteine containing peptides. In contrast to 
the allyl and methallyl selenocyanates, geranyl selenocyanate required 
triphenylphosphine for the introduction of linanyl group to cysteine. The reaction 
of Boc-L-Cys-OEt (208) with geranyl selenocyanates 198 took place with the 
formation of a new stereogenic center, which was obtained as a 1:1 mixture of 
two diastereomers. (Entry 3, Table 3). 
Entry 
 
           Thiol                   
 
    Selenocyanate 
 
             Product 
 
Yield 
1 
 
 
              187 
 
 
 
176 
 
 
189 
 
80 
 
2 
 
 
 
             188 
 
 
 
177 
 
 
190 
 
 
68 
 
 
3 
 
188 
 
 
 
178 
 
Boc-HN CO2Et
S
      191 
 
66 
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Table 3. Allylation of cysteine thiols with allyl selenocyanates 
2.2.3 Application to cysteine containing peptides 
Functionalization of cysteine containing tripeptides like Boc-(α-OMe)- γ-L-
Glu-L-Cys-Gly-OMe (212) and Boc-L-Cys-L-Ala-L-Trp-OMe (213) was explored 
with the selenocyanate methodology (Table 4). The transfer of allyl and methallyl 
groups to these peptides did not require phosphine. However, geranyl and 
farnesyl selenocyanates 198 and 199 needed triphenylphosphine to effect the 
rearrangement into linalyl sulfide and nerolidyl sulfide respectively. The observed 
difficulty in the latter rearrangements is caused by the transformation of stable 
prenyl system into less stable isoprenyl system (Table 4, Entry 3, 5 and 6). This 
result parallels that of Hofle and Baldwin who had earlier observed a similar 
behavior of allylic disulfides with the prenyl system undergoing the phosphine 
promoted rearrangement slowly. Nevertheless, it is noteworthy that the seleno 
sulfide rearrangement for cysteine functionalization is compatible with the indole 
nitrogen in tryptophan (Entry 4, 5 and 6, Table 4).  
 
Entry 
 
           Thiol                   
 
    Selenocyanate 
 
              Product 
 
Yield 
1 
 
 
              192 
 
 
 
176 
 
 
194 
 
75 
 
2 
 
 
              192 
 
 
 
177  
195 
 
 
71 
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O
H
N
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O
NH
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193 
 
 
179 
 
 
 
199 
 
 
 
 
40 
 
 
Table 4. Application to cysteine containing tripeptides 
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2.3 Application of selenocyanate methodology to the allylation of a protein 
  Pleasingly, Davis and coworkers have used this selenocyanate 
methodology to allylate a protein for its subsequent use in olefin metathesis.117 In 
this application the allyl selenocyanate (196) was treated with a single-cysteine 
mutant of subtilisin from Bacillus lentus (SBL-S156C). The intermediate Se-allyl 
selenosulfide was formed and even was detected by ESI mass spectroscopy. 
The intermediate then smoothly rearranged to S-allyl cysteine 201 over a period 
of 2 h as shown in Scheme 49.  
 
Scheme 49. Cysteine specific allylation via selenocyanate method 
Davis et al have shown that the S-allyl cysteine 201 could be conveniently 
employed in olefin cross-metathesis (Scheme 50). 
 
Scheme 50. Cross metathesis at S-allyl cysteine 
2.4 Application to a fluorous system 
The selenocyanate methodology was further extended to the incorporation 
of a fluorous tag to a cysteine containing peptide. The fluorous tagged methallyl 
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selenocyanate 180 was synthesized according to Scheme 54. Thus, the 
commercially available fluorous aldehyde 203 was treated with a Mannich base 
to give the vinyl aldehyde 204. This aldehyde was reduced with sodium 
borohydride in methanol to give the alcohol 205 in 81% yield. The allyl alcohol 
was converted to allyl bromide 175 by treatment with triphenylphosphine and 
carbontetrabromide. Finally the fluorous bromide thus obtained was treated with 
potassium selenocyanate in acetone at room temperature to give the 
corresponding fluorous selenocyanate 180 in 75% yield (Scheme 51). 
 
Scheme 51.  Synthesis of a fluorous selenocyanate 
The fluorous substituted methallyl selenocyanate 180 when treated with 
Boc-L-Cys-L-Ala-L-Trp-OMe (193) formed the selenosulfide intermediate. Unlike 
the simple methallyl system, this fluorous methallyl selenocyanate required 
triphenylphosphine to yield the rearranged product 206 at room temperature as 
shown in Scheme 52. 
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Scheme 52.  Allylation with a fluorous tag by the selenocyanate method 
2.5 Application to carbohydrate chemistry 
        To test the ligation in carbohydrate based thiols, the simple allyl 
selenocyanate 196 was reacted with 1-thio-β-D-glucose tetraacetate (90) to give 
the corresponding seleno sulfide intermediate. The rearrangement of this 
anomeric selenosulfide proceeded slowly at room temperature over a period of 
days butwas accelerated by increasing the reaction temperature to 65 °C to give 
the product 230 as shown in Scheme 53. This rearrangement took place with 
complete retention of the anomeric stereochemistry, and serves to highlight the 
application to carbohydrate based thiols. 
 
Scheme 53. Ligation reaction of anomeric thiol 
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2.6 Effect of various substituents on allylic selenosulfide rearrangement 
2.6.1 Rearrangements requiring triphenylphosphine 
 The selenosulfide ligation proceeds through an unfavorable equilibrium 
with a selenosulfoxide via a reversible [2,3]-sigmatropic rearrangement. The 
triphenylphosphine removes the selenium atom from the transient 
selenosulfoxide to drive equilibrium in the forward direction as shown in Scheme 
54, when selenium loss is not spontaneous. 
 Unlike the allyl and methallyl selenocyanates, the geranyl and farnesyl 
selenocyanates required triphenylphosphine for rearrangement into linalyl and 
nerolidyl groups (Scheme 54). The difficulty in the latter rearrangements reveals 
the fact that the substituents have a major role in this deselenative allylic 
rearrangement. This is in accordance with the work of Baldwin et al who studied 
the rate constants for rearrangements of the related various substituted allylic 
disulfides.97 The phosphine mediated rearrangement of geranyl and farnesyl 
selenosulfides is shown in Scheme 54.  
 
Scheme 54. Effect of substitution pattern on selenosulfide rearrangement 
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 More recently, Liu et al have studied computationally the effect of the 
substitution pattern on the allylic disulfide rearrangement118 and as the 
selenosulfides follows a parallel mechanism. Therefore, it is reasonable to 
extrapolate their conclusions to it. Thus, for the allylic disulfide rearrangements 
these workers computed that substituting two methyl groups for hydrogen at R3 
would increase the free energy barrier by 1.8 kcal/mol thereby slowing down the 
rearrangement 10 fold at room temperature118. This prediction is in line with the 
earlier experimental results of Baldwin et al who hypothesized that the increased 
bulk at R3 reduces the concentration of thiosulfoxides in the equilibrium between 
alkyl allyl disulfides and thiosulfoxides.97 In geranyl and farnesyl selenocyanates 
studied here, substitution at R3 has a significant effect on the deselenative allylic 
rearrangement. Thus, by analogy, in this series, the prenyl type substituents at 
R3 significantly increase the energy barrier to the rearrangement. In the simple 
allyl and methallyl selenocyanates where R3 is hydrogen, the energy barrier is 
lower and the selenium atom is spontaneously excised from the selenosulfoxide 
intermediate.  
 The allylation of anomeric thiol proceeds slowly at room temperature but 
the reaction can be caused to take place at higher temperatures. This is best 
rationalized by the involvement of the sulfur atom in the anomeric thiol in an 
exoanomeric interaction. In agreement with the experimental work, Liu et al 
observed a higher energy barrier (23.2 kcal/mol) for a rearrangement involving 
an anomeric thiol derived allylic disulfide. In case of fluorous selenocyanate 
(Entry 7, Table 8), the relatively slow rearrangement is the result of the electron 
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withdrawing substituent disfavoring the formation of the selenosulfoxide 
intermediate shown in Scheme 39. The various selenosulfide rearrangements 
found to require triphenylphosphine are listed in Table 5. 
Entry 
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O
H
N
S
O
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HN
CO2Me
C6F13
206 
65 
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                 91 
 
 
 
 
176 
 
 
 
207 
 
55 
 
Table 5. Rearrangements required triphenylphosphine 
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2.7 Attempts toward the synthesis of S-linked glycoconjugates through 
selenocyanate methodology 
 With a view to the formation of various glycoconjugates attention was next 
focused to the synthesis of cyclic selenocyanates based on a pyranose skeleton 
(Scheme 55).      
 
Scheme 55. Schematic pathway for an S-glycoconjugate through 
selenocyanate 
It was envisaged that the glycoconjugate 208 could be obtained from the 
rearranged product 209 derived from the coupling of the sugar allyl 
selenocyanate 211 with the cysteine containing peptide 212. The synthesis of the 
sugar allyl selenocyanate donor 211 began with the isopropylidenation of the 
commercially available methyl α-D-glucopyranoside (213) using 2,2-
dimethoxypropane and p-toluene-sulfonic acid, followed by benzylation with 
sodium hydride and benzyl bromide. Finally deacetylation in 60% aqueous acetic 
acid afforded the methyl 2,3-di-O-benzyl-α-D-glucopyranoside (214) in 50% 
yield.119 Regioselective oxidation of the primary 6-hydroxyl group with sodium 
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hypochlorite in the presence of catalytic amount of TEMPO120 afforded the 
corresponding carboxylate, which was esterified in acidic methanol to give the 
methyl ester 215 in 75% yield (Scheme 56). 
 
 
Scheme 56. Synthesis of methyl ester 
Acetylation of 215, with pyridine and acetic anhydride, followed by β-
elimination with DBU gave the corresponding α,β-unsaturated ester 216 in good 
yield. A subsequent LAH reduction gave the allyl alcohol 217 as shown in 
Scheme 57. 
 
Scheme 57. Synthesis of allyl alcohol 
 The allyl alcohol 217 was treated with carbon tetrabromide and 
triphenylphosphine121-122 to give the allyl bromide123 218 in 80% yield. The allyl 
selenocyanate 211 was formed cleanly when the bromide was treated with 
potassium selenocyanate in acetone at room temperature (Scheme 58). 
48 
  
 
Scheme 58. Synthesis of sugar selenocyanate 
 Initially the reaction of a simple cysteine thiol with this sugar 
selenocyanate 211 was chosen as a model reaction. When the selenocyanate 
was treated with N-Boc-L-Cys-OEt (188) in methanol the selenosulfide 
intermediate 219 was smoothly formed over a period of 2 h. The solvent was 
removed and the crude product was even purified over silica gel to give the sugar 
selenosulfide in 65% yield and its structure was confirmed by 1H NMR and 13C 
NMR spectroscopy and ESI mass spectroscopy (Scheme 59).  
 
Scheme 59. Synthesis of a selenosulfide 
 The sugar selenosulfide 219 did not extrude the selenium spontaneously 
unlike the simple allyl and methallyl selenosulfides. Therefore, 
triphenylphosphine was added to promote the rearrangement, unfortunately, the 
symmetrical diselenide 220 was obtained instead of the desired rearrangement 
(Scheme 60). Treatment of 219 with piperidine which was successful in driving 
the rearrangement of some allylic disulfides had no effect in this particular case.     
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Scheme 60. Reaction of triphenylphosphine on selenosulfide 
 It would appear that the electron-rich nature of the enol ether double bond 
is sufficient to retard the rearrangement. The parallel can again be drawn with the 
computational studies of Liu et al who noted the effect of various substituents on 
the allylic disulfide rearrangement. Thus the electron rich enol ether with its 
unfavorable polarity increases the energy barrier to the 2,3-sigmatropic 
rearrangement which retards the formation of the selenosulfoxide intermediate. 
This being the case competing reactions encroach and the nucleophilic attack of 
triphenylphosphine on selenosulfide 219 produced the symmetrical diselenide 
220 (Scheme 60). 
2.8 Secondary selenocyanates 
 Bearing in mind the above synthesis, a second approach to the synthesis 
of the S-linked glycoconjugates that avoids the use of enol ethers was planned 
as shown in Scheme 61. Thus, the possibility that the secondary selenocyanate 
213 and the cysteine containing peptide 212 would form a selenosulfide capable 
of undergoing the desired rearrangement was investigated.  
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Scheme 61. Alternate way for the S-linked glycoconjugates 
 The synthesis of the sugar selenocyanate started with the commercially 
available methyl α-D-glucopyranoside (213) which was treated with tert-
butyldimethylsilyl chloride and imidazole in dry DMF to protect the primary 
hydroxyl group.124 According to literature procedure, the triol 224 was treated 
with dibutyltin oxide to form the tin acetal.125 The acetal was transformed to the 
corresponding ester regioselectively by treatment with benzoylchloride and 
triethylamine to afford the vicinal diol125 225 in 80% yield as shown in Scheme 
62.  
                                  
Scheme 62. Synthesis of vicinal diol 
 The vicinal diol 225 was refluxed in toluene with iodoform, 
triphenylphosphine and imidazole to give the olefin125 226 in 90% yield. The 
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treatment of 226 with catalytic sodium in dry methanol produced the allyl alcohol 
227 quantitatively. The allyl alcohol 227 was treated with methanesulfonyl 
chloride and Hunig’s base in dichloromethane to give the mesylate 228 as shown 
in Scheme 63.  
 
Scheme 63. Synthesis of an allyl mesylate 
 The initial attempts to synthesize the selenocyanate by the nucleophilic 
displacement of the mesylate 228 with potassium selenocyanate under ambient 
conditions were unsuccessful. However, the treatment of the mesylate with 
potassium selenocyanate in refluxing THF gave an inseparable mixture of 
selenocyanates 229 and 230 in poor yield (Scheme 64). 
 
Scheme 64. Synthesis of a secondary selenocyante 
 As the nucleophilic substitution of the secondary mesylate proved to be 
difficult, the displacement of the corresponding allyl bromide with KSeCN was 
attempted. The allyl alcohol 227 when treated with carbon tetrabromide and 
triphenylphosphine gave the corresponding bromide 231 in 52% yield. However 
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no product was observed when the allyl bromide 231 was treated with potassium 
selenocyanate at room temperature. When the reaction was carried out in 
refluxing THF, mixture of selenocyanates was formed as shown in Scheme 65. 
 
Scheme 65. Reaction of a sec-bromide with KSeCN  
 The mixtures of secondary selenocyanates obtained in these reactions 
were in accordance with a result reported by Sharpless who attempted to 
prepare secondary selenocyanate 232 and selenide 233 but obtained only the 
rearranged primary isomers with selenium bound to the primary carbon.100 This is 
attributed to the instability of the secondary selenides which were converted to 
the primary selenides via a rapid [1,3]-sigmatropic rearrangement (Scheme 66). 
 
Scheme 66. Rearrangement of secondary selenocyanates and diselenides 
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2.9 Conclusion 
 Allylic selenocyanates were shown to bear important precursors for 
functionalization of thiols by the selenosulfide rearrangement. The tedious 
experimental procedure and instability associated with the Se-allyl seleno Bunte 
salts is avoided by use of the selenocyanates, which makes them an excellent 
alternative. However the attempted syntheses of S-linked glycoconjugates 
through the selenocyanate pathway revealed two major limitations. The 
incompatibility of electron-rich alkenes such as enol ethers and the instability of 
secondary and tertiary allylic selenocyanates. These limitations prompted further 
investigations on the allylic disulfide rearrangement which are described in the 
next chapter.  
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CHAPTER III. Desulfurative Allylic Disulfide Rearrangement 
3.1 Background and significance  
 The deselenative allylic rearrangement of primary allyl selenosulfides was 
best employed for the introduction of tertiary allyl sulfides. However, the 
introduction of geranyl or farnesyl groups failed due to the instability associated 
with the secondary selenocyanates and the selenides. This prompted the 
revisitation of the allylic disulfide rearrangements. Ideally, the application of 
dechalcogenative allylic selenosulfide or disulfide rearrangements towards the 
functionalization of peptidyl thiols would be conducted in a phosphine free 
manner. Therefore, studies described in this chapter were directed toward two 
goals. Firstly, the synthesis of secondary and tertiary allylic disulfides for the 
introduction of primary thio ether groups and secondly the elaboration of a 
phosphine free desulfurative allylic rearrangement such as might be applicable 
for the application of this novel ligation to biologically relevant systems. 
3.2 Drawbacks of triphenylphosphine 
 It was observed in the Crich laboratory, as exemplified in Scheme 69, the 
reaction of octyl geranyl disulfide 236 with triphenylphosphine proceeds in 
toluene at 110 °C by the desired rearrangement pathway to give the octyl linalyl 
sulfide 237. However, the treatment of phenyl geranyl disulfide 238 with 
triphenylphosphine under the same conditions gave only phenyl geranyl sulfide 
239 (Scheme 67).126 
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Scheme 67. Effect of triphenylphosphine 
 The second of these two reactions appeared to be a simple desulfurization 
rather than a dechalcogenative allylic disulfide rearrangement. The 
desulfurization reaction of organic disulfides with amino phosphines involving an 
Arbuzov type mechanism was proposed by Harpp et al103 involving nucleophilic 
attack of phosphine on the disulfide as shown in Scheme 68. The attack of the 
thiolate anion on the phosphonium intermediate results in the formation of phenyl 
geranyl sulfide 239. 
S
S
238
S
239PPh3
S
PPh3
S
- PPh3
 
Scheme 68. Arbuzov type mechanism in the formation of phenyl geranyl 
sulfide 
3.2.1 Use of other thiophilic reagents 
The use of morpholine or piperidine to drive the allylic sulfoxide/sulfenate 
rearrangement, and the reaction of molecular sulfur atom by allylic sulfides was 
known in the literature99,127 and was extended by the Crich group to the 
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desulfurative allylic disulfide rearrangement. Thus, when the allyl disulfide 
derived from the disulfide 240 was treated with benzene ethanethiol the 
intermediated disulfide rearranged to the corresponding allyl sulfide 241 on 
treatment with 2 equiv piperidine at room temperature in methanol.126 The 
rearrangement of allyl aryl disulfides to allyl aryl sulfides was also successful with 
piperidine (Scheme 69). However, in both the cases only moderate E/Z 
selectivity was obtained. 
S PhCH2CH2SH
piperidine
SCH2CH2Ph
HO
62%
E/Z; 2.6:1
240 241
240
piperidine
Me SH
Me S OH
66%
E/Z; 2.5:1242
SBt
OH
S
SBt
OH
 
Scheme 69. Rearrangement with piperidine 
 It also was found in the Crich laboratory that the rearrangement of allyl 
aryl disulfides to allyl aryl sulfides could be accomplished in refluxing methanol 
without recourse to phosphines or any other external reagent to give exclusively 
E selective products.126 For example, when the secondary allylic disulfide 240 
was refluxed in methanol with various aromatic thiols, the rearranged aryl allyl 
sulfides were obtained as shown in Scheme 70. 
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Scheme 70. Rearrangement with refluxing methanol 
Unfortunately the refluxing conditions required to promote the desulfurative 
rearrangement without phosphine exclude application to peptidyl thiols and thiols 
containing polysaccharide units. Other methods, perhaps using metal catalysis, 
were therefore sought but first simple model systems had to be prepared.  
3.3 Synthesis of secondary allylic disulfides 
 The allylic desulfurative rearrangement proceeds through a reversible 
[2,3]-sigmatropic rearrangement, in which the thiophilic reagent removes one 
atom of sulfur from the transient thiosulfoxide intermediate. As observed by 
Baldwin97 and the recent computational studies by Liu et al118 have shown that 
the disulfide rearrangement is principally dependent on the substituents on the 
allylic carbon to which sulfur is attached (Scheme 35). With a secondary or 
tertiary disulfide the rate constants for the desulfurative rearrangement at 60 °C 
in benzene are several orders of magnitude higher than rearrangements of 
primary disulfides. Recently, the synthesis of a secondary allylic disulfide was 
reported by Crich and Yang as shown in Scheme 71.128 The synthesis began 
with the commercially available cis-but-2-ene-1,4-diol which was converted to 
mono silyl ether. The alcohol 244 was converted to allylic thiolcarbamate 247 in 
two steps and the obtained thiol carbamate was cleaved by the treatment with 
ethanolamine in THF. The crude thiol was treated with 2,2’-di(1,3-benzothiazolyl) 
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disulfide to give the allylic disulfide 248 in 40% for the two steps. The protecting 
group was then cleaved by the acidic hydrolysis to give the sulfenyl donor 240 in 
70% yield (Scheme 71). 
 
Scheme 71. Earlier method for the synthesis of a secondary allyl disulfide 
3.3.1 Modified synthesis of a secondary allylic disulfide 
 A modified synthesis of pyridyl containing secondary allylic disulfide was 
planned for an efficient scale-up. The synthesis began with the commercially 
available 3,4-dihydroxybutene (249) which was readily converted to the cyclic 
thiocarbonate 250 with thiophosgene and pyridine in the presence of DMAP. The 
thiocarbonate 250 was subjected to the Newman-Kwart129 rearrangement to give 
the thiolcarbonate 251 in excellent yield.  The palladium catalyzed rearrangement 
was very efficient in ethanol as compared to the complex thermal processes.130-
133 After careful investigations it was observed that the thiol carbonate could be 
converted to the secondary disulfide in a two-step protocol. Thus the cyclic 
thiolcarbonate 251 was reduced with lithium aluminum hydride and the resulting 
mecapto alcohol was immediately converted to the corresponding pyridyl 
disulfide 252 by treatment with 2,2’-dipyridyl disulfide in 45% yield as shown in 
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Scheme 72. The low yield was attributed to the oxidation of the resulting 
mercapto thiol under basic conditions.   
 
Scheme 72. Efficient synthesis of a secondary allyl disulfide 
3.3.2 Synthesis of tridecenyl containing allylic disulfide 
 The synthesis of tridecene containing secondary allylic disulfide was 
accomplished according to the known procedure.134 The trans-2-tridecen-1-ol 
(253) was converted to allylic xanthate 254 and advanced to dithiocarbonate 255 
via a thermal [3,3]-sigmatropic rearrangement. The dithiocarbonate group in 255 
was then cleaved using ethanolamine to afford the secondary thiol. The thiol was 
treated with dipyridyl disulfide in methanol at room temperature to give the 
secondary allylic disulfide 256 as a sulfenyl donor. The disulfide was further 
purified by column chromatography over silica gel in 80% yield (Scheme 73).  
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Scheme 73. Synthesis of a secondary allylic disulfide 
3.4 Synthesis of a tertiary allyl disulfide 
Similarly, the sulfenating agent 260 was synthesized from the commercially 
available trans,trans-farnesol (257) according to the known procedure.134 The 
thiol carbamate 259 was reduced with lithium aluminum hydride in diethyl ether 
to give the tertiary thiol in 83% yield. The crude thiol was immediately treated 
with bis(benzothiazolyl)disulfide to the corresponding benzothiazolyl disulfide 260 
to avoid the [1,3]-shift of the the tertiary thiol to the stable primary isomer under 
basic conditions as reported by Hackler et al (Scheme 74).135 
OH O
S
NMe2
1) NaH, ClCSNMe2
85%
S O
NMe2
S
SBt
85%
1) LiAlH4, Et2O, 83%
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Scheme 74. Synthesis of a tertiary allylic disulfide 
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3.5 Application of secondary and tertiary allylic disulfides 
With the successful synthesis of secondary and tertiary allylic disulfides in hand, 
the search for a completely phosphine free system to promote the desulfurative 
rearrangement began. It was believed that polar solvents would accelerate the 
[2,3]-sigmatropic rearrangement by stabilizing the transient polar thiosulfoxide 
intermediate. This line of thinking was consistent with the work of Moore and 
Trego who observed earlier that the desulfurative rearrangement of 1,3-
dimethylbut-2-enyl tert-butyl disulfide was faster in an ethanol/benzene 
combination compared to benzene alone.95 Therefore, polar solvents were 
chosen for the applicability of secondary and tertiary allylic disulfides to the 
functionalization of simple thiols and cysteine containing peptides. With the view 
of finding a suitable thiophilic reagent and to test the desulfurative rearrangement 
at room temperature, a model disulfide was synthesized according to Scheme 
75. The obtained secondary allyl disulfide 252 was treated with Boc-L-Cys-OMe 
in methanol to give the model disulfide 261 in 55% yield. 
 
Scheme 75. Synthesis of a model disulfide 
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3.6 Phosphine free thiophilic reagent 
It was hypothesized that thiophilic metallic salts would remove the sulfur atom 
from the thiosulfoxide intermediate because of their increased affinity towards 
sulfur atom as shown in Scheme 76.  
 
Scheme 76. Metal mediated allylic desulfurative rearrangement 
 To test this hypothesis, various commercially available metallic salts were 
treated with the model allylic disulfide 261 in deuteriated methanol and 
deuteriated acetonitrile separately. The rearrangement was monitored by proton 
NMR spectroscopy (Scheme 77). 
 
 
Scheme 77. Reaction of an allylic disulfide with metallic salts 
3.6.1 Silver mediated allylic disulfide rearrangement 
 To this end various transition metallic salts were screened for the 
desulfurative allylic rearrangement (Table 6). Among the metal salts investigated, 
copper (I) chloride and silver nitrate promoted the desulfurative rearrangement 
smoothly at room temperature. However, silver nitrate furnished the best results 
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in methanol presumably because silver possesses a higher thiophilic character 
compared to copper and the other transition metals investigated. The 
rearrangement of the model disulfide 261 was performed in ethanol and dimethyl 
formamide with 2.2 equiv of silver nitrate separately and the rearranged products 
were observed in 68% and 70% respectively. This clearly demonstrates that the 
extrusion of sulfur from the thiosulfoxide is accelerated by silver and facilitated by 
polar solvents. More recently, Liu et al computationally supported the effect of 
polar solvents on the desulfurative [2,3]-rearrangement.118 
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  CD3CN
 
 
 CD3OD
 
 
               CoCl2 
   
     <5% 
 
     <5% 
 
               NiCl2 
 
     <5% 
 
     <5% 
 
               CuCl 
 
      25% 
 
      55% 
 
            Fe(NH4)2(SO4)2 
 
     <5% 
 
     <5% 
 
              AgNO3 
 
     38% 
 
      72% 
 
Table 6. Rearrangement of model disulfide with different metal salts 
3.7 Synthesis of an allyl aryl sulfide 
 With the successful ligation of a cysteine thiol in hand, the silver mediated 
desulfurative allylic disulfide rearrangement was applied to a range of examples. 
Notably, when the disulfide formed from the reaction of secondary allyl disulfide 
252 and 4-chloro thiophenol was treated with silver nitrate the corresponding allyl 
aryl sulfide 263 was obtained in 51% yield (Scheme 78) whereas under similar 
conditions triphenylphosphine did not effect any rearrangement but excised the 
sulfur atom from the disulfide.126  
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Scheme 78. silver nitrate mediated syntheis of an allyl aryl sulfide 
3.8 Application to carbohydrate chemistry 
3.8.1 Rearrangements involving anomeric thiol 
 The silver mediated desulfurative rearrangement was further applied to 
the synthesis of neoglycoconjugates and thio ether containing polysaccharides. 
The objective here was to investigate the scope of the desulfurative allylic 
disulfide rearrangement with silver nitrate. To start with, the desulfurative 
rearrangement of an electron deficient anomeric thiol was tested. When the silyl 
ether protected allylic disulfide 264 when treated with 1-thio glucose tetraacetate 
(91), the mixed disulfide was formed very cleanly in 3 h. The mixed disulfide 
when treated with silver nitrate rearranged to the corresponding thio ether 265 in 
67% yield with the concomitant cleavage of the silyl ether group (Scheme 79). 
However under identical conditions, triphenylphosphine cleaved the disulfide 
bond without producing any significant amount of the rearranged product. The 
superiority of the silver-mediated reaction is therefore evident.  
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Scheme 79. Reaction with an anomeric thiol 
 The successful rearrangement involving the electron deficient anomeric 
thiol encouraged the use of silver mediated allylic desulfurative rearrangement to 
the lipidation of the anomeric thiol. The incorporation of tridecenyl and farnesyl 
groups on 1-thio glucose tetraacaetate (91) was smoothly performed with silver 
nitrate at room temperature in methanol. The introduction of the farnesyl chain 
proceeded with a 1.5:1 ratio favoring the E-isomer (Table 7). The isolated yields 
of the rearranged products are compared with the triphenylphosphine mediated 
reactions and it is noteworthy to mention that the phosphine mediated 
rearrangement was again inferior as it needed reflux temperatures in benzene to 
furnish the rearrangement.  
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66% 
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1.8:1 
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Table 7. Lipidation of anomeric thiol 
3.8.2 Application to cysteine functionalization 
 The silver mediated rearrangement was further applied to the 
functionalization of cysteine containing tripeptides and the yields were compared 
to the phosphine mediated yields (Table 8). In all the cases the silver mediated 
rearrangement proceeded smoothly to afford the products at room temperature. 
The incorporation of tridecenyl group to the cysteine tripeptide was smooth in 
methanol whereas more nucleophilic (4-dimethylaminophenyl)-
diphenylphosphine was required to furnish the rearrangement in a mixture of 
methanol and THF134 (Entry 1, Table 8). Similarly the rearrangement of tertiary 
allyllic disulfide produced the corresponding primary thio ether with a ratio of 
1.5:1, favoring the E-isomer (Entry 2, Table 8). 
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1.5:1 
 
 
70% 
E/Z = 
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Table 8. Functionalization of cysteine tripeptides 
3.9 Olefinic stereoselection 
 The silver promoted desulfurative rearrangement follows the phosphine 
pathway in its olefinic selectivity. The desulfurative rearrangement of the 
secondary allylic disulfides takes place with comparable E-selectivity to other 
[2,3]-simatropic rearrangements such as the Evans-Mislow rearrangement99 or 
the [2,3]-Wittig rearrangement.136 The transition state for this rearrangement is 
likely based on an envelope like conformation which is of either an endo and or 
an exo type. On examination it was found that the alkyl group prefers the exo 
orientation, leading to the preferential formation of E-products (Scheme 80). 
However, with the tertiary allylic disulfides E/Z mixtures of the rearranged 
products are formed favoring E-isomers.  
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Scheme 80. Mechanism for E-selectivity on [2,3]-sigmatropic 
rearrangement 
3.9.1 Application to the synthesis of glycoconjugate 
 The applicability of the silver mediated allylic desulfurative rearrangement 
was further demonstrated in cysteine derivatization and to the synthesis of 
glycoconjugate in the absence of protecting groups. Thus, a secondary allylic 
disulfide 252 when treated with cysteine containing tripeptide (271), rearranged 
to the corresponding product 272 with excellent E-selectivity (Entry 1, Table 9). 
The conjugation of free sugar128 273 with the tripeptide L-glutathione (271) 
followed by the addition of silver nitrate was successfully achieved to give the 
glycoconjugate 274 in 65% yield (Entry 2, Table 9). 
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Entry                     Thiol    Allylic Partner                    Product AgNO3-
Mediated 
Yield 
 
 
1 
 
 
271 
 
 
     
           252 
 
        
272 
 
 
     85% 
 
 
 
2 
 
 
 
271 
 
 
            273 
 
 
 
274 
 
 
 
   65% 
                                                                
Table 9. Silver mediated synthesis of neoglycoconjugates 
 
4.0 Conclusion 
 The synthesis of secondary and tertiary allylic disulfides enabled the 
introduction of primary thio ether groups. To discharge the dechalcogenative 
allylic disulfide rearrangement from its phosphine dependency and to apply the 
desulfurative rearrangement to biologically relevant systems, a new variant has 
been designed. The strong thiophilicity of silver promotes the key desulfurization 
of transient thiosulfoxide in the desulfurative allylic rearrangement. The failure of 
triphenylphosphine to remove the sulfur from thiosulfoxide and the forcing 
conditions employed to the synthesis of allyl aryl sulfides was overcome in the 
silver mediated allylic desulfurative rearrangement. The silver mediated 
desulfurative rearrangement enabled the functionalization of cysteine peptides 
under mild conditions. The ambient reaction conditions required for the 
rearrangement of the allylic disulfide containing an electron deficient anomeric 
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thiol compared to the reflux conditions employed with triphenylphosphine make 
the silver mediated method a powerful tool for the lipidation of anomeric thiols. 
The silver mediated ligation of thiol containing oligosaccharide units for the 
synthesis of complex oligosaccharides would be discussed in the next chapter. 
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CHAPTER IV. Application of the Silver Mediated Desulfurative Allylic 
Rearrangement to the Synthesis of Glucan Mimics. 
4.1 Background and biological significance of (1,3)-β-glucans 
 The research described in this chapter was focused mainly on the 
synthesis of complex oligosaccharide mimics making use of the silver mediated 
allylic rearrangement. It is becoming increasingly important that certain protein-
carbohydrate interactions require long sequences of oligosaccharides for 
optimum binding. Dectin-1, a C-type lectin is a cell surface immune receptor for 
β-glucans and its binding is directed exclusively to 1,3-linked glucose oligomers 
with the minimum length required for detectable binding being a 10- or 11-mer. 
These bigger oligosaccharides are difficult to obtain from any naturally occurring 
biological sources in a homogeneous form. Therefore methods need to be 
developed for the synthesis of these complex oligosaccahrides under mild 
reaction conditions. It was envisaged that the silver mediated desulfurative 
rearrangement has the potential as a chemoselective ligation technique and 
could be used to stitch shorter oligosaccharide units to one another to form larger 
ensembles. Initial attention was focused to the synthesis of β-(1,3)-glucan mimics 
since poly-β-(1,3)-glucosides, or β-(1,3)-glucans have been extensively studied 
for their immunological and pharmacological effects, in particular because of their 
immunostimulating and antitumoral properties.137-138 The β-(1,3)-glucans are 
found in nature as essential constituents of the cell wall in fungi139 or and as 
major storage source in brown seaweed.140 Recently, these polysaccharides 
have also been classified as biological response modifiers.141-142 Derivatives of β-
(1,3)-glucan have been used as enzyme inhibitors and as vehicles for drug 
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delivery.143-149  Non-cellulosic β-glucans consist of a backbone of glucose 
residues usually joined by β-[1→3] linkages. The bacterial β-glucan, curdlan, 
which contains only β-[1→3] glucosidic linkages, is shown in Figure 1.  
 
Figure 1.   Curdlan, a β-(1,3)- glucan 
 
β-(1,3)-glucans have been prepared both chemically and enzymatically by 
transglycosylation or by glycosynthases.150-153  
4.2 Synthesis of glucan mimics 
4.2.1 Synthesis of a glucan mimic disaccharide 
In the approach conceived toward the protecting group-free synthesis of 
glucan mimics it was envisaged that a short linker resulting from the desulfurative 
ligation could be used to link oligosaccharide unit with another. In a first approach 
to the problem, the synthesis of a disaccharide mimic having a β-[1→3]-
glucosidic linkage was undertaken in which the linker unit could be derived by the 
silver promoted allylic disulfide rearrangemet as shown in the retrosynthetic 
analysis (Scheme 81). 
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Scheme 81. Retro synthetic scheme for a glucan mimic disaccharide 
 According to this retrosynthetic analysis, the target glucan mimic 
disaccharide would be derived from the silver mediated desulfurative allylic 
rearrangement of the disulfide. The allylic disulfide would be derived by the 
individual fragment coupling between the glucose thiol and the disulfide linked 
methyl glycoside. This disulfide containing allylic tether linked glycoside would be 
derived from a protected diacetone glucose moiety. It was envisioned that the 
orthogonally protected butenyl group would allow the later functionalization of the 
diacetone glucose ring to the desired disulfide linked donor. Reducing this 
analysis to practice, the synthesis of the disaccharide mimic began with the 
commercially available cis-butene-1,4-diol (244) which was treated with 
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naphthylmethyl bromide in THF with sodium hydride to give the protected mono 
ether 275 in 85% yield. The alcohol was mesylated with methanesulfonyl chloride 
and Hunig’s base in dichloromethane. The crude mesylate was directly advanced 
to the next step when it was treated with diacetone-D-glucose (276) in DMF with 
sodium hydride to give the compound 277 in 75% yield. The acetonide protecting 
groups in compound 277 were cleaved by heating the compound in aqueous 
acetic acid, after which the acetate groups were reinstalled by treating it with 
acetic anhydride and pyridine with a catalytic amount of DMAP to give 278 as 
shown in Scheme 82. 
                                                                    
Scheme 82. Synthesis of a protected glucopyranoside with linker  
  Subsequently, the anomeric acetate group was selectively cleaved with 
hydrazine acetate in DMF and the so-obtained hemiacetal was treated with 
trichloroacetonitrile and DBU in dichloromethane to give the trichloroacetimidate 
donor 279 in two steps with 68% yield. Attempted glycosylation of methanol with 
this donor in the presence of 4 Ǻ molecular sieves was unsuccessful. However, 
glycosylation of methanol in the absence of molecular sieves at – 50 °C gave the 
β-methyl glycoside 280 in 75% yield. Oxidative cleavage of the naphthylmethyl 
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group with DDQ in dichloromethane and water at room temperature then gave 
the alcohol 281 in 88% yield (Scheme 83). 
            
                                                    
Scheme 83. Synthesis of the alcohol  
 The disulfide linker was attached to the methyl glucopyranoside 281 as 
shown in Scheme 84. Thus, alcohol 281 was treated with phenyl 
chlorothionocarbonate and pyridine in dichloromethane in the presence of DMAP 
to give the thionocarbonate 282 in 90% yield whose [3,3]-sigmatropic 
rearrangement proceeded smoothly in refluxing toluene to give the thiol 
carbonate 283 in 90% yield. The acetate groups and the thiol carbonate were 
hydrolyzed with 1 M KOH in methanol in one pot. The allyl thiolate was carefully 
acidified with Amberlyst resin and added to a solution containing 2,2`-dipyridyl 
disulfide in methanol. Evaporation of methanol and chromatographic purification 
yielded the allylic disulfide 284 in 76% yield over two steps as a mixture of two 
diastereoisomers.    
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Scheme 84. Synthesis of a sugar-based allyl pyridyl disulfide 
 After the successful installation of the allylic disulfide linker sulfenyl 
transfer to an anomeric thiol and subsequent desulfurative rearrangement was 
attempted in methanol. The metal promoted synthesis of disaccharide mimic 
achieved in this manner is shown Scheme 85. Thus, saponification of the 
commercially available 1-thio glucose tetraacetate (91) with methanolic sodium 
followed by the treatment with acidic resin provided the glucose thiol. The crude 
glucose thiol was added to the allylic disulfide 284 to give the mixed disulfide with 
the liberation of the 2-pyridine thiol. When the mixed disulfide was treated with 
silver nitrate in methanol, the disulfide bearing anomeric thiol smoothly 
rearranged to give the disaccharide mimic 285 in 70% yield with trans olefinic 
configuration on the linker. The olefinic stereochemistry was unambiguously 
supported by proton NMR as the coupling constant found to be 16 Hz (Scheme 
85). 
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Scheme 85. Synthesis of a glucan mimic disaccharide 
4.3 Synthesis of an alternative disaccharide mimic 
 An alternative approach to the problem employs a carbohydrate in which 
the 3-OH has been replaced by a thiol group in which the anomeric position of 
the second reaction partner carries the sulfenyl transfer moiety as set out in the 
retrosynthesis below (Scheme 86). 
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Scheme 86. Alternative retrosynthetic scheme for a disaccharide mimic 
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4.3.1 Synthesis of the disulfide linked glycopyranoside 
The shortest entry to an anomeric sulfenyl donor involves Lewis acid 
promoted glycosylation of the disulfide alcohol 252 with a glucose 
trichloroacetimidate donor (Scheme 87). However, Crich and Yang128 had 
already investigated this approach in another context and found it to be 
challenging as a consequence of which it was not considered further here. 
 
Scheme 87. First retrosynthetic scheme for the sulfenyl donor 
 Therefore, an alternate approach was employed to connect the linker to 
the anomeric carbon. Commercially available glucose pentaacetate (286) was 
treated with 33% HBr in acetic acid to give acetobromoglucose which was 
condensed with cis-but-2-ene-1,4-diol by the Koenigs-Knorr method154 to give the 
β-D-glucoside 287 in 90% yield by the classical neighboring group participation 
mechanism. The stereochemistry of the coupling product was confirmed by the 
large 3JH1,H2 coupling constant (7-8 Hz). The thiocarbonylation of the resulting 
glycosyl alcohol with CS2 and NaH in DMF proceeded with a low yield. However, 
the treatment of the alcohol 287 with phenylchlorothionocarbonate and pyridine 
as a base with a catalytic DMAP gave the product in high yield. This 
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thionocarbonate 288 underwent a [3,3]-sigmatropic rearrangement in refluxing 
toluene afforded the allyl thiolcarbonate 289 as a mixture of stereoisomers 
(Scheme 88). 
 
Scheme 88. Synthesis of glycosyl allylic thiolcarbonate 
 The one-pot hydrolysis of the thiolcarbonate 289 with the remaining 
acetoxy groups was performed with 1 M KOH in methanol. After acidification with 
Amberlyst resin, the resulting allylic thiol was immediately transferred to a 
solution of 2,2’-dipyridyl disulfide in methanol. The disulfide exchange reaction 
was monitored by TLC and was complete in several hours at room temperature. 
Evaporation of the solvent followed by purification of the disulfide by column 
chromatography gave the pure anomeric sulfenyl donor 290 in 76% yield 
(Scheme 89).    
 
Scheme 89. Synthesis of a sulfenyl donor with linker on anomeric carbon 
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4.3.2 Synthesis of 3-thio methyl glycoside  
 The synthesis of the thiol was accomplished in several steps. Thus, 
1,2,4,6 tetra-O-acetyl-3-S-acetyl-3-deoxy glucopyranoside was prepared 
following the known literature procedure155 beginning with commercially available 
diacetone-D-glucose 276 which was oxidized with pyridinium dichromate and 
acetic anhydride. The resulting ketone was reduced with sodium borohydride in 
aqueous ethanol to give the allose-configured alcohol 291 in 80% overall yield. 
This alcohol 291 was treated with triflic anhydride and pyridine in 
dichloromethane to give the corresponding triflate which was displaced with 
potassium thioacetate in DMF with a catalytic amount of 18-crown-6. Finally, the 
furanoside ring was cleaved with aqueous acetic acid and the acetoxy groups 
were installed by the treatment with acetic anhydride and pyridine with DMAP to 
give the pyranoside 293 in 86% yield (Scheme 90). 
 
Scheme 90. Synthesis of 1,2,4,6 tetra-O-acetyl-3-S-acetyl-3-deoxy 
glucopyranoside 
 Initial attempts to hydrolyze the anomeric acetate in presence of the thio 
acetoxy group in compound 293 with hydrazine acetate were ineffective, just as 
attempts to convert the anomeric acetate to anomeric bromide with either HBr in 
acetic acid or with N-bromo succinimide in wet acetone were unsuccessful owing 
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to the fact that the thio acetoxy group is more labile than the anomeric acetate. 
Eventually, titanium tetrabromide was used as an alternative brominating source 
to convert the anomeric acetate to the corresponding bromide in presence of a 
thio acetate group, based on the use of this reagent in a similar case reported by 
Elhalabi and Rice.156 Pleasingly, titanium tetrabromide converted the anomeric 
acetate to the bromide after 96 h in a mixture of ethylacetate and 
dichloromethane without affecting the thioacetoxy group. The anomeric bromide 
was immediately taken to next step without any delay by stirring with silver 
carbonate in an acetone and water mixture at room temperature to give the 
alcohol 294 in 86% for two steps. The trichloroacetimidate group was introduced 
by treating the alcohol with trichloroacetonitrile in presence of DBU. Activation of 
this donor 295 with TMSOTf in the presence of methanol gave the methyl 
glycoside 296 in 76% yield as shown in Scheme 91.  
 
Scheme 91. Synthesis of methyl glycoside 
 The methyl glycoside 296 was saponified under Zemplen conditions with 
metallic sodium in degassed methanol and the resulting thiolate solution was 
acidified and then added immediately to a solution of the allylic disulfide 290 in 
methanol. The mixed disulfide was formed in 3-4 h as observed by the mass 
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spectrometry and also by the yellow color of the reaction medium (due to the 
release of 2-pyridine thiol). Silver nitrate subsequently was added to the crude 
allylic disulfide obtained in this manner to furnish the rearranged product 297. 
The more hindered thiol completely rearranged and afforded the allyl thio ether in 
65% after 24 h. The olefinic configuration was once again found to be trans with 
the coupling constant between the olefinic protons being 15.5 Hz (Scheme 92). 
 
 
Scheme 92. Second silver mediated ligation for the synthesis of a 
disaccharide mimic 
4.4 Silver mediated desulfurative ligation to the syntheses of 
tetrasaccharide mimics 
4.4.1 First approach for a tetrasaccharide mimic 
 Having successfully demonstrated the synthesis of two disaccharide 
mimics, attention was turned to mimics of higher oligosaccharides, with special 
focus on tetrasaccharides obtained by ligating two laminaribiosyl units. Again, 
this chemistry could be approached from two different directions and attention 
was first focused on the use of an anomeric thiol as analyzed in Scheme 93. 
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Scheme 93.  First retrosynthetic approach for a tetrasaccharide mimic 
4.4.2 Synthesis of a laminaribiosyl disulfide as a sulfenyl donor 
 The initial idea for the laminaribiosyl sulfenyl donor is shown below 
(Scheme 94). However, the attempted glycosylation of the acceptor 298 with the 
trichloroacetimidate donor 279 produced no significant product.  
 
Scheme 94.  Attempted glycosylation to synthesize a disaccharide  
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 The hydrolyzed donor and the acceptor were completely recovered from 
the reaction mixture. It was considered that the combination of the strongly 
disarmed donor with the poorly nucleophilic acceptor alcohol was the reason for 
the failure of this glycosylation reaction. It was anticipated that the glycosylation 
of the less hindered dicetone-D-glucose acceptor 276 with this donor 279 and 
derivatization of the furanose ring to the pyranoside would solve this problem. 
Accordingly, the neighboring group assisted glycosylation of diacetone-D-glucose 
with the trichloroacetimidate donor 279 in the presence of TMSOTf in 
dichloromethane at room temperature gave the glycoside 299 stereoselectively in 
60% yield. The acetonide groups in this glycoside were cleaved with aqueous 
acetic acid and the acetate groups were installed to give the protected 
laminaribioside 300 in 82% yield. The trichloroacetimidate donor was introduced 
after the facile cleavage of the anomeric acetate with hydrazine acetate and 
treatment of the alcohol with trichloroacetonitrile and DBU. The glycosylation with 
methanol at - 50 °C in presence of catalytic amount of TMSOTf produced the 
methyl glycoside 302 in 60% yield as shown in Scheme 95.   
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Scheme 95.  Synthesis of a methyl laminaribioside 
 The oxidative cleavage of the naphthylmethyl group in 302 was performed 
with DDQ in dichloromethane and water to give the alcohol 303 in 85% yield. The 
disulfide linker was attached to the alcohol using a similar procedure employed 
for the monosaccharide. Thus, alcohol 303 was treated with 
phenylchlorothionocarbonate and pyridine as a base with a catalytic amount of 
DMAP in dichloromethane to give the thionocarbonate 304 in 88% yield. The 
[3,3]-sigmatropic rearrangement of the thionocarbonate gave the allylic 
thiolcarbonate 305 as a mixture of diastereomers in 90% yield. The global 
saponification of the allylic thiolcarbonate with the acetoxy groups with 1 M KOH 
in degassed methanol afforded the allylic thiol which was acidified and added 
immediately to a solution of 2,2’-dipyridyl disulfide in methanol, with monitoring of 
the progress of the reaction by TLC as well as by mass spectrometry. This 
disulfide linked laminaribioside 306 was purified by column chromatography over 
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silica gel using methanol and dichloromethane as eluent to give the product in 
68% isolated yield (Scheme 96).     
                                                                        
Scheme 96. Synthesis of lalaminaribioside sulfenyl donor 
4.4.3 Synthesis of laminaribiosyl thiol 
 The synthesis of the peracetyl laminaribiosyl thiol 310 began with a known 
glycosylation reaction.  Diacetone-D-glucose (276) was glycosylated with the 
known glucosyl trichloroacetimidate 307 donor in presence of TMSOTf in 
dichloromethane. The glycosylated product 308 was treated with aqueous acetic 
acid to remove the acid labile acetonide groups and acetoxy groups were 
installed with the treatment of acetic anhydride and pyridine to give the peracetyl 
glucopyranoside. This laminaribiosyl acetate was treated with 33% HBr in acetic 
acid to give the laminaribiosyl bromide 309 in 80% yield. Treatment with thiourea 
provided the laminaribiosyl isothiouronium bromide, which, on saponification with 
sodium meta-bisulfite, gave the protected laminaribiosyl thiol 310 in 65% yield as 
shown in Scheme 97.  
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Scheme 97. Synthesis of laminaribiosyl thiol 
 The unprotected laminaribiosyl sulfenyl donor and the laminaribioside thiol 
acceptor were ligated with silver nitrate to give the free tetrasaccharide 311 as 
shown in Scheme 98. The acetoxy protecting groups were removed from 
peracetyl laminaribiosyl thiol 310 by saponification with 2-3 equivalents of 
metallic sodium in degassed methanol and, after acidification, the deprotected 
thiol was immediately added to the sulfenyl donor 310 and the disulfide exchange 
reaction was monitored by mass spectrometry. After the completion of the 
disulfide exchange, 2.0 equivalents of silver nitrate were added to furnish the 
glycoligation product 311. The progress of this glycoligation was monitored by 
mass spectrometry and also by the appearance of a black precipitate. The silver 
complex was removed by centrifugation and reaction mixture was purified by 
reverse phase chromatography to give the tetrasaccharide mimic in 55% yield 
over two steps (Scheme 98).     
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Scheme 98. Synthesis of a tetrasaccharide mimic 
4.5 Synthesis of an alternative tetrasaccharide mimic 
 Attention was next focused on the alternative sequence employing an 
anomeric sulfenyl donor, according to the analysis to Scheme 99.  
 
Scheme 99. Retrosynthetic plan for another tetrasaccharide mimic 
4.5.1 Synthesis of the laminaribiosyl donor 
 The installation of the disulfide linker began with the peracetyl 
laminaribiosyl bromide 309, which was coupled with cis-butene 1,4-diol (244) 
89 
  
using the Koenigs-Knorr protocol154 resulting in the β-glycoside 312 with its 8.0 
Hz coupling for the newly introduced glycosidic bond, in 80% yield as shown in 
Scheme 100. 
 
Scheme 100. Koenigs-Knorr synthesis of β-glycoside from laminaribiosyl 
bromide 
 The alcohol 312 was functionalized as an allylic thiolcarbonate in two 
steps as shown in Scheme 101. In this sequence, the initial treatment of the 
alcohol with phenyl clorothionocarbonate and the thermal [3,3]-sigmatropic 
rearrangement of the thionocarbonate gave the allylic thiolcarbonate 314 in 95% 
yield as a mixture of isomers.  
 
Scheme 101. Synthesis of peracetyl laminaribiosyl allylic thiolcarbonate 
 The protected thiolcarbonate 314 was saponified with powdered 
potassium hydroxide in methanol and the so-obtained thiol was transferred to the 
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2,2’-dipyridyl disulfide in methanol without any isolation. Thus the synthesis of the 
laminaribiosyl sulfenyl donor 315 was accomplished in 70% yield (Scheme 102).  
 
Scheme 102. Synthesis of laminaribiosyl allylic sulfenyl donor  
4.5.2 Synthesis of the glucan thiol acceptor 
 The synthesis of the laminaribio-3-thiol was planned as shown in the retro 
Scheme 103 and employed a benzylidene acetal group for the acceptor as 
several other groups had reported good success with 3-OH acceptors protected 
in this manner. 
 
Scheme 103. Retrosynthetic scheme for the laminarabio-3-thiol 
 With the trichloroacetimidate donor 295 in hand, the synthesis of the 
benzylidene protected acceptor began with the commercially available diacetone-
D-glucose (276). The synthesis of the benzyl glycoside was accomplished in 
several steps following the known literature protocol.152 Naphthylmethyl 
protection of the diacetone glucose provided the ether 316 in 85% yield. The 
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acetonide cleavage and the installation of the acetoxy groups gave the 3-O-
naphthylmethyl protected glucopyranoside 317 in 80% yield as shown in Scheme 
104. 
 
Scheme 104. Synthesis of a 3-O-ether linked glucopyranoside  
 The treatment of the glucopyranoside with ethanethiol under Lewis acidic 
condition provided the ethyl thio glucopyranoside donor 318 in 75% yield. 
Zemplen saponification of the donor 318 gave the triol which was treated with 
benzaldehyde dimethyl acetal in the presence of p-toluene sulfonic acid to give 
the alcohol 319 in 73% yield over two steps. This alcohol was treated with 
benzoyl chloride and pyridine in presence of DMAP to yield the thio 
glucopyranoside 320 in 70% yield (Scheme 105). 
 
Scheme 105. Synthesis of thio glucopyranoside  
 The thioglucopyranoside 320 was activated with TESOTf in the presence 
of benzyl alcohol and 4 Ǻ molecular sieves to give the benzyl glucopyranoside 
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321 in 70% yield. The naphthylmethyl ether was then removed by DDQ oxidation 
to give the acceptor 322 in 65% yield as shown in Scheme 106. 
 
Scheme 106. Synthesis of the acceptor 
 Unfortunately, the glycosylation of the benzylidene protected acceptor with 
the trichloroacetimidate donor 295 yielded the disaccharide 323 only in 25% 
yield. Nevertheless, the benzylidene acetal in this disaccharide was cleaved by 
treatment with aqueous acetic acid to give the precursor 324 in 90% yield 
(Scheme 107). 
 
 
Scheme 107. Synthesis of a glucan thiol acceptor 
 The protected thiol 324 was treated with sodium in methanol to give the 
thiol which was added to a solution of laminaribiosyl disulfide 315 in methanol 
without any isolation. After the formation of the new disulfide, silver nitrate was 
added and the progress of the reaction was monitored by mass spectrometry and 
the tetrasaccharide mimic 325 was isolated in 50% yield (Scheme 108).  
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Scheme 108. Synthesis of a second tetrasaccharide mimic  
4.6 Synthesis of a head to head tetrasaccharide mimic 
 With the successful synthesis of two tetrasaccharide mimics, attention was 
focused on synthesizing the head to head tetrasaccharide mimic. Thus, the silver 
mediated glycoligation reaction was applied to the synthesis of a head to head 
tetrasaccharide mimic in which both the disulfide linker and the thiol were 
attached to their respective anomeric carbons. This head to head (1,3)-β-glucan 
mimic tetrasaccharide 326 was obtained by ligating the laminaribioside sulfenyl 
donor 315 with the laminaribioside thiol  310 as shown in Scheme 109.   
 
 
Scheme 109. Synthesis of a head to head tetrasaccharide mimic 
4.7 Synthesis of a mixed disaccharide mimic 
 The silver mediated allylic desulfurative rearrangement was further 
demonstrated through the synthesis a mixed glucan disaccharide mimic. In this 
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sequence the sulfenyl donor 284 was treated with glucose 6-thiol, kindly provided 
by Ms Moume-Pymbock, in the Crich lab. The silver mediated desulfurative 
rearrangement was very effective and yielded the mixed disaccharide mimic 351 
in 70% yield (Entry 7, Table 13). The silver mediated protecting group free 
syntheses of various glucan mimics achieved in the course of this study are 
summarized in Table 10. 
Entry          Sulfenyl donor In situ generated thiol 
acceptor 
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Table 10. Silver mediated glycoligation to the synthesis of various glucan 
mimics 
4.8 Conclusion 
 In summary, the desulfurative allylic rearrangement provides a new 
chemical ligation method. The silver mediated allylic desulfurative rearrangement 
has been employed as a powerful ligation method for the synthesis (1,3)-β 
glucan mimics. The synthesis of disaccharide and tetrasaccharide mimics was 
achieved in two different ways with comparable yields. However, for the 
synthesis of tetrasaccahride mimics, the approach involving the ligation of the 
laminaribiosyl thiol derived from 310 with the glucan disulfide donor 306 was 
more convenient than the rearrangement involving the glucan thiol derived from 
324 with the laminaribiosyl disulfide donor 315 since the rearrangement was 
complete in the former.  
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CHAPTER V.  Experimental Section 
 
General: All solvents were dried and distilled by standard protocols. All 
reactions were conducted under an inert atmosphere of argon or nitrogen unless 
otherwise stated. All organic extracts were dried over sodium sulfate, and 
concentrated under aspirator vacuum. Chromatographic purifications were 
carried out over silica gel using Analogix fractional collectors. Unless otherwise 
stated optical rotations were recorded on an Autopol® III automatic polarimeter in 
CHCl3 solution and 1H and 13C spectra were recorded in either CDCl3 or CD3OD 
solution. Mass spectra were recorded by the Research Resources Center at the 
University of Illinois at Chicago and Central Instrumentation Facility at Wayne 
State University. Reverse phase HPLC (RPHPLC) purification was performed 
with 215 and 254 nm UV detection, using a C-18 analytical and preparative 
columns (250 × 4.6) and (250 × 21.4), respectively. All runs used linear gradients 
of A in B (A: CH3CN or MeOH and B: Water). 
Experimental Section 
1. General procedure for the synthesis of selenocyanates 
To a stirred solution of allyl halide (1.0 mmol) in degassed acetone (10 
mL) under an argon atmosphere, added potassium selenocyanate (1.2 mmol) in 
(10 mL) dropwise. The reaction mixture was stirred for 12 h. Solvents were 
evoparated and the reaction mixture is diluted with EtOAc and then washed with 
water. The organic part was washed with saturated NaCl solution, dried over 
sodium sulfate and evaporated to dryness. The crude selenocyanates were used 
directly without further purification. 
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2. General procedure for the coupling reaction of thiols with 
selenocyanates 
To the freshly prepared selenocyanate (1.2 mmol) in degassed methanol 
(10 mL) under an argon atmosphere was added a solution of thiol (1.0 mmol) in 
methanol (5 mL) dropwise over 1 h at room temperature. The reaction mixture 
was stirred for 12 h and filtered through celite pad, washed with methanol (2 x 15 
mL). The solvents were evoparated to dryness and purified by column 
chromatography to yield the rearranged product. PPh3 (2.5 mmol) was used in 
some cases to complete the rearrangement. 
3. General procedure for the acetonide removal from derivatives of 1,2;5,6-
diisopropylideneglucofuranose derivatives and the subsequent installation 
of acetate groups.   
The acetonide protected glucofuranoside (1.0 mmol) was dissolved in 
80% acetic acid (10.0 mL) and heated with stirring to 95 °C for 8 h. After cooling 
the solvents were removed under reduced pressure, and the reaction mixture 
was azeotroped with toluene (2 X 30 mL).  The crude product was dried under 
vacuo and dissolved in acetic anhydride (10.0 mmol), pyridine (10.0 mmol) and 
DMAP (0.1 mmol) and stirred at room temperature for 12 h. The solvents were 
evaporated under vacuum and the crude product was partitioned between ethyl 
acetate (30.0 mL) and water. The organic part was washed with brine (50 mL), 
dried, and evaporated to dryness. 
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4. General procedure for the preparation of glycosyl trichloroacetimidates. 
To a stirred solution of the anomeric acetate (1.0 mmol) in DMF (10.0 mL), 
NH2NH2.AcOH (1.5 mmol) was added, after which the reaction mixture was 
stirred at room temperature for 3-4 h before it was diluted with ethyl acetate (100 
mL) and washed with brine (50 mL). The organic portion was separated and 
dried to give the hemiacetal, which was dissolved in dichloromethane (100 mL) 
and treated with trichloroacetonitrile (10.0 mmol), followed by DBU (0.1 mmol). 
The reaction mixture was stirred at room temperature for 12 h before the solvents 
were evaporated and the crude product was purified by column chromatography 
using ethyl acetate/hexanes as eluent. 
5. General procedure for the glycosylation with trichloroacetaimidates.  
The trichloroacetimidate (1.2 mmol), alcohol (1.0 mmol) and activated 4 A° 
molecular sieves were mixed in dichloromethane (10 mL) and stirred at room 
temperature for 0.5 h before TMSOTf (0.125 mmol) was added.  Stirring was 
continued at room temperature for 12 h before triethylamine (0.2 mmol) was 
added and the reaction mixture was filtered.  The solvents were evaporated and 
the crude product was purified by column chromatography using ethyl 
acetate/hexanes as eluent. 
6. General procedure for the deprotection of naphthylmethyl groups.  
The protected pyranoside (1.0 mmol) was dissolved in a mixture of ~9:1 
dichloromethane and water (10 mL) and DDQ (1.3 mmol) was added.  The 
reaction mixture was stirred at room temperature for 3-4 h until TLC showed the 
starting material has been consumed. The reaction mixture was diluted with ethyl 
acetate (100 mL) and washed with saturated aqueous NaHCO3 (50 mL). The 
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combined organic part was dried and evaporated to dryness. The crude product 
was purified by column chromatography using ethyl acetate/hexanes as eluent. 
7.  General procedure for the preparation of allylic thionocarbonates.  
A solution of phenyl chlorothionocarbonate (2.0 mmol) in dichloromethane 
(2 mL) was added to a solution of the alcohol (1.0 mmol), pyridine (15.0 mmol) 
and DMAP (0.1 mmol) in dichloromethane (10.0 mL) and the resulting dark-
yellow solution was stirred at room temperature for 4 h. The reaction mixture was 
poured into H2O (20 mL) and extracted with dichloromethane (3 x 10 mL). The 
combined organic phases were dried, filtered, evaporated, and purified by 
column chromatography.  
8. General procedure for the [3,3]-sigmatropic rearrangement of allylic 
thionocarbonates.  
A solution of allylic thionocarbonate (1 mmol) in toluene (10.0 mL) was 
heated at reflux for 12 h. Evaporation of the solvent and chromatographic 
purification of the crude products using ethyl acetate/hexanes as eluent afforded 
the products. 
9. General procedure for the conversion of allylic thiocarbonates to allylic 
pyridinsulfanyl disulfides.  
The peracetyl glycosyl thiolcarbonate (1.0 mmol) was dissolved in MeOH 
(X mL) at 0 °C with stirring and 1 M KOH (6.0 mmol-12.0 mmol, 1.5 equiv per 
acetate group) was added dropwise. After 3-4 h, the pH of the reaction mixture 
was adjusted to 7 by careful addition of Amberlyst15 H+ resin. The reaction 
mixture was then filtered, and the filtrate was washed with methanol (5 mL). The 
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combined filtrate was added to a solution of 2,2’-dipyridyl disulfide (1.25 mmol) in 
MeOH (2.0 mL) at room temperature for 4 h. The solvents were removed and the 
product was purififed by column chromatography using MeOH/dicloromethane as 
eluent.   
10. General procedure for the silver nitrate promoted rearrangement of 
allylic disulfides.   
A stirred solution of protected thiol in degassed methanol (0.5 M) was 
treated with metallic sodium (2-3 equiv) and stirred under a N2 atmosphere for 4-
6 h until the saponification was complete (monitored by ESI mass spectrometry 
and TLC).  The reaction mixture was acidified with Amberlyst 15 resin and 
filtered.  The resin was washed with methanol (3 X 5 mL).  The combined 
washings and the filtrate were concentrated to a final volume of 1-2 mL and 
transferred to a stirred solution of disulfide (0.05 M) in methanol. The reaction 
mixture was stirred at room temperature under a nitrogen atmosphere until 
disulfide exchange was complete (ESI mass spectrometry). The reaction mixture 
was then treated with silver nitrate (2.0 equiv) and stirred in the dark for 16-24 h.  
After the completion of reaction (monitored by ESI mass spectrometry), NaCl (10 
equiv) was added and the reaction mixture was stirred for 3-4 h. The reaction 
mixture was diluted with methanol and centrifuged to remove the black 
precipitate. The solvent was then concentrated to afford the crude product which 
was purified by column chromatography on silica gel to give the rearranged 
product.  
Allyl hexadecyl sulfide (184).  
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Following the general procedure 2, the title compound was obtained in 
70% as colorless liquid. The selenosulfide intermediate did not require any 
triphenylphosphine for the [2,3]-sigmatropic rearrangement. The characterization 
data were in agreement with literature values. 1H NMR (500 MHz, CDCl3,): δ 0.88 
(t, J = 6.5 Hz, 3H), 1.25-1.31 (m, 24H), 1.36 (m, 2H), 1.56 (m, 2H), 2.45 (t, J = 
7.5 Hz, 2H), 3.12 (d, J = 7.5 Hz, 2H), 5.07 (d, J = 10.0 Hz, 1H), 5.09 (d, J = 16.5 
Hz, 1H), 5.79 (ddt, J = 10.0 Hz, J = 16.5 Hz, J = 7.0 Hz, 1H). 13C NMR (100 MHz, 
CDCl3,): δ 14.2, 22.7, 28.9, 29.2, 29.3, 29.4, 29.5, 29.6, 29.7, 30.7, 32.0, 34.8, 
116.7, 134.6, EIHRMS Calcd. For C19H38S [M]+ 298.2694, found: 298.2697. 
Allyl phenethyl sulfide (185).  
Following the general procedure 2, the title compound was obtained in 
70% as colorless liquid. The selenosulfide intermediate did not require any 
triphenylphosphine for the [2,3]-sigmatropic rearrangement. 1H NMR (400 MHz, 
CDCl3,): δ 2.71- 2.75 (m, 2H), 2.86-2.90 (m, 2H), 3.15 (d, J = 7.0 Hz, 2H), 5.09 
(d, J = 16.6 Hz, 1H), 5.13 (d, J = 11.2 Hz, 1H), 5.72-5.82 (m, 1H), 7.20-7.33 (m, 
5H); 13C NMR (100 MHz, CDCl3,): δ 32.0, 34.8, 36.0, 117.0, 126.3, 128.3, 128.4 
(2C), 128.5, 134.4, 140.6; EIHRMS Calcd for C11H14S [M+Na]+: 178.0816, found: 
178.0831. 
Linalyloctyl sulfide (186).   
Following the general procedure 2, the title compound was obtained in 
70% yield as colorless oil. The selenosulfide intermediate required 2.5 equiv of 
triphenylphosphine for the completion of the [2,3]-sigmatropic rearrangement. 1H 
NMR (CDCl3, 400 MHz): δ 0.87 (t, J = 7 Hz, 3H), 1.25-1.28 (m, 8H), 1.32-1.34 
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(m, 5H), 1.57 (s, 3H), 1.55-1.61 (m, 4H), 1.67 (s, 3H), 1.92-2.10 (m, 2H), 2.29-
2.37 (m, 2 H), 4.94 (d, J = 17.8 Hz, 1H), 5.05 (d, J = 9.5 Hz, 1H), 5.11-5.09 (m, 
1H), 5.76-5.83 (m, 1H); 13C NMR (CDCl3, 100 MHz): δ 14.1, 17.6, 22.6, 23.1, 
23.4, 25.6, 28.3, 29.1, 29.2, 29.3, 29.5, 31.8, 40.3, 49.7, 111.9, 124.0, 131.7, 
143.7; EIHRMS Calcd. for C18H34S1 [M]+•: 282.2381, found 282.2385. 
N-Acetyl-S-allyl-L-cysteine methyl ester (189).  
Following the general procedure 2, the title compound was obtained in 
80% as colorless liquid. The selenosulfide intermediate did not require any 
triphenylphosphine for the [2,3]-sigmatropic rearrangement and the 
characterization data were in agreement with the literature values. 1H NMR (400 
MHz, CDCl3,): δ 2.06 (s, 3H),2.87 (dd, J = 5.2 Hz, J = 14.0 Hz, 1H), 2.95 (dd, J = 
4.8 Hz, J = 13.6 Hz, 1H), 3.11 (d, J = 6.0 Hz, 2H), 3.79 (s, 3H), 4.77-4.82 (m, 
1H), 5.09 (d, J = 10.0 Hz, 1H), 5.13 (d, J = 2.0 Hz, 1H), 5.70-5.77 (m, 1H), 6.2 
(br. d, J = 6.4 Hz, 1H); 13C NMR (100 MHz, CDCl3,): δ  23.1, 32.6, 35.1, 51.6, 
52.6, 117.9, 133.5, 169.8, 171.4. 
N-(tert-butoxycarbonyl)-S-(2-methylallyl)-L-cysteine ethyl ester (190)126; 
Following the general procedure 2, the title compound was obtained in 68% as 
colorless liquid. The selenosulfide intermediate did not require any 
triphenylphosphine for the [2,3]-sigmatropic rearrangement. [α]27D +18.4 (c=1, 
CHCl3); 1H NMR (400 MHz, CDCl3,): δ = 1.29 (t, J = 7.2 Hz, 3H), 1.45 (s, 9H), 
1.79 (s, 3H), 2.80 (dd, J = 5.5 Hz, J = 13.6 Hz, 1H), 2.89 (dd, J = 4.5 Hz, J = 13.8 
Hz, 1H), 3.09 (d, J = 13.5 Hz, 1H), 3.11 (d, J = 13.5 Hz, 1H), 4.21 (q, J = 7.2 Hz, 
2H), 4.47-4.49 (m, 1H), 4.84 (s, 1H), 4.87 (d, J = 1.5 Hz, 1H), 5.30 (d, J = 7.4 Hz, 
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1H); 13C NMR (100 MHz, CDCl3,): δ 14.1, 20.5, 28.2 (3C), 33.1, 39.8, 53.1, 61.6, 
80.0, 114.3, 140.6, 155.1, 171.1; ESIHRMS Calcd for C14H25NO4S [M+Na]+: 
326.1402, found: 326.1410. 
N-(tert-butoxycarbonyl)-S-linalyl-L-cysteine ethyl ester (191);  
Following the general procedure 2, the title compound was obtained in 
66% yield as colorless oil. The selenosulfide intermediate required 2.5 equiv of 
triphenylphosphine for the completion of the [2,3]-sigmatropic rearrangement.  
[α]27D +6.4 (c=1, CHCl3); 1H NMR (CDCl3, 400 MHz): δ 1.28 (t, J = 7.2 Hz, 3H), 
1.33 (d, J = 1.1 Hz, 3H), 1.45 (s, 9H), 1.57 (s, 3H), 1.55-1.60 (m, 2H), 1.66 (s, 
3H), 1.92 -2.09 (m, 2H), 2.79 (d, J = 4.8 Hz, 2H), 4.20 (q, J = 7.2 Hz, 2H), 4.47-
4.49 (m, 1H), 4.95 (d, J = 18.3 Hz, 1H), 5.04-5.09 (m, 1H), 5.08 (d, J = 10.9 Hz, 
1H), 5.25 (d, J = 7.9 Hz, 1H), 5.70-5.78 (m, 1H); 13C NMR (CDCl3, 100 MHz): δ 
14.1, 17.6, 23.1, 23.3, 25.6, 28.3 (3C), 31.1, 40.2, 50.4, 53.0, 61.6, 79.9, 113.0, 
123.7, 131.9, 142.9, 155.1, 170.9; ESIHRMS Calcd for C20H35NO4S [M+Na]+: 
408.2185, found: 408.2175. 
N-(tert-Butoxycarbonyl)-S-allyl-glutathione dimethyl ester (194).  
Following the general procedure 2, the title compound was obtained in 
75% as colorless liquid. The selenosulfide intermediate did not require any 
triphenylphosphine for the [2,3]-sigmatropic rearrangement. [α]27D -31.1 (c=1, 
MeOH); 1H NMR (400 MHz, MeOD,): δ 1.44 (s, 9H), 1.86-1.95 (m, 1H),2.11-2.17 
(m, 1H), 2.37 (t, J = 7.6 Hz, 2H), 2.68 (dd, J = 8.8 Hz, J = 13.9 Hz,1H), 2.94 (dd, 
J = 5.5 Hz, J = 13.9 Hz, 1H), 3.17 (d, J = 6.8 Hz, 2H), 3.71 (s, 3H), 3.72 (s, 3H), 
3.95 (s, 2H), 4.13-4.17 (m, 1H), 4.53-4.56 (m, 1H), 5.09 (d, J = 10 Hz, 1H), 5.16 
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(d, J =17.2 Hz, 1H), 5.75-5.82 (m, 1H); 13C NMR (100 MHz, MeOD): δ 26.9, 27.2 
(3C), 31.4, 31.8, 34.0, 40.4, 51.2, 51.3, 52.3, 53.0, 79.2, 116.4, 134.0, 156.6, 
170.0, 171.9, 173.0, 173.3; ESIHRMS Calcd for C20H33N3O8S [M+Na]+: 
498.1886, found: 498.1895. 
N-(tert-Butoxycarbonyl)-S-(2-methylallyl) glutathione dimethyl ester (195). 
Following the general procedure 2, the title compound was obtained in 71% as 
colorless liquid. The selenosulfide intermediate did not require any 
triphenylphosphine for the [2,3]-sigmatropic rearrangement. [α]27D -39.1 (c=1, 
MeOH); 1H NMR (400 MHz, CDCl3,): δ 1.42 (s, 9H), 1.79 (s, 3H), 1.93-1.97 (m, 
1H), 2.17-2.18 (m, 1H), 2.37 (t, J = 7.5 Hz, 2H), 2.81 (d, J = 6.5 Hz, 2H), 3.14 (s, 
2H), 3.72 (s, 3H), 3.73 (s, 3H), 3.98 (dd, J = 5.4 Hz, J = 18.0 Hz, 1H), 4.06 (dd, J 
= 5.3 Hz, J = 18.1 Hz, 1H), 4.36 (m, 1H), 4.59 (q, J = 6.8 Hz, 1H), 4.86 (d, J = 1.3 
Hz, 1H), 4.89 (s, 1H), 5.39 (d, J = 7.2 Hz, 1H), 6.86 (br s, 1H), 7.05 (br. s, 1H); 
13C NMR (100 MHz, CDCl3): δ 20.6, 28.2 (3C), 28.7, 32.1, 32.5, 39.5, 41.2, 52.1, 
52.4, 52.5, 52.6, 80.2, 114.5, 140.7, 155.7, 169.9, 170.6, 172.1, 172.8; ESIHRMS 
Calcd for C21H35N3O8S [M+Na]+: 512.2043, found: 512.2064. 
N-(tert-Butoxycarbonyl)-S-linalyl glutathione dimethyl ester (196).  
Following the general procedure 2, the title compound was obtained in 
55% yield as colorless oil. The selenosulfide intermediate required 2.5 equiv of 
triphenylphosphine for the completion of the [2,3]-sigmatropic rearrangement. 
[α]27D -18.0 (c=1, MeOH); 1H NMR (MeOD, 400 MHz): δ 1.37 (d, J = 3.6 Hz, 3H), 
1.43 (s, 9H), 1.53-1.61 (m, 2H), 1.61 (s, 3H), 1.67 (s, 3H), 1.86-2.17 (m, 4H), 
2.35 (t, J = 7.5 Hz, 2H), 2.61-2.69 (m, 1H), 2.80-2.86 (m, 1H), 3.71 (s, 3H), 3.72 
105 
  
(s, 3H), 3.93 (s, 2H), 4.14-4.16 (m, 1H), 4.48-4.51 (m, 1H), 5.02 (d, J = 17.5 Hz, 
1H), 5.08-5.12 (m, 1H), 5.10 (d, J= 10.5 Hz, 1H), 5.78-5.85 (m, 1H); 13C NMR 
(MeOD, 100 MHz): δ = 16.3, 22.5, 22.8, 24.4, 27.0, 27.3 (3C), 30.0, 31.4, 40.2, 
40.5, 50.2, 51.2, 51.3, 53.1, 53.3, 79.2, 112.1, 123.6, 131.3, 143.2, 156.7, 170.1, 
171.9, 173.1, 173.2; ESIHRMS Calcd for C27H45N3O8S [M+Na]+: 594.2825, 
found: 594.2846. 
N-(tert-butoxycarbonyl)-S-(2-methylallyl)-L-cysteinyl-L-alanyl-L-tryptophan 
methyl ester (197).  
Following the general procedure 2, the title compound was obtained in 
65% yield as colorless oil. The selenosulfide intermediate required 2.5 equiv of 
triphenylphosphine for the completion of the [2,3]-sigmatropic rearrangement. 
[α]27D +15.6 (c=1, CHCl3); 1H NMR (CDCl3, 400 MHz): δ 1.32 (d, J = 7.0 Hz, 3H), 
1.47 (s, 9H), 1.78 (s, 3H), 2.69 (dd, J = 6.2 Hz, J = 13.8 Hz, 1H), 2.78 (dd, J = 5.8 
Hz, J = 13.9 Hz, 1H), 3.04 (d, J = 13.5 Hz, 1H), 3.08 (d, J = 13.5 Hz, 1H), 3.27 
(dd, J = 5.8 Hz, J = 14.8 Hz, 1H), 3.33 (dd, J = 5.3 Hz, J = 14.8 Hz, 1H), 3.69 (s, 
3H), 4.09-4.21 (m, 1H), 4.44 (t, J = 7.2 Hz, 1H), 4.85-4.89 (m, 3H), 5.29 (br s, 
1H), 6.72 (d, J = 6.1 Hz, 1H ), 6.78 (d, J = 6.9 Hz, 1H), 6.97 (s, 1H), 7.09 (t, J = 
7.2 Hz, 1H), 7.15 (t, J = 7.1 Hz, 1H), 7.33 (d, J = 8 Hz, 1H), 7.49 (d, J = 7.8 Hz, 
1H), 8.44 (br s,1H); 13C NMR (CDCl3, 100 MHz): δ 17.8, 20.6, 27.4, 28.2 (3C), 
33.3, 39.6, 48.8, 52.6, 52.8, 53.6, 80.7, 109.5, 111.3, 114.5, 118.4, 119.5, 122.1, 
123.1, 127.4, 136.0, 140.7, 155.6, 170.4, 171.2, 171.9; ESIHRMS Calcd. for 
C27H38N4O6S [M+Na]+: 569.2410, found: 569.2407. 
BocNH-L-Cys-(S-linalyl)-L-Ala-L-Trp-OMe (198).  
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Following the general procedure 2, the title compound was obtained in 
50% yield as colorless oil. The selenosulfide intermediate required 2.5 equiv of 
triphenylphosphine for the completion of the [2,3]-sigmatropic rearrangement. 
[α]27D +9.0 (c=1, CHCl3); 1H NMR (CDCl3, 400 MHz): δ 1.30 (d, J = 7.2 Hz, 3H), 
1.33 (s, 3H), 1.47 (s, 9H), 1.56 (s, 3H), 1.67 (s, 3H), 1.73-1.75 (m, 2H), 1.91-2.05 
(m, 2H), 2.56 - 2.65 (m, 1H), 2.74 - 2.82 (m, 1H), 3.26 (dd, J = 5.8 Hz, J = 14.8 
Hz, 1H), 3.33 (dd, J = 5.3 Hz, J = 14.8 Hz, 1H), 3.68 (s, 3H), 4.10 - 4.23 (m, 1H), 
4.39 - 4.46 (m, 1H), 4.83-4.88 (m, 1H), 4.96 (d, J = 17.6 Hz, 1H), 5.04 -5.08 (m, 
1H), 5.09 (d, J = 11.0 Hz, 1H), 5.29 (m, 1H), 5.72-5.79 (m,1H), 6.75 (br s, 2H), 
6.97 (s, 1H), 7.09 (t, J = 7.2 Hz, 1H), 7.15 (t, J = 7.1 Hz, 1H), 7.33 (d, J = 8.0 Hz, 
1H), 7.49 (d, J = 7.8 Hz, 1H), 8.50 (br s, 1H); 13C NMR (CDCl3, 100 MHz): δ 17.6, 
17.7, 23.1, 23.3, 25.6, 27.4, 28.3 (3C), 30.8, 40.1, 48.8, 50.9, 52.4, 52.7, 53.8, 
80.7, 109.4, 111.3, 113.3, 118.4, 119.5, 122.0, 123.2, 123.6, 127.4, 132.0, 136.0, 
142.9, 155.6, 170.3, 171.2, 171.9; ESIHRMS Calcd for C33H48N4O6S [M+Na]+: 
651.3193, found: 651.3173. 
BocNH-L-Cys-(S-nerolidyl)-L-Ala-L-Trp-OMe (199).  
Following the general procedure 2, the title compound was obtained in 
40% yield as colorless oil. The selenosulfide intermediate required 2.5 equiv of 
triphenylphosphine for the completion of the [2,3]-sigmatropic rearrangement. 
[α]27D +9.9 (c=1, CHCl3); 1H NMR (CDCl3, 400 MHz):δ 1.30 (d, J = 7.2 Hz, 3H), 
1.34 (s, 3H), 1.47 (s, 9H), 1.58 (s, 3H), 1.61 (s, 3H), 1.67 (s, 3H), 1.71-1.73 (m, 
2H), 1.93-2.07 (m, 6H ), 2.56- 2.65 (m, 1H), 2.74-2.82 (m, 1H), 3.26 (dd, J = 5.8 
Hz, J = 14.8 Hz, 1H), 3.33 (dd, J = 5.3 Hz, J = 14.8 Hz, 1H), 3.68 (s, 3H), 4.10-
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4.23 (m, 1H), 4.39 - 4.46 (m, 1H), 4.83 - 4.88 (m, 1H), 4.96 (d, J = 17.6 Hz, 1H), 
5.06-5.09 (m, 2H), 5.10 (d, J = 11.0 Hz, 1H), 5.24 (m, 1H), 5.72-5.79 (m, 1H), 
6.75 (br s, -NH, 2H), 6.97 (s, 1H), 7.09 (t, J = 7.2 Hz, 1H), 7.15 (t, J = 7.1 Hz, 1H), 
7.33 (d, J = 8.0 Hz, 1H), 7.49 (d, J = 7.8 Hz, 1H), 8.50 (br. s 1H); 13C NMR 
(CDCl3, 100 MHz): δ 15.9, 17.6, 23.0, 23.1, 23.3, 25.7, 26.6, 27.4, 28.3 (3C), 
30.8, 39.6, 40.6, 48.8, 50.9, 52.4, 52.7, 53.8, 80.7, 109.5, 111.3, 113.4, 118.4, 
119.5, 122.0, 123.2, 123.5, 124.2, 127.4, 131.4, 135.6, 136.0, 143.0, 155.6, 
170.3, 171.2, 171.9; ESIHRMS Calcd for C38H56N4O6S [M+Na]+:719.3819, found: 
719.3835. 
4,4,5,5,6,6,7,7,8,8,9,9,9-Tridecafluoro-2-methylenenonanal (204). 
 
To a stirred solution of 2H,2H,3H,3H perfluoro nan-1-al 203 (0.4 g, 1.06 
mmol) and triethylamine (0.44 mL, 3.18 mmol) in CH2Cl2 (10 mL) was added N,N-
dimethylmethyleneiminium iodide ( 0.4 g, 2.15 mmol) and the reaction mixture 
was stirred at room temperature for 15 h at room temperature. The reaction 
mixture was diluted with saturated NaHCO3 solution (30 mL) and CH2Cl2 (20 mL). 
The combined organic portion was washed with water followed by brine solution 
(20 mL) and dried over Na2SO4. It was concentrated and the residue was purified 
by column chromatography over silica gel using 5% EtOAc/hexanes as eluent to 
afford the title product as oil. 1H NMR (500 MHz, CDCl3): δ 9.58 (s, 1H), 6.65 (s, 
1H), 6.41 (s, 1H), 3.12 (t, J = 19.5 Hz, 2H). 13C NMR (125 MHz, CDCl3): δ 192.1, 
139.7, 138.7, 118.5, 116.0, 114.3, 112.4, 110.3, 108.5, 28.2. 
4,4,5,5,6,6,7,7,8,8,9,9,9-Tridecafluoro-2-methylenenonan-1-ol (205). 
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To a stirred solution of CeCl3.7H2O (385 mg, 1.03 mmol) in dry MeOH 
were added successively NaBH4 (58 mg, 0.5 mmol) and a solution of aldehyde 
204 (200 mg, 1.5 mmol) in MeOH (3 mL) at 0 °C. After 2 h, the reaction mixture 
was diluted with EtOAc (10 mL) and the solutions were filtered through a celite 
pad. To the filtrate, saturated NaHCO3 solution (10 mL) and EtOAc (20 mL) were 
added and partitioned. The combined organic portion was washed with water 
followed by brine solution (10 mL) and dried over Na2SO4. It was concentrated 
and the residue was purified by column chromatography over silica gel using 5% 
EtOAc/hexanes as eluent to afford the title product as oil.  1H NMR (500 MHz, 
CDCl3): 1H NMR δ 5.43 (s, 1H), 5.20 (s, 1H), 4.17 (d, J = 5.5 Hz, 2H), 2.88 (t, J = 
30.0 Hz, 2H), 1.82 (s, 1H). 13C NMR (125 MHz, CDCl3): δ 137.3, 123.0, 118.5, 
117.2, 115.7, 112.4, 110.5, 108.3, 65.7, 33.9, 33.8, 33.6.  
2-(Bromomethyl)-4,4,5,5,6,6,7,7,8,8,9,9,9-tridecafluoronon-1-ene (175). 
 
To a stirred solution of 205 (245 mg, 0.63 mmol)  in CH2Cl2 (10 mL) was 
added triphenylphosphine (411 mg, 1.57 mmol) and carbontetrabromide (521 
mg, 1.57 mmol) at 0 °C. The reaction mixture was slowly warmed to room 
temperature and continued stirring for another 3 h under an argon atmosphere. 
The reaction mixture was diluted with saturated NaHCO3 solution (30 mL) and 
CH2Cl2 (20 mL). The combined organic portion was washed with water followed 
by brine solution (20 mL) and dried over Na2SO4. It was concentrated and the 
residue was purified by column chromatography over silica gel using 
EtOAc/hexanes as eluent to afford the title product as yellow oil. 1HNMR (500 
MHz, CDCl3):  δ 5.55 (s, 1H), 5.27 (s, 1H), 4.07 (s, 2H), 3.03 (t, J = 19.5 Hz, 2H). 
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13C NMR (125 MHz, CDCl3): δ 134.4, 123.5, 118.5, 117.2, 115.7, 112.4, 110.5, 
108.3, 36.2 (2C), 34.4, 34.2, 31.6. 
4,4,5,5,6,6,7,7,8,8,9,9,9-Tridecafluoro-2-(selenocyanatomethyl)non-1-ene 
(180). 
Following the general procedure 1, the title compound was obtained as 
colorless oil in 75% yield. 1H NMR (500 MHz, CDCl3): δ 5.53 (s, 1H), 5.35 (s, 
1H), 3.78 (s, 2H), 3.03 (m, 2H). 13C NMR (125 MHz, CDCl3): δ 132.1, 125.1, 
100.6, 35.1 (2C), 34.9, 34.8 (2C), 34.6. 
BocNH-L-Cys-( S-1,1,1,2,2,3,3,4,4,5,5,6,6-tridecafluoro-8-ene-9-methylenyl)L-
Ala-LTrp-OMe (206).  
Following the general procedure 2, the title compound was obtained in 
65% yield as colorless oil. The selenosulfide intermediate required 2.5 equiv of 
triphenylphosphine for the completion of the [2,3]-sigmatropic 
rearrangement.Colorless oil; [α]19D + 19.6 (c=1.1, CHCl3); 1H NMR (CDCl3, 400 
MHz): δ 1.32 (d, J = 7.0 Hz, 3H), 1.44 (s, 9H), 2.64 (dd, J = 6.0 Hz, J = 13.5 Hz, 
1H), 2.71 (dd, J = 5.5 Hz, J = 14.0 Hz, 1H), 2.94 (dt, J = 5.5 Hz, J = 19.5 Hz, 2H), 
3.14 (d, J =14.0 Hz, 1H), 3.20 (d, J = 13.5 Hz, 1H), 3.27 (dd, J = 5.5 Hz, J = 15.0 
Hz, 1H), 3.33 (dd, J = 5.0 Hz, J = 14.5 Hz, 1H), 3.67 (s, 3H), 4.18-4.19 (m, 1H), 
4.45 (t, J = 7.5 Hz, 1H), 4.86-4.90 (m, 1H), 5.16 (s, 1H), 5.28 (s, 1H), 5.32 (br. d, 
J = 8.5 Hz, 1H), 6.75 (d, J = 6.5 Hz, 1H), 6.83 (d, J = 7.5 Hz, 1H), 6.95 (s, 1H), 
7.09 (t, J = 8.5 Hz, 1H), 7.15 (t, J = 7.0 Hz, 1H), 7.32 (d, J = 8.5 Hz, 1H), 7.48 (d, 
J = 8.0 Hz, 1H), 8.45 (br. s, 1H); 13C NMR (CDCl3, 125 MHz): δ 18.2, 27.4, 28.2 
(3C), 32.9, 34.1, 38.4, 48.9, 52.3, 52.9, 53.7, 80.7, 108.5, 109.4, 110.2, 111.3, 
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112.6, 113.4, 115.7, 117.8, 118.3, 119.5, 122.1, 123.1, 127.5, 133.0, 136.1, 
155.5, 170.3, 171.4, 172.0; 19F NMR (CDCl3, 282 MHz): δ -53.7, -50.5, -49.3, -
40.2, -8.3; ESIHRMS Calcd for C33H37F13N4O6S1 [M+H]+: 865.2299, found 
865.2298. 
S-Allyl 2,3,4,6-Tetra-O-acetyl-1-thio-β-D-glucopyranoside (207).  
Following the general procedure 2, the title compound was obtained in 
55% yield as colorless oil. The selenosulfide intermediate was heated with 2.5 
equiv of triphenylphosphine in MeOH to complete the [2,3]-sigmatropic 
rearrangement. [α]27D -15.7 (c=1, CHCl3); 1H NMR (400 MHz, CDCl3,): δ 2.01 (s, 
3H), 2.03 (s, 3H), 2.05 (s, 3H), 2.08 (s, 3H), 3.22 (dd, J = 5.9 Hz, J = 13.5 Hz, 
1H), 3.39 (dd, J = 8.6 Hz, J = 13.5 Hz, 1H), 3.63 - 3.67 (m, 1H), 4.13 (dd, J = 2.3 
Hz, J = 12.3 Hz, 1H), 4.22 (dd, J = 5.1 Hz, J = 12.3 Hz, 1H), 4.48 (d, J = 10.1 Hz, 
1H), 5.06 (t, J = 9.9 Hz, 1H), 5.07 (t, J = 9.8 Hz, 1H), 5.12-5.13 (m, 1H), 5.15 - 
5.17 (m, 1H), 5.22 (t, J = 9.3 Hz, 1H), 5.76 - 5.8 (m, 1H); 13C NMR(100 MHz, 
CDCl3,): δ 20.5, 20.6, 20.7, 20.7, 32.8, 62.2, 68.3, 69.8, 73.8,75.7, 81.8, 118.0, 
133.3, 169.4, 169.4, 170.2, 170.6. ESIHRMS Calcd for C17H24O9S [M+Na]+: 
427.1039 found 427.1050. 
Methyl (methyl 2,3-di-O-benzyl-α-D-glucopyranoside-α-D-
glucopyranosyl)uronate (215). 
To a stirred solution of Methyl 2,3-di-O-benzyl-α-D-glucopyranoside 214 
(2.2 g, mmol) in a mixture of saturated solution of NaHCO3 (25 mL) and THF (25 
mL) was added KBr (75 mg) and TEMPO (75 mg). The reaction mixture was 
cooled to 0 °C and commercial bleach (60 mL) was added slowly over a period of 
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2 h. The reaction mixture was quenched with the addition of sodium thiosulfate 
solution (25 mL) and acidified with 1N HCl solution (40 mL). It was extracted with 
EtOAc (100 mL) and the organic portion was dried over Na2SO4 and evaporated 
to dryness. To a stirred solution of this crude acid in MeOH (40 mL) was added 
IR-120 H+ resin (2.0 g) and the mixture was refluxed under N2 atmosphere for 24 
h. Solvents were evaporated and the residue was purified by column 
chromatography using EtOAc/hexanes as eluent to give the title product 75% 
yield. 1H NMR (500 MHz, CDCl3): δ 7.39 – 7.28 (m, 10H), 4.93 (d, J = 11.0 Hz, 
1H), 4.83 (d, J = 11.5 Hz, 1H), 4.80 (d, J = 12.0 Hz, 1H), 4.68 – 4.65 (m, 2H), 
4.17 (d, J = 9.5 Hz, 1H), 3.86 – 3.81 (m, 3H), 3.79 (s, 3H), 3.55 (dd, J = 9.0 Hz, J 
= 3.0 Hz, 1H), 3.44 (s, 3H). 13C NMR (125 MHz, CDCl3): δ 170.9, 138.8, 138.2, 
128.7, 128.7, 128.4, 128.2, 128.1, 128.0, 98.9, 80.6, 78.7, 75.7, 73.8, 72.0, 70.8, 
56.1, 52.9. 
Methyl (methyl 2,3-di-O-benzyl-4-deoxy-α-D-erythreo-
glucopyranosyl)uronate (216). 
To a stirred solution of 215 (1.65 g, 4.11 mmol) in CH2Cl2 (20 ml) was 
added DMAP (50 mg, 0.411 mmol) and pyridine (1.66 ml, 20.5 mmol). Acetyl 
chloride (0.65 g, 8.22 mmol) was added and the reaction was stirred at room 
temperature for 2 h. The reaction mixture was quenched with the addition of 
saturated NH4Cl (25 ml) and diluted with CH2Cl2 (40 ml). The combined organic 
part was washed with water (50 ml) and dried over Na2SO4. The solvents were 
evaporated to dryness and the residue was dissolved in benzene (20 ml). DBU 
(3.12 g, 20.5 mmol) was added and the reaction was refluxed for 2 h under an 
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atmosphere of N2. Solvents were removed under vacuum and the crude product 
was purified by column chromatography over silica gel using 40% 
EtOAc/hexanes as eluent to afford the title product. [α]27D 30.7 (c=1, CHCl3);  1H 
NMR (500 MHz, CDCl3): δ 7.38 – 7.28 (m, 10H), 6.15 (d, J = 3.0 Hz, 1H), 4.93 (d, 
J = 2.0 Hz, 1H), 4.83 (d, J = 12.0 Hz, 1H), 4.73 (d, J = 12.0 Hz, 1H), 4.71 (s, 2H), 
4.38 (dd, J = 7.5 Hz, J = 3.0 Hz, 1H), 3.81 (s, 3H), 3.81 – 3.79 (m, 2H), 3.50 (s, 
3H). 13C NMR (125 MHz, CDCl3): δ 162.8, 140.8, 138.2, 138.1, 128.7, 128.7, 
128.4, 128.3, 128.2, 128.0, 128.0, 128.0, 111.0, 100.1, 76.2, 73.6, 73.4, 72.2, 
57.1, 52.6. 
Methyl 2,3-di-O-benzyl-4-deoxy-hex-4-enopyranoside (217). 
To a stirred solution of 216 (1.2 g, 3.08 mmol) in THF (20 ml) was added 
LAH (293 mg, 7.71 mmol) and the reaction mixture was stirred at 0 °C for 4 h. 
The reaction mixture was quenched with the addition of saturated water (10 ml) 
and the addition of 1N NaOH (10 ml). The reaction mixture was diluted with 
EtOAc (30 ml) and filtered through a pad of silate. The combined organic portion 
was washed with water (30 ml) and dried over Na2SO4. The solvents were 
evaporated to dryness and the crude product was purified by column 
chromatography over silica gel using 60% EtOAc/hexanes as eluent to afford the 
title product. [α]27D 32.7 (c=1, CHCl3);  1H NMR (500 MHz, CDCl3): δ 7.39 – 7.28 
(m, 10H), 5.02 (d, J = 3.0 Hz, 1H), 4.85 (d, J = 2.5 Hz, 1H), 4.81 – 4.75 (m, 2H), 
4.62 (s, 2H), 4.19 – 4.18 (m, 1H), 4.05 – 4.03 (m, 2H), 3.78 (dd, J = 6.5 Hz, J = 
2.0 Hz, 1H), 3.52 (s, 3H). 13 C NMR (125 MHz, CDCl3): δ 138.6, 138.3 (2C), 
128.7, 128.6, 128.3, 128.1, 127.9, 127.9, 99.8, 76.1, 73.4, 73.3, 71.5, 62.5, 57.0 
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Methyl 2,3-di-O-benzyl-4,6-dideoxy-6-bromomethyl hex-4-enopyranoside 
(218). 
To a stirred solution of alcohol 217 (760 mg, 2.13 mmol) in CH2Cl2 (30 mL) 
was added triphenylphosphine (670 mg, 2.56 mmol) and carbon tetrabromide 
(849 mg, 2.56 mmol) at – 78 °C. The reaction mixture was slowly allowed to 
reach to room temperature. The reaction mixture was diluted with CH2Cl2 (30 ml) 
and water (30 ml). The organic portion was separated and dried over Na2SO4. 
The solvents were evaporated to dryness and the crude product was purified by 
column chromatography over neutral alumina using 30% EtOAc/hexanes as 
eluent to afford the title product. [α]27D 43.7 (c=1, CHCl3); 1H NMR (500 MHz, 
CDCl3): δ 7.40 – 7.28 (m, 10H), 5.13 (d, J = 3.0 Hz, 1H), 4.88 (d, J = 2.5 Hz, 1H), 
4.83 – 4.75 (m, 2H), 4.81 (d, J = 12.0 Hz, 1H), 4.76 (d, J = 12.0 Hz, 1H), 4.68 – 
4.62 (m, 2H), 4.26 (dd, J = 7.5 Hz, J = 3.0 Hz, 1H), 3.85 (s, 2H), 3.78 (dd, J = 7.5 
Hz, J = 2.5 Hz, 1H), 3.57 (s, 3H). 13C NMR (125 MHz, CDCl3): δ 147.8, 138.5, 
138.3, 128.7, 128.7, 128.3, 128.2, 128.1, 128.1, 128.0, 128.0, 127.9, 127.9, 
102.2, 99.8, 76.5, 73.7, 73.4, 72.0, 57.0, 30.6. 
Methyl 2,3-di-O-benzyl-4,6-dideoxy-6-selenocyanatomethyl hex-4-
enopyranoside (211). 
Following the general procedure 1, the title product was obtained in 70% 
yield and was directly proceeded to the next step without further purification. 1H 
NMR (500 MHz, CDCl3): δ 7.38 – 7.28 (m, 10H), 5.09 (d, J = 3.0 Hz, 1H), 4.87 (d, 
J = 2.0 Hz, 1H), 4.81 – 4.74 (m, 2H), 4.63 (s, 2H), 4.20 (dd, J = 6.5 Hz, J = 2.5 
Hz, 1H), 3.76 (dd, J = 6.0 Hz, J = 2.5 Hz, 1H), 3.69 – 3.67 (m, 1H), 3.62 – 3.61 
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(m, 1H), 3.57 (s, 3H). 13C NMR (125 MHz, CDCl3): δ 146.9, 138.4, 138.2, 128.7, 
128.7, 128.6, 128.6, 128.3, 128.2, 128.0, 128.0, 128.0, 101.9, 100.2, 75.9, 73.4, 
73.1, 71.7, 57.4, 30.8. 
Methyl 3-[(3,4-bis(benzyloxy)-2-methoxy-3,4-dihydro-2-H-pyran-6-
yl)methylselenylthio]-2-(tert-butoxycarbonylamino)propanoate (213). 
To a stirred solution of crude selenocyanate 211(180 mg, mmol) in MeOH 
(5.0 mL) was added Boc-L-Cys-OMe (100 mg, mmol) in MeOH (2.0 mL). The 
reaction was stirred at room temperature for 2 h. Solvents were evaporated and 
the crude selenosulfide was purified by column chromatography over silica gel 
using 50% EtOAc/hexanes as eluent to give the title product 65% yield. 1H NMR 
(500 MHz, CDCl3): δ 7.39 – 7.28 (m, 10H), 5.33 (d, J = 8.0 Hz, 1H), 4.97 (d, J = 
3.0 Hz, 1H), 4.83 (d, J = 2.5 Hz, 1H), 4.81 – 4.74 (m, 2H), 4.65 – 4.64 (m, 2H), 
4.56 – 4.53 (m, 1H), 4.17 (dd, J = 6.5 Hz, J = 2.5 Hz, 1H), 3.78 – 3.74 (m, 1H), 
3.73 (s, 3H), 3.54 (s, 3H), 3.50 – 3.46 (m, 3H), 3.29 – 3.22 (m, 2H), 1.45 (s, 9H). 
13C NMR (125 MHz, CDCl3): δ 171.5, 148.7, 138.6, 138.4, 128.7, 128.6, 128.6, 
128.3, 128.1, 127.9, 127.8, 100.2, 99.9, 76.1, 73.6, 73.3, 71.5, 57.2, 53.9, 52.7, 
40.7, 34.3, 28.6. 
1,2-bis[(3,4-bis(benzyloxy)-2-methoxy-3,4-dihydro-2-H-pyran-6-
yl)methyl]diselane (220). 
1H NMR (500 MHz, CDCl3): δ 7.36 – 7.26 (m, 20 H), 4.93 (d, J = 5.0 Hz, 
2H), 4.78 (d, J = 4.0 Hz, 2H), 4.74 (d, J = 6.5 Hz, 4H), 4.59 (s, 4H), 4.15 (dd, J = 
11.0 Hz, J = 5.0 Hz, 2H), 3.71 (dd, J = 12.0 Hz, 4.0 Hz, 2H), 3.54 (s, 4H), 3.50 (s, 
6H). 
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Methyl 2-O-benzoyl-6-O-(tert-butyldiphenylsilyl)-3,4-dideoxy-α-D-hex-3-eno 
pyranoside (226).  
Following the known literature procedure methyl 2-O-benzoyl-6-O-(tert-
butyldiphenylsilyl)-α-D-glucopyranoside (225) was converted to the title product 
and the characterization data were in agreement with the literature data. 1H NMR 
(500 MHz, CDCl3): δ 8.09 (d, J = 8.0 Hz, 1H), 7.69 – 7.68 (m, 4H), 7.58 – 7.55 
(m, 2H), 7.46 – 7.38 (m, 8H), 6.04 (d, J = 10.5 Hz, 1H), 5.81 (d, J = 10.5 Hz, 1H), 
5.53 (s, 1H), 5.21 (d, J = 4.0 Hz, 1H), 4.28 – 4.27 (m, 1H), 3.81 (dd, J = 9.5 Hz, J 
= 5.5 Hz, 1H), 3.74 (dd, J = 10.5 Hz, J = 6.0 Hz, 1H), 3.45 (s, 3H), 1.08 (s, 9H). 
Methyl 6-O-(tert-butyldiphenylsilyl)-3,4-dideoxy-α-D-hex-3-eno pyranoside 
(227). 
To a stirred solution of 226 (490 mg, 2.0 mmol) in MeOH (20.0 mL) was 
added a catalytic amount of metallic sodium. The reaction mixture was stirred at 
room temperature for 2 h and neutralized with Amberlyst 15 H+ resin. Solvents 
were removed and the residue was purified by column chromatography over 
silica gel using 50% EtOAc/hexanes to give the title compound as colorless oil. 
[α]D26 – 8.0 (c = 1, CHCl3). 1H NMR (500 MHz, CDCl3) δ 7.68 – 7.66 (m, 2H), 
7.44 – 7.36 (m, 8H), 5.84 (d, J = 10.5 Hz, 1H), 5.74 (d, J = 10.5 Hz, 1H), 4.86 (d, 
J = 4.0 Hz, 1H), 4.19 – 4.12 (m, 2H), 3.74 (dd, J = 10.0 Hz, J = 5.5 Hz, 1H), 3.65 
(dd, J = 10.0 Hz, J = 5.5 Hz, 1H), 3.49 (s, 3H), 2.19 (d, J = 11.0 Hz, 1H), 1.06 (s, 
9H). 13C NMR (CDCl3) δ 135.7, 135.6, 129.7, 127.7, 127.7, 127.4, 98.0, 68.9, 
66.1, 64.4, 55.9, 26.8, 19.3 
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Methyl 2-O-sulfonyl methyl-6-O-(tert-butyldiphenylsilyl)-3,4-dideoxy-α-D-
hex-3-eno pyranoside (228). 
To a stirred solution of alcohol 227 (190 mg, 0.48 mmol) in CH2Cl2 (10.0 
mL) was added triethylamine (0.13 mL, 0.96 mmol) followed by methane 
sulfonylchloride (0.05 mL, 0.72 mmol) at 0 °C and the reaction mixture was 
stirred at the same temperature for 2 h. The reaction mixture was diluted with 
saturated NaHCO3 solution (10.0 mL). The organic part was separated and 
evaporated to dryness to give the title product in 75% yield as colorless oil. [α]D26 
– 18.0 (c = 1, CHCl3).  1H NMR (500 MHz, CDCl3) δ 7.69 – 7.67 (m, 5H), 7.46 – 
7.38 (m, 5H), 6.06 – 6.04 (m, 1H), 5.79 – 5.76 (m, 1H), 5.22 – 5.20 (m, 1H), 5.11 
– 5.10 (m, 1H), 4.27 – 4.25 (m, 1H), 3.78 (dd, J = 10.5 Hz, J = 5.5 Hz, 1H), 3.73 
(dd, J = 10.5 Hz, J = 5.5 Hz, 1H), 3.51 (s, 3H), 3.00 (s, 3H), 1.09 (s, 9H). 13C 
NMR (125 MHz, CDCl3) δ 135.7, 135.6, 133.3, 133.2, 131.5, 129.9, 129.8, 127.8, 
121.8, 96.0, 71.6, 69.5, 65.6, 56.1, 38.8, 26.8, 19.3 
Methyl 2-deoxy-2-selenocyanato-6-O-(tert-butyldiphenylsilyl)-3,4-dideoxy-α-
D-hex-3-eno pyranoside (229).. 
To a stirred solution of 228 (130 mg, 0.27 mmol) in THF (5.0 mL) was 
added potassium selenocyanate (79 mg, 0.54 mmol). The reaction was refluxed 
for 12 h under an atmosphere of N2. Solvents were evaporated and the reaction 
mixture was washed with EtOAc (10.0 mL) and water (10.0 mL). The organic 
portion was dried over Na2SO4 and evaporated to dryness to give the title 
compound as an inseparable mixture. 1H NMR (500 MHz, CDCl3) δ 7.73 – 7.66 
(m, 5H + 5H), 7.49 – 7.38 (m, 5H + 5H), 6.30 (dd, J = 10.0 Hz, J = 5.5 Hz, 1H), 
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6.10 (d, J = 10.5 Hz, 1H), 5.97 – 5.93 (m, 2H), 4.97 (d, J = 2.5 Hz, 1H), 4.31 – 
4.30 (m, 1H), 4.25 – 4.22 (m, 2H), 4.01 (dd, J = 5.5 Hz, J = 2.5 Hz, 1H), 3.97 – 
3.95 (m, 1H), 3.94 – 3.91 (m, 1H), 3.88 – 3.84 (m, 3H ), 3.81 – 3.78 (m, 1H), 3.46 
(s, 3H, one isomer), 3.37 (s, 3H, one isomer), 1.08 (s, 9H, one isomer), 1.07 (s, 
9H, one isomer). 13C NMR (125 MHz, CDCl3) δ 135.7, 135.6, 135.5, 133.3, 
132.3, 130.1, 130.1, 130.0, 129.8, 129.8, 129.6, 128.6, 128.2, 128.0, 127.9 (2C), 
127.8 (2C), 127.8, 124.5, 121.7, 120.7, 100.4, 95.4, 95.0, 95.0, 71.5, 71.4, 70.2, 
68.8, 68.7, 67.9, 65.7, 65.2, 62.8, 56.2, 56.0, 55.8, 55.8, 55.6, 50.3, 43.4, 42.9, 
39.7, 38.8, 26.9, 26.8, 19.4, 19.2. 
Methyl 2-deoxy-2-bromo-6-O-(tert-butyldiphenylsilyl)-3,4-dideoxy-α-D-hex-3-
eno pyranoside (231).. 
To a stirred solution of alcohol 227 (200 mg, 0.50 mmol) in CH2Cl2 (10 mL) 
was added triphenylphosphine (158 mg, 0.60 mmol) and carbon tetrabromide 
(199 mg, 0.60 mmol) at –78 °C. The reaction mixture was slowly allowed to reach 
to room temperature. The reaction mixture was diluted with CH2Cl2 (10 ml) and 
water (10 ml). The organic portion was separated and dried over Na2SO4. The 
solvents were evaporated to dryness and the crude product was purified by 
column chromatography over neutral alumina using 30% EtOAc/hexanes as 
eluent to afford the title product. [α]D26 – 36.0 (c = 1, CHCl3).   1H NMR (500 MHz, 
CDCl3) δ 7.74 – 7.72 (m, 5H), 7.46 – 7.40 (m, 5H), 6.01 – 6.00 (m, 2H), 5.09 (s, 
1H), 4.39 – 4.37 (m, 2H), 3.91 (dd, J = 10.5 Hz, J = 5.0 Hz, 1H), 3.80 (dd, J = 
10.0 Hz, J = 6.5 Hz, 1H), 3.47 (s, 3H), 1.12 (s, 9H).13C NMR (500 MHz, CDCl3) δ 
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135.7, 135.7, 133.4, 133.4, 129.8, 127.8, 124.3, 100.7, 68.7, 65.7, 56.0, 42.7, 
26.9, 19.4. 
Methyl 2-deoxy-2-selenocyanato-6-O-(tert-butyldiphenylsilyl)-3,4-dideoxy-α-
D-hex-3-eno pyranoside (229). 
To a stirred solution of 231 (100 mg, 0.22 mmol) in THF (5.0 mL) was 
added potassium selenocyanate (38 mg, 0.26 mmol). The reaction was refluxed 
for 16 h under an atmosphere of N2. Solvents were evaporated and the reaction 
mixture was washed with EtOAc (10.0 mL) and water (10.0 mL). The organic 
portion was dried over Na2SO4 and evaporated to dryness to give the title 
compound as an inseparable mixture. 1H NMR (500 MHz, CDCl3) δ 7.73 – 7.66 
(m, 5H + 5H), 7.49 – 7.38 (m, 5H + 5H), 6.30 (dd, J = 10.0 Hz, J = 5.5 Hz, 1H), 
6.10 (d, J = 10.5 Hz, 1H), 5.97 – 5.93 (m, 2H), 4.97 (d, J = 2.5 Hz, 1H), 4.31 – 
4.30 (m, 1H), 4.25 – 4.22 (m, 2H), 4.01 (dd, J = 5.5 Hz, J = 2.5 Hz, 1H), 3.97 – 
3.95 (m, 1H), 3.94 – 3.91 (m, 1H), 3.88 – 3.84 (m, 3H ), 3.81 – 3.78 (m, 1H), 3.46 
(s, 3H, one isomer), 3.37 (s, 3H, one isomer), 1.08 (s, 9H, one isomer), 1.07 (s, 
9H, one isomer). 13C NMR (125 MHz, CDCl3) δ 135.7, 135.6, 135.5, 132.8, 
132.6, 132.4, 130.1, 130.0, 129.8, 129.8, 128.6, 128.2, 127.9, 127.8, 127.7, 
120.6, 101.6, 101.6, 100.4, 95.4, 95.0, 68.9, 67.9, 65.6, 65.1, 55.6, 43.4, 42.9, 
26.9, 26.8, 19.2. 
Dithiocarbonic acid O-[4-(tert-butyl-dimethyl-silanyloxy)-but-2-enyl] ester S-
methyl ester. (246).  
To a solution of (E)-4-(tert-butyldimethylsiloxy)-but-2-en-1-ol 245 (2.02 g, 
10.0 mmol) in THF (40 mL) was added NaH (520 mg, 13.0 mmol, 60% in mineral 
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oil) in portion at 0 °C. The solution was stirred for 45 minutes and carbon 
disulfide (1.5 mL, 25.0 mmol) was added. After 30 minutes, methyl iodide (0.94 
mL, 15.0 mmol) was added slowly and the solution was stirred at room 
temperature for 45 minutes. The reaction was quenched with NH4Cl and 
extracted with Et2O. The organic layer was washed with water, brine and 
evaporated. Chromatographic purification (hexanes/CH2Cl2) afforded 246 (2.56 
g, 87%) as yellow oil. 1H NMR (400 MHz, CDCl3): δ 5.80 (m, 1H), 5.69 (m, 1H), 
5.19 (d, J = 6.6 Hz, 2H), 4.30 (d, J = 5.6 Hz, 2H), 2.56 (s, 3H), 0.90 (s, 9H), 0.08 
(s, 6H); 13C NMR (100 MHz, CDCl3): δ 215.8, 135.2, 123.1, 69.8, 60.1, 26.2, 
19.4, 18.6, -5.0; EIHRMS Calcd. for C12H24O2S2SiNa [M+Na]+ 315.08850, found 
315.0870. 
Dithiocarbonic acid S-[1-(tert-butyldimethylsiloxymethyl)-allyl]ester-S-
methyl ester (247);  
Following the general procedure 7, and eluting with hexanes/CH2Cl2 from 
95/5 to 80/20 afforded the title product 247 (552 mg, 94%) as yellow oil and the 
characterization data were in agreement with the literature. 1H NMR (400 MHz, 
CDCl3): δ 5.88 (ddd, J = 17.0, 10.4, 8.0 Hz, 1H), 5.32 (dt, J = 17.0, 1.0 Hz, 1H), 
5.17 (d, J = 10.4 Hz, 1H), 4.32 (m, 1H), 3.78 (m, 2H), 2.41 (s, 3H), 0.88 (s, 9H), 
0.05 (s, 6H); 13C NMR (100 MHz, CDCl3): δ 189.2, 134.9, 118.2, 65.5, 50.6, 26.1, 
18.5, 13.3, -5.1, -5.2; EIHRMS Calcd. for C12H24O2S2SiNa [M+Na]+: 315.08850, 
found 315.0884. 
2-[1-(tert-Butyl-dimethyl-silanyloxymethyl)-allyldisulfanyl]-benzothiazole 
(248).  
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To a solution of 247 (838 mg, 2.97 mmol) in THF (7.0 mL) was added 
ethanolamine (1 mL, 17.2 mmol) and the solution was stirred at room 
temperature for 4 h. A solution of 2,2’-dithiobis(benzothiazole) (1.9 g, 5.73 mmol) 
in chloroform (40 mL) was added over a period of 15 min and the reaction 
mixture was stirred for another 1 h. The reaction mixture was filtered over celite 
and washed with water extracted with CH2Cl2 (20.0 mL), dried over Na2SO4 and 
evaporated. Chromatographic purification (hexane/CH2Cl2 from 95/5 to 80/20) 
afforded the title product as colorless oil and the characterization data were in 
agreement with the literature. 1H NMR (400 MHz, CDCl3): δ 7.86 (d, J = 8.4 Hz, 
1H), 7.79 (d, J = 8.1 Hz, 1H), 7.43 (m, 1H), 7.33 (m, 1H), 5.83 (ddd, J = 17.1, 
10.3, 9.0 Hz, 1H), 5.28 (d, J = 17.1 Hz, 1H), 5.23 (d, J = 10.3 Hz, 1H), 3.96 (dd, J 
= 10.6, 5.7 Hz, 1H), 3.91 (dd, J = 10.6, 5.7 Hz, 1H), 3.75 (dt, J = 9.0, 5.7 Hz, 1H), 
0.92 (s, 9H), 0.089 (s, 3H), 0.086 (s, 3H); 13C NMR (100 MHz, CDCl3): δ 173.9, 
155.4, 136.1, 133.7, 126.4, 124.7, 122.3, 121.3, 120.3, 64.8, 58.0, 26.1, 18.6, -
5.1; EIHRMS Calcd for C17H25NOS3SiNa [M+Na]+ 406.07655, found 406.0762. 
2-(Benzothiazol-2-yldisulfanyl)-but-3-en-1-ol (240).  
To a stirred solution of 248 (255 mg, 0.8 mmol) in MeOH/CH2Cl2 (2:8) was 
added PTSA (141 mg, 0.78 mmol) and the reaction mixture was stirred at room 
temperature for 16 h. The reaction mixture was diluted with CH2Cl2 (20.0 mL) and 
the combined organic layers were washed with brine, dried over Na2SO4, filtered 
and evaporated. Chromatographic purification (hexanes/EA from 95/5 to 80/20) 
afforded the title product 240 (147 mg, 70%) as white solid. 1H NMR (400 MHz, 
CDCl3) δ 7.90 (d, J = 8.1 Hz, 1H), 7.77 (d, J = 8.0 Hz, 1H), 7.45 (m, 1H), 7.35 (m, 
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1H), 5.92 (m, 1H), 5.33 (d, J = 17.9 Hz, 1H), 5.29 (d, J = 10.7 Hz, 1H), 3.90 (m, 
1H), 3.80-3.73 (m, 1H). 13C NMR (100 MHz, CDCl3) δ 170.7, 153.1, 136.1, 133.4, 
126.8, 125.4, 122.1, 121.5, 120.0, 62.2, 57.3. 
4-Vinyl-[1,3]dioxolane-2-thione (250).   
To a stirred solution of but-3-ene-1,2-diol 249 (10.0 g, 113.5 mmol) in 
dichloromethane (200 mL) under a nitrogen atmosphere was added pyridine 
(19.7 g, 249.7 mmol) followed by DMAP (1.39 g, 11.35 mmol) at 0 oC. 
Thiophosgene (14.36 g, 124.8 mmol) dissolved in dichloromethane (100 mL) 
then was added dropwise over a period of 2 h. The reaction mixture was stirred 
at room temperature for 3 h and then diluted with 1.0 M HCl (100 mL). The 
organic part was separated and washed with sat NaCl (100 mL), dried over 
sodium sulfate and evaporated to dryness. The crude product was purified by 
column chromatography using EtOAc/hexanes as eluent to give 4-vinyl-
[1,3]dioxolane-2-thione (250) as a dark yellow liquid. (12.5 g, 85%). IR (neat): 
1709 cm-1. 1H NMR (500 MHz): 5.95 (ddd, J = 17.5, J = 10.0, J = 7.0 Hz, 1H), 
5.56 (d, J = 17.0 Hz, 1H), 5.51 (d, J = 10.5 Hz, 1H), 5.34 (q, J = 8.0 Hz, 1H), 4.78 
(t, J = 8.5 Hz, 1H), 4.36 (t, J = 8.5 Hz, 1H). 13CNMR (125 MHz): δ 191.7, 131.2, 
122.8, 82.7, 73.1. EI+: calc. for C5H6O2S 130.0089, found 130.0064.        
4-Vinyl-1,3-oxathiolan-2-one (251).   
To a stirred solution of 4-vinyl-[1,3]dioxolane-2-thione (250) (5.08 g, 39.07 
mmol) in degassed ethanol (150 mL) (0.26 M) was added Pd(PPh3)4 (904 mg, 
0.78 mmol).  The reaction mixture was stirred at 75 oC for 1 h after which the 
dark brown mixture was cooled to room temperature, and solvents were 
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evaporated and the product was purified by column chromatography using 
EtOAc/Hexanes as eluent to give 4-vinyl-1,3-oxathiolan-2-one (251) as a 
colorless oil. (4.0 g, 80%). IR (neat): 1738 cm-1. 1H-NMR (500 MHz): δ 5.89 (ddd, 
J = 17.0, J = 10.0, J = 7.0 Hz, 1H), 5.41 (d, J = 17.0 Hz, 1H), 5.29 (d, J = 10.0 
Hz, 1H), 4.62 - 4.55 (m, 2H), 4.24 - 4.19 (m, 1H). 13C-NMR (125 MHz): δ 172.8, 
133.2, 120.4, 72.7, 51.6.  EI+: calc. for C5H6O2S 130.0089, found 130.0089. 
2-(Pyridin-2-yldisulfanyl)-but-3-en-1-ol (252).   
To a stirred solution of 4-vinyl-1,3-oxathiolan-2-one (251) (2.0 g, 15.4 
mmol) in dry ether (15 mL) cooled to 0 oC was added LiAlH4 (584 mg, 15.4mmol).  
The reaction mixture was stirred at the same temperature for 30 min and then at 
room temperature for 2 h before ethyl acetate (5 mL) was added followed by the 
sequential addition of 1.0 M HCl (10.0 mL) and MeOH (10.0 mL).  The reaction 
mixture was stirred at room temperature for 30 min and then filtered through a 
pad of Celite with washing of the filter pad with MeOH (10.0 mL) and 1.0 M HCl 
(5.0 mL). The filtrate and washings were transferred to a solution of 2,2’dipyridyl 
disulfide (3.0 g, 13.62 mmol) in MeOH (10.0 mL). The reaction mixture was 
stirred at room temperature under a nitrogen atmosphere for 1 h before the 
solvents were evaporated and the crude reaction mixture was dissolved in EtOAc 
(100.0 mL), and washed with sat bicarbonate solution (50 mL).  The ethyl acetate 
portion was further washed with brine solution (50 mL), dried over sodium 
sulfate, filtered and evaporated to dryness. The crude product was purified by 
column chromatography on silica gel using EtOAc/Toluene as eluent to give 2-
(pyridin-2-yldisulfanyl)-but-3-en-1-ol (252) as a colorless liquid. (1.47 g, 45% for 
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two steps). 1H-NMR (400 MHz): δ 8.48 (dd, J = 1.5 Hz, J = 4.8 Hz, 1H), 7.56 (m, 
1H), 7.38 (d, J = 7.8 Hz, 1H), 7.14 (dd, J = 7.2 Hz, J = 4.8 Hz, 1H), 5.94 (m, 1H), 
5.88 (m, 1H), 5.24 (dd, J = 16.5 Hz, J = 9.3 Hz, 2H), 3.79 (m, 1H), 3.62 (m, 2H). 
13C-NMR (125 MHz,): δ 159.2, 150.0, 137.1, 134.3, 122.2, 121.8, 118.6, 61.4, 
56.6. ESIHRMS: calc. for C9H11NOS2Na [M+Na+ 236.0180, found 236.0191. 
(E)-S-Methyl O-tridec-2-enyl carbonodithioate (254).  
To a solution of trans-2-tridecen-1-ol (1.0 g, 3.0 mmol) in benzene (15.0 
mL) and THF (2.0 mL) was added NaH (775 mg, 5.4 mmol). Thereaction mixture 
was stirred at room temperature for 1 hour and CS2 (0.56 mL, 9.0 mmol) was 
added. After 30 minutes, methyl iodide (0.35 mL, 5.40 mmol) was added slowly 
and the milky solution was stirred at room temperatue for 40 minutes. The 
reaction was quenched with AcOH (3 mL) and filtered through a pad of celite.. 
The precipitate was washed with Et2O (2 x 30 mL) and the combined organic 
layers were evaporated. Chromatographic purification (hexanes/CH2Cl2 from 
100/0 to 90/10) afforded the title product (1.0g, 80%) as colorless oil. 1H NMR 
(300 MHz, CDCl3): δ 5.87 (m, 1H), 5.68 (m, 1H), 5.03 (d, J = 6.7 Hz, 2H), 2.56 (s, 
3H), 2.07 (q, J = 6.9 Hz, 2H), 1.40-1.20 (m, 16H), 0.88 (t, J = 6.9 Hz, 3H). 
S-Methyl S-tridec-1-en-3-yl carbonodithioate (255).  
Following the general procedure 7 the title compound was obtained in 
90% yield and the characterization data were in agreement with the literature. 1H 
NMR (400 MHz, CDCl3): δ 5.75 (m, 1H), 5.24 (dt, J = 17.0, 1.0 Hz, 1H), 5.09 (d, J 
= 10.1 Hz, 1H), 4.16 (q, J = 7.6 Hz, 1H), 2.40 (s, 3H), 1.68-1.62 (m, 2H), 1.36-
1.23 (m, 16H), 0.87 (t, J = 6.8 Hz, 3H); 13C NMR (100 MHz, CDCl3): δ = 189.3, 
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137.8, 116.8, 48.8, 34.3, 32.2, 29.9, 29.8, 29.7, 29.6, 29.5, 27.3, 23.0, 14.4, 13.3; 
EIHRMS: Calcd for C15H28OS2 [M]+ 288.15816, found 288.1589. 
2-(2-(Tridec-1-en-3-yl)disulfanyl)pyridine (256). 
 Following the same procedure used for the conversion of compound 251 
to Compound 252, the title product was obtained in 80% yield for the two steps 
and the characterization data were in agreement with the literature. 1H NMR (400 
MHz, CDCl3): δ= 8.42 (d, J = 4.6 Hz, 1H), 7.71 (dd, J = 8.0 Hz, 1H), 7.61 (m, 1H), 
7.05 (m, 1H), 5.62 (ddd, J = 16.9, 9.7, 9.5 Hz, 1H), 5.09-5.01 (m, 2H), 3.36 (m, 
1H), 1.77 (m, 1H), 1.62 (m, 1H), 1.45-1.10 (m, 16H), 0.87 (t, J = 6.7 Hz, 3H); 13C 
NMR (100 MHz, CDCl3): δ= 161.2, 149.5, 137.4, 137.0, 120.6, 120.0, 117.9, 
55.3, 33.6, 32.2, 29.8, 29.7, 29.6, 29.55, 29.4, 27.6, 22.9, 14.4; ESIHRMS Calcd 
for C18H30NS2 [M+H]+ 324.18142, found 324.18121. 
O-(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trienyl dimethylcarbamothioate 
(258).  
To a stirred solution of DMF (8.0 mL) was added sodium hydride (1.12 g, 
28 mmol) and trans, trans-farnesol 257 (5.01 mL, 20 mmol) in DMF (8.0 mL). The 
reaction mixture was stirred under an atmosphere of N2 1 h. The reaction mixture 
was cooled to 0 ºC, and dimethylthiocarbamoyl chloride (3.46 g, 28 mmol) was 
added in DMF (6.0 mL). The mixture was heated to 60 ºC for 1 h, then cooled to 
room temperature and poured into 1% KOH (80.0 mL). The aqueous layer was 
extracted with ether (2 X 50 mL). The ethereal layer was washed with brine, dried 
over Na2SO4, filtered and evaporated. Chromatographic purification afforded the 
title compound 258 (5.1 g, 85%) as slight yellow oil and the characterization data 
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were in agreement with the literature. 1H NMR (400 MHz, CDCl3): δ 5.41 (m, 1H), 
5.10-5.04 (m, 2H), 4.96 (d, J = 7.0 Hz, 2H), 3.35 (s, 3H), 3.09 (s, 3H), 2.12-2.00 
(m, 6H), 1.98-1.93 (m, 2H), 1.71 (s, 3H), 1.66 (s, 3H), 1.58 (s, 6H); 13C NMR (100 
MHz, CDCl3): δ 188.5, 142.3, 135.6, 131.5, 124.5, 123.9, 118.8, 68.8, 42.9, 39.9, 
39.7, 38.0, 26.9, 26.4, 25.9, 17.9, 16.9, 16.3; 
ESIHRMS: Calcd for C18H32NOS [M+H]+ 310.21991, found 310.21930. 
(E)-S-3,7,11-trimethyldodeca-1,6,10-trien-3-yl dimethylcarbamothioate (259). 
Following the general procedure 7, and eluting with EtOAc/hexanes the title 
compound was obtained in 85% yield and the characterization data were in 
agreement with the literature. 1H NMR (400 MHz, CDCl3): δ 6.15 (dd, J = 17.4, 
10.6 Hz, 1H), 5.16 (d, J = 17.4 Hz, 1H), 5.13 (d, J = 10.6 Hz, 1H), 5.12-5.05 (m, 
2H), 2.94 (s, 6H), 2.06-1.84 (m, 8H), 1.67 (s, 3H), 1.60 (s, 3H), 1.59 (s, 3H), 1.58 
(s, 3H); 13C NMR (100 MHz, CDCl3): δ 167.9, 143.3, 135.6, 131.6, 124.6, 124.0, 
113.6, 54.4, 40.4, 39.9, 36.7, 27.0, 26.0, 23.8, 23.5, 18.0, 16.3; ESIHRMS Calcd. 
for C18H32NOS [M+H]+ 310.2199, found 310.3193. 
2-(1,5,9-Trimethyl-1-vinyl-deca-4,8-dienyldisulfanyl)-benzothiazole (260). 
Following the similar procedure used for the conversion of compound 251 to 
Compound 252, the title product was obtained in 80% yield for the two steps and 
the characterization data were in agreement with the literature. 1H NMR (400 
MHz, CDCl3): δ 7.84 (d, J = 8.1 Hz, 1H), 7.77 (d, J = 7.9 Hz, 1H), 7.41 (m, 1H), 
7.31 (m, 1H), 5.84 (dd, J = 17.3, 10.6 Hz, 1H), 5.14 (d, J = 17.3 Hz, 1H), 5.11 (d, 
J = 10.6 Hz, 1H), 5.12-5.05 (m, 2H), 2.10-1.96 (m, 6H), 1.83-1.78 (m, 2H), 1.68 
(s, 3H), 1.59 (s, 6H), 1.48 (s, 3H); 13C NMR (100 MHz, CDCl3): δ 174.3, 155.0, 
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140.7, 136.2, 136.0, 131.7, 126.7, 124.7, 124.4, 123.4, 122.3, 121.2, 116.1, 58.1, 
39.90, 39.86, 26.8, 26.0, 23.8, 22.8, 18.0, 16.3; ESIHRMS Calcd for C22H29NS3 
[M]+ 403.1462, found 403.1447. 
Methyl 2-tert-butoxycarbonylamino-3-(1-hydroxymethyl-allyldisulfanyl)-
propionate (261).  
To a stirred solution of 2-(pyridin-2-yldisulfanyl)-but-3-en-1-ol (252) (160 
mg, 0.75 mmol) in methanol (6.0 mL) was added a solution of N-Boc-L-Cys-OMe 
(176 mg, 0.75 mmol) in methanol (1.5 mL). The reaction mixture was stirred at 
room temperature under N2 atmosphere for 4 h before the solvents were 
removed and the crude product was purified by column chromatography on silica 
gel using EtOAc/hexanes as eluent to give methyl 2-tert-butoxycarbonylamino-3-
(1-hydroxymethyl-allyldisulfanyl)-propionate (261) as a thick oil (139 mg, 55%). 
1H-NMR (500 MHz): δ 5.81 – 5.78 (m, 1H), 5.38 (d, J = 8.0 Hz, 1H), 5.35 – 5.26 
(m, 2H), 4.64 – 4.62 (m, 1H), 3.94 (d, J = 6.5 Hz, 2H), 3.80 (s, 3H), 3.57 – 3.49 
(m, 1H), 3.22 – 3.11 (m, 2H), 2.23 (br s, 1H), 1.42 (s, 9H), 13C NMR (125 MHz): δ 
171.7, 155.6, 134.8, 134.7, 119.7, 119.6, 80.9, 63.6, 57.2, 56.7, 53.5, 53.2, 42.0, 
41.8, 28.8. ESIHRMS: calc. for C13H23NO5S2Na [M+Na]+ 360.0915, found 
360.0933.  
 (E)-N-tert-Butoxycarbonyl-S-(4-hydroxybut-2-enyl)-L-cysteine methyl ester 
(262).  
Following the general procedure (10) for the silver nitrate promoted 
rearrangement of allylic disulfides compound 262 was prepared in 72% yield as 
an oil. [α]23D 23.5 (c = 1.0); 1H-NMR (500 MHz): δ 5.80 (dd, J = 15.0, J = 5.0 Hz, 
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1H), 5.68 (dd, J = 15.0, J = 6.0 Hz, 1H),  5.28 (d, J = 7.5 Hz, 1H), 4.51 (d, J = 8.0 
Hz, 1H), 4.15 (d, J = 5.5 Hz, 2H), 3.78 (s, 3H), 3.17 (d, J = 7.0 Hz, 2H), 2.84 (dd, 
J = 14.0, J = 5.5 Hz, 2H), 1.90 (br s, 1H), 1.46 (s, 9H). 13C-NMR (125 MHz): δ 
172.0, 156.0, 133.3, 127.7, 80.7, 63.2, 53.6, 52.8, 34.3, 33.3, 28.5. ESIHRMS: 
calc. for C13H23NO5SNa [M+Na]+ 328.1195, found 328.1183. 
(E)-4-(4-Chlorophenylsulfanyl)but-2-en-1-ol (263).   
Following the general procedure (10) for the silver nitrate promoted 
rearrangement of allylic disulfides, compound 19 was prepared in 51% yield.  1H 
NMR (500 MHz, C6D6) δ 6.94 – 6.87 (m, 5H), 5.47 – 5.41 (ddd, J = 15.0, J = 5.0, 
J = 1.3 Hz, 1H), 5.33 – 5.28 (ddd, J = 15.4, J = 5.0, J = 1.0 Hz, 1H), 3.60 (d, J = 
4.5 Hz, 2H), 3.05 (dd, J = 7.0, J = 1.0 Hz, 2H) 13C NMR (125 MHz) δ 135.2, 
133.3, 132.1, 131.0, 129.0, 125.4, 62.4, 35.7 
1-tert-Butyldimethylsilyloxy-2-(pyridin-2-yldisulfanyl)-but-3-ene (264).   
To a stirred solution of 2-(pyridin-2-yldisulfanyl)-but-3-en-1-ol (252) (1.0 g, 
4.69 mmol) in DMF (10.0 mL) under a nitrogen atmosphere was added imidazole 
(319 mg, 4.69 mmol) followed by tert-butyldimethylsilyl chloride (716 mg, 4.69 
mmol) at 0 oC. The reaction mixture was stirred at room temperature for 10 h. 
The reaction mixture was diluted with ethyl acetate (100 mL) and washed with 
water (100 mL). The organic part was washed with saturated NaCl solution (50 
mL), dried over sodium sulfate and evaporated to dryness. The crude product 
was purified by column chromatography on silica gel using EtOAc/Hexanes as 
eluent to give the title product (264) as oil. (1.20 g, 80%). 1H-NMR (500 MHz): δ 
8.44 (ddd, J = 5.0, J = 2.0, J = 1.0 Hz, 1H), 7.56 (m, 1H), 7.38 (d, J = 7.8 Hz, 1H), 
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7.14 (dd, J = 7.2, J = 4.8 Hz, 1H), 5.94 (m, 1H), 5.88 (m, 1H), 5.24 (dd, J = 16.5, 
J = 9.3 Hz, 2H), 3.79 (m, 1H), 3.62 (m, 1H), 0.90 (s, 9H), 0.06 (s, 6H). 13C-NMR 
(125 MHz): δ 161.2, 149.5, 137.1, 134.5, 120.6, 119.8, 119.2, 64.7, 57.1, 26.1, 
18.6, -5.1. ESIHRMS: calc. for C15H25NOS2SiNa [M+Na]+ 350.1045, found 
350.1042.  
(E)-S-4-Hydroxybut-2-enyl 2,3,4,6-tetra-O-acetyl-1-thio-β-D-glucopyranoside 
(265).   
To a stirred solution of 1-tert-butyldimethylsilyloxy-2-(pyridin-2-
yldisulfanyl)-but-3-ene (264) (115mg, 0.35mmol) in MeOH (2.0 mL) was added 1-
thio-β-D-glucose tetraacetate 91 (100 mg, 0.29 mmol) under a nitrogen 
atmosphere. The yellow colored solution was stirred at room temperature for 1 h 
before the solvents were removed and the crude reaction mixture was purified by 
column chromatography on silica gel to give the mixed disulfide. The mixed 
disulfide (78 mg, 0.13 mmol) was dissolved in MeOH (2.0 mL) and silver nitrate 
(46 mg, 0.27 mmol) was added. The reaction mixture was stirred at room 
temperature under a N2 atmosphere in the dark for 16 h before NaCl (75 mg, 1.3 
mmol) was added and the solution was stirred for 3-4 h and then diluted with 
MeOH (10.0 mL) , centrifuged.  The supernatant were evaporated to give the 
crude product which was purified by column chromatography on silica gel using 
EtOAc/Hexanes as eluent to give 265 (45 mg, 67%). [α]23D -49.5 (c = 1.0); 1H 
NMR (500 MHz) δ 5.78 (ddd, J = 15.5, J = 5.0, J = 5.0 Hz, 1H), 5.71 (dddd, J = 
15.5, J = 6.5, J = 6.5, J = 1.0 Hz, 1H), 5.22 (dd, J = 9.6, J = 9.5 Hz, 1H), 5.07 (dd, 
J = 9.6, J = 9.5 Hz, 1H), 5.06 (dd, J = 9.6, J = 9.5 Hz, 1H), 4.50 (d, J = 10.0 
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Hz,1H), 4.24 (dd, J = 12.0, J = 5.0 Hz, 1H), 4.18 - 4.10 (m, 2H), 4.15 (dd, J = 
12.0, J = 2.0 Hz, 1H), 3.68 (ddd, J = 9.5, J = 5.0, J = 2.0, 1H), 3.38 (dd, J = 13.5, 
J = 7.5, 1H), 3.26 (ddd, J = 13.5, J = 6.0, J = 1.0 Hz, 1H), 2.09 (s, 3H), 2.04 (s, 
3H), 2.03 (s, 3H), 2.00 (s, 3H), 1.77 (br s, 1H). 13C NMR (125 MHz) δ 170.9, 
170.5, 169.7, 169.6, 133.0, 127.2, 82.2, 76.0, 74.1, 70.2, 68.6, 63.0, 62.4, 31.6, 
20.9, 20.9, 20.8, 20.8  ESIHRMS: calc. for C18H26O10SNa [M+Na]+ 457.1144, 
found 457.1138. 
Tridec-2-enyl-(tetra-O-acetyl-1-thio-β-D-glucopyranoside) (266).  
Following the general procedure (10) for the silver nitrate promoted 
rearrangement of allylic disulfides the title compound 266 was prepared in 62% 
yield with spectral data consistent with the literature. 1H-NMR (500 MHz): δ 5.60-
5.54 (m, 1H), 5.44-5.39 (m, 1H), 5.20 (d, J = 9.5 Hz, 1H), 5.10-5.05 (m, 2H), 4.47 
(d, J = 10.0 Hz, 1H), 4.25 (dd, J = 11.0 Hz, J = 5.5 Hz, 1H), 4.13 (dd, J = 12.5 Hz, 
J = 2.5 Hz, 1H), 3.66 -3.63 (m, 1H), 3.55 (dd, J = 13.0 Hz, J = 8.0 Hz, 1H), 3.20 
(dd, J = 12.5 Hz, J = 6.5 Hz, 1H), 2.09 (s, 3H), 2.04 (s, 3H), 2.03(s, 3H), 2.01(s, 
3H), 1.4 (m, 3H), 1.27 (m, 15H), 0.88 (t, J = 7.5 Hz, 3H). 13C-NMR (125 MHz): δ 
170.8, 170.5, 169.6, 135.4, 124.7, 82.1, 75.9, 74.2, 70.2, 68.6, 62.5, 32.5, 32.4, 
32.1, 29.8, 29.7, 29.6, 29.5, 22.9, 20.9, 20.9, 20.8, 20.8, 14.3.  
3,7,11-Trimethyl-dodeca-2,6,10-trienyl-tetra-O-acetyl-1-thio-β-D-
glucopyranoside (267).    
To a stirred solution of 2-(1,5,9-trimethyl-1-vinyl-deca-4,8-dienyldisulfanyl)-
benzothiazole (260) (78 mg, 0.19 mmol) in methanol (3.0 mL) was added 
triethylamine (27 µL, 0.19 mmol) followed by 1-thio-β-D-glucose tetraacetate (91) 
130 
  
(54 mg, 0.16 mmol). After1 h, silver nitrate (58 mg, 0.34 mmol) was added and 
the reaction mixture was stirred under a N2 atmosphere in the dark for 48 h. After 
following the general work up procedure the crude product was purified by 
column chromatography to give the title product (267) in 50% yield with spectral 
data consistent with the literature.  1H-NMR (500 MHz): δ 5.23-5.19 (m, 2x2H), 
5.11-5.04 (m, 2x4H), 4.44 (dd, J = 10.0 Hz, J = 3.0 Hz, 1H), 4.27-4.23 (m, 1H), 
4.15 (d, J = 11.0 Hz, 1H), 3.65-3.63 (m, 1H), 3.52-3.45 (m, 1H), 3.20-3.16 (m, 
1H), 2.08 (s, 3H), 2.06 (s, 3H), 2.03(s, 3H), 2.01(s, 3H), 1.68-1.67 (m, 6H), 1.61 
(s, 8H). 13C-NMR (125 MHz): δ 170.8, 170.5, 170.4, 169.6, 140.6, 135.7, 131.5, 
124.5, 124.4, 123.8, 123.7, 119.9, 119.1, 82.7, 82.4, 76.1, 76.0, 74.2, 70.0, 78.6, 
68.5, 62.5, 62.4, 39.9, 39.8, 31.8, 27.5, 26.9, 26.9, 26.8, 26.7, 25.9, 23.7, 20.9, 
20.9, 20.8, 20.8, 17.9, 16.2, 16.1. 
N-tert-Butoxycarbonyl-S-(tridec-2-enyl)glutathione dimethyl ester (268).  
Following the general procedure (10) for the silver nitrate promoted 
rearrangement of allylic disulfides the title compound 268 was prepared in 61% 
yield with spectral data consistent with the literature. 1H-NMR (500 MHz): δ  7.06 
(br s, 1H), 6.77 (d, J = 6.0 Hz, 1H), 5.64-5.58 (m, 1H), 5.42-5.32 (m, 2H), 4.56 (d, 
J = 7.5 Hz, 1H), 4.39 (m, 1H), 4.13-3.98 (m, 2H), 3.76 (s, 3H), 3.75 (s, 3H), 3.15 
(d, J = 7.5 Hz, 2H), 2.92-2.80 (m, 2H), 2.36-2.35 (m, 2H), 2.05-2.01 (m, 3H), 1.44 
(s, 9H), 1.35-1.26 (m, 16H), 0.88 (t, J = 7.0 Hz, 3 H). 13C-NMR (125 MHz): δ 
173.1, 172.3, 170.9, 170.1, 155.9, 136.5, 135.3, 125.2, 124.3, 80.4, 68.2, 52.9, 
52.7, 52.6, 52.5, 41.5, 34.5, 32.6, 32.5, 32.4, 32.3, 32.1, 29.8, 29.7, 29.5, 29.5, 
29.4, 28.9, 28.5, 27.5, 25.8, 22.9, 14.4. 
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N-tert-Butoxycarbonyl-S-(3,7,11-trimethyldodeca-2,6,10-trienyl)glutathione 
dimethyl ester (269).   
To a stirred solution of 2-(1,5,9-trimethyl-1-vinyl-deca-4,8-dienyldisulfanyl)-
benzothiazole (260) (120 mg, 0.30 mmol) in methanol (5.0 mL) was added 
triethylamine (38 µL, 0.27 mmol) followed by Boc-(α-OMe)-γ-L-Glu-L-Cys-Gly-
OMe (192) (100 mg, 0.23 mmol). After 1 h, silver nitrate (78 mg, 0.46 mmol) was 
added and the reaction mixture was stirred under a N2 atmosphere in the dark for 
16 h. After following the general work up procedure the crude product was 
purified by column chromatography on silica gel to give the title product in 60% 
yield with spectral data consistent with the literature. 1H-NMR (500 MHz): δ  7.04 
(br s, 1H), 6.76 (br s, 1H), 5.30-5.24 (m, 2H), 5.11-5.08 (m, 2H), 4.59-4.57 (m, 
1H), 4.41 (br s, 1H), 4.12-3.98 (m, 2H), 3.76 (s, 3H), 3.75 (s, 3H), 3.27-3.21 (m, 
2H), 2.95-2.84 (m, 2H), 2.39-2.36 (m, 2H), 2.21-2.12 (m, 1H), 2.09-2.04 (m, 6H), 
1.99-1.96 (m, 3H), 1.69 (s, 6H), 1.66 (s, 3H), 1.61 (s, 3H), 1.45 (s, 9H). 13C-NMR 
(125 MHz): δ 173.1, 172.4, 170.9, 170.2, 155.9, 140.2, 135.8, 135.5, 131.5, 
131.5, 124.5, 124.5, 123.9, 123.9, 123.8, 120.6, 119.8, 80.3, 53.0, 52.7, 52.6, 
41.5, 39.9, 39.8, 33.2, 32.3, 32.0, 30.1, 30.0, 28.7, 28.5, 26.9, 26.9, 26.7, 26.6, 
25.9, 23.6, 17.9, 16.4, 16.2. 
N-tert-Butoxycarbonyl-S-(4-hydroxybut-2-enyl)glutathione dimethyl ester 
(270).  
Following the general procedure for the silver nitrate promoted 
rearrangement of allylic disulfides, a stirred solution of 2-(pyridin-2-yldisulfanyl)-
but-3-en-1-ol (252) (70 mg, 0.25 mmol) in methanol (5.0 mL) was treated with 
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Boc-(α-OMe)-γ-L-Glu-L-Cys-Gly-OMe (192) (108 mg, 0.25 mmol). The reaction 
mixture was stirred under a N2 atmosphere for 12 h before silver nitrate (85 mg, 
0.50 mmol) was added and the mixture stirred in the dark for 16 h before the 
general work up procedure was applied. The crude product was purified by 
column chromatography on silica gel using CHCl3/MeOH as eluent to give the 
title product (17) in 65% yield. [α]23D -2.0 (c 0.85); 1H NMR (400 MHz) δ 7.16 (br 
s, 1H), 6.93 – 6.91 (d, J = 7.6 Hz, 1H), 5.87 – 5.80 (m, 1H), 5.72 -5.65 (m, 1H), 
5.39 – 5.37 (d, J = 7.6 Hz, 1H), 4.64 – 4.59 (q, J = 7.2 Hz, 1H), 4.37 (brs, 1H), 
4.12 (s, 2H), 4.03 – 4.02 (d, J = 5.6 Hz, 2H), 3.74 (s, 3H), 3.73 (s, 3H), 3.27 (br s, 
1H), 3.20 – 3.18 (d, J = 7.2, 2H), 2.90 – 2.86 (m, 1H), 2.80 – 2.76 (m, 1H), 2.37 – 
2.33 (m, 2H), 2.17 – 2.14 (m, 1H), 1.94 – 1.91 (m, 1H), 1.42 (s, 9H). 13C NMR 
(100 MHz) δ 173.1, 172.6, 170.9, 170.3, 156.1, 133.4, 128.4, 80.6, 63.1, 53.0, 
52.9, 52.7, 41.5, 34.5, 33.0, 32.4, 29.0, 28.6.  ESIHRMS: calc. for 
C21H35N3O9SNa [M+Na]+ 528.19920, found 528.2016.  
 (E)-S-(4-hydroxybut-2-enyl)-glutathione (272).  
 Glutathione (271) (29 mg, 0.09 mmol) was dissolved in 2 mL Tris buffer 
(0.2M, pH 8) and the resulting solution was treated with 2-(pyridin-2-
yldisulfanyl)but-3-en-1-ol (252) (75 mg, 0.35 mmol) dissolved in 2.0 mL 
CH3CN/THF (1:1).  The reaction mixture was stirred at room temperature for 12 h 
after which excess disulfide and liberated pyridinethiol were removed by washing 
with t-butyl methyl ether (5 mL). The residue was dissolved in water (3 mL) and 
treated with silver nitrate (2.2 equiv).  The yellow suspension was allowed to stir 
for 24 h and then treated with 3 mL of 5% dil HCl and centrifuged.  The 
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supernatant was injected into a reversed-phase HPLC system for purification 
using a gradient of 100% A to 50% B developed over 50 min (A, 0.1% 
TFA/CH3CN; B, 0.1% TFA/H2O; column. Varian Microsorb C18 250 x 21.4 mm; 
flow rate. 10 mL/min; UV detection. 215nm). Lyophillization of the fraction eluting 
at 19 min afforded the rearranged glutathione 272 in 85% yield as white foam. 
[α]23D -23.2 (c 0.8, CH3OH); 1H NMR (500 MHz, CD3OD) δ 5.80 – 5.74 (m, 1H), 
5.69 – 5.64 (m, 1H), 4.53 (dd, J = 11.5, J = 6.0Hz, 1H), 4.06 (d, J = 5.0 Hz, 2H), 
3.97 (d, J = 8.0 Hz, 2H), 3.61 (t, J = 8.5 Hz, 1H), 3.18 (d, J = 8.0 Hz, 2H), 2.99 
(dd, J = 17.5, J = 6.0 Hz, 1H), 2.70 (dd, J = 17.0, J = 11.5 Hz, 1H), 2.57 – 2.50 
(m, 2H), 2.48 – 2.03 (m, 2H); 13C NMR (125 MHz, CD3OD) δ 173.9, 172.7, 172.4, 
170.4, 132.8, 126.9, 61.8, 54.2, 53.2, 40.7, 33.2, 32.1, 31.7, 26.6  ESIHRMS: 
calc. for C14H23N3O7SNa [M+Na]+ 400.1154, found 400.1150.  
(E)-S-[4-(β-D-Galactopyranosyloxy)but-2-enyl]glutathione (274).   
Glutathione (11 mg, 0.03 mmol) was dissolved in 0.5 mL Tris buffer (0.2M, 
pH 8) to which 2-(2-pyridyldisulfanyl)-3-enyl β-D-galactopyranoside (273) (37.5 
mg, 0.10 mmol) dissolved in 0.5 mL CH3CN was added.  The reaction mixture 
was stirred at room temperature for 16 h before the excess disulfide and 
liberated pyridine thiol were removed by washing with t-butyl methyl ether (5 mL). 
The residue was dissolved in water (3 mL) and treated with silver nitrate (2.2 eq).  
The yellow suspension was allowed to stir for 24 h and then was treated with 3 
mL of 5% dil HCl and centrifuged.  The supernatant was injected into a reversed-
phase HPLC system for purification to give the product in 65% yield whose 
spectral data were consistent with the literature. 1H NMR (500 MHz, D2O) δ 5.69 
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– 5.66 (m, 2H), 4.43 (dd, J = 8.0, J = 5.5 Hz, 1H), 4.29 (d, J = 8.0 Hz, 1H), 4.27 
(dd, J = 12.5, J = 4.0 Hz, 1H), 4.11 (dd, J = 12.0, J = 5.0 Hz, 1H), 3.88 (s, 2H), 
3.83 – 3.78 (m, 2H), 3.67 – 3.59 (m, 2H), 3.55 – 3.49 (m, 2H), 3.39 (dd, J = 10.0, 
J = 8.0 Hz, 1H), 3.11 (d, J = 6.0 Hz, 1H), 2.88 (dd, J = 14.0, J = 5.5 Hz, 1H), 2.71 
(dd, J = 14.0, J = 8.5 Hz, 1H), 2.46 – 2.41 (m, 2H), 2.09 – 2.41 (m, 2H). 13C NMR 
(125 MHz, D2O) δ 174.7, 173.2, 173.0 (2C), 130.6, 128.9, 101.8, 75.3, 72.9, 
70.9, 69.5, 68.8, 61.1, 53.2, 53.1, 41.4, 32.9, 31.7, 31.2, 25.9. 
(Z)-4-(2-Naphthylmethyloxy)but-2-ene-1-ol (275).  
To a stirred solution of cis-1,4-but-2-ene-diol 244 (2.39 g, 27.1 mmol) in 
THF (10 mL) under an atmosphere of N2 was added sodium hydride (0.38 g, 9.5 
mmol) at 0 °C and the reaction mixture was stirred at room temperature for 1 h. 
2-(Bromomethyl)-naphthalene (2.0 g, 9.0 mmol) was added and the reaction was 
continued at room temperature for 2 h and heated at reflux for 6h. The reaction 
mixture was cooled to room temperature, diluted with saturated NH4Cl solution 
(30 mL) and ethylacetate (20 mL). The organic portion was separated, dried over 
sodium sulfate and evaporated to dryness. The crude product was purified over 
silica gel using EtOAc/hexanes as eluent to give the title compound 275 as thick 
oil (1.76 g, 85%). 1H NMR (500 MHz): δ 7.87 – 7.85 (m, 3H), 7.80 (s, 1H), 7.51 – 
7.48 (m, 3H), 5.83 (dt, J = 11.0 Hz, J = 6.0 Hz, 1H), 5.78 (dt, J = 11.0 Hz, J = 6.0 
Hz, 1H), 4.69 (s, 2H), 4.17 (d, J = 6.0 Hz, 2H), 4.13 (d, J = 6.5 Hz, 2H), 2.39 (br 
s, 1H). 13C NMR (125 MHz): δ 135.6, 133.5, 133.3, 132.8, 128.5, 128.3, 128.1, 
127.9, 126.9, 126.4, 126.2, 126.1, 72.8, 65.9, 58.8. ESIHRMS: calc. for 
C15H16O2Na [M+Na]+ 251.1048, found 251.1055 
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1,2:5,6-Di-O-isopropylidene-3-O-4-(2-naphthylmethyloxy)but-2Z-enyl-α-D-
glucofuranose (277). 
To a stirred solution of (Z)-4-(2-naphthylmethyloxy)but-2-ene-1-ol 275 
(1.76 g, 7.71 mmol) in dichloromethane (20 mL) under an atmosphere of N2 was 
added triethylamine (1.60 mL, 11.56 mmol) followed by DMAP (94 mg, 0.77 
mmol) at 0 °C. A solution of methanesulfonyl chloride (0.75 mL, 9.64 mmol) in 
CH2Cl2 (2 mL) was added dropwise. The reaction mixture was stirred for 2 h and 
then diluted with saturated NaCl solution (20 mL). The organic portion was 
separated and the aqueous part was again washed with dichloromethane (15 
mL). The combined organic part was dried over sodium sulfate and evaporated 
to dryness. The crude mesylate (2.36 g, ~ 100%) was used immediately without 
any purification. To a stirred solution of diacetone-D-glucose 276 (2.0 g, 7.7 
mmol) in dimethylformamide (10.0 mL) was added sodium hydride (338 mg, 8.5 
mmol) at 0 °C. The reaction was stirred at room temperature for 1 h followed by 
the addition of the crude mesylate (2.36 mmol, 7.7 mmol) in dimethylformamide 
(50 mL). The reaction is stirred at 60 °C for 12 h and diluted with water (100 mL) 
and ethylacetate (100 mL). The organic part was separated and washed with 
saturated NaCl solution (100 mL), dried over sodium sulfate and evaporated to 
dryness. The crude product was purified by column chromatography using 
EtOAc/hexanes as eluent to give the title product 277 as thick gum (2.61 g, 
72%). [α]23D -2.0 (c 0.85); 1H NMR (500 MHz): δ 7.86 – 7.84 (m, 3H), 7.80 (s, 
1H), 7.51 – 7.47 (m, 3H), 5.87 (d, J = 4.0 Hz, 1H), 5.85 – 5.83 (m, 1H), 5.79 – 
5.74 (m, 1H), 4.69 (s, 2H), 4.52 (d, J = 4.0 Hz, 1H), 4.32 – 4.28 (m, 1H), 4.26 – 
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4.22 (dd, J = 13.0 Hz, 6.5 Hz, 1H), 4.19 (d, J =  6.0 Hz, 1H), 4.17 – 4.15 (m, 2H), 
4.13 – 4.11(m, 1H), 4.09 – 4.07 (m, 1H), 4.03 – 3.99 (m, 1H), 3.92 (d, J = 3.0 Hz, 
1H) 1.51 (s, 3H), 1.42 (s, 3H), 1.34 (s, 3H), 1.30 (s, 3H) .13C NMR (125 MHz): δ 
135.8, 133.5, 133.3, 130.0, 129.3, 128.5, 128.1, 127.9, 126.7, 126.4, 126.2, 
125.9, 112.0, 109.2, 105.5, 83.0, 81.8, 81.4, 72.7, 72.6, 67.6, 66.5, 66.0, 27.1, 
27.0, 26.5, 25.6. ESIHRMS: calc. for C27H34O7Na [M+Na]+ 493.2202, found 
493.2216 
1,2,4,6-tetra-O-acetyl-3-O-[(Z)-4-(2-naphthylmethyloxy)but-2-enyl]-D-α,β-
glucopyranoside (278).  
Following the general procedure 3, and eluting with 50% EtOAc/hexanes 
the title compound was obtained in 89% yield. 1H NMR (500 MHz): δ 7.84 - 7.83 
(m, 3H), 7.78 (s, 1H) 7.50 – 7.46 (m, 3H), 6.29 (d, J = 3.5 Hz, 1H), 5.81 – 5.77 
(m, 1H), 5.67 – 5.58 (m, 2H), 5.09 – 5.03 (m, 2H), 4.99 – 4.97 (m, 1H), 4.67 (s, 
2H, major), 4.66 (s, 2H, minor), 4.25 – 4.13 (m,3H), 4.12 – 4.04 (m, 3H), 4.00 – 
3.97 (m, 1H), 3.81 (t, J = 9.5 Hz, 1H), 3.64 – 3.62 (m, 1H), 3.58 – 3.54 (m, 1H), 
2.12 – 1.97 (s, 12H major + 12H minor). 13C NMR (125 MHz): δ 170.9, 169.7, 
169.4, 169.2, 168.9, 135.7, 133.5, 133.2, 129.6, 129.4, 129.3, 129.2, 128.5, 
128.5, 128.1, 128.0, 127.9, 126.7, 126.7, 126.4, 126.2, 125.9, 125.9, 92.1, 89.6, 
79.7, 76.6, 73.2, 72.7, 71.6, 71.5, 70.4, 69.3, 69.1, 68.4, 67.8, 65.9, 65.8, 62.0, 
61.9, 21.0, 20.9, 20.8, 20.7. ESIHRMS: calc. for C29H34O11Na [M+Na]+ 581.1999, 
found 528.1998.  
2,4,6-tri-O-acetyl-3-O-[(Z)-4-(2-naphthylmethyloxy)but-2-enyl]-α-D-
glucopyranosyl trichloroacetimidate (279).  
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Following the general procedure 4, and eluting with 40% EtOAc/hexanes 
the title compound was obtained in 76% yield. [α]23D 63.8 (c = 1); 1H NMR (500 
MHz): δ 8.67 (s, 1H), 7.85 – 7.82 (m, 3H), 7.78 (s, 1H), 7.50 – 7.46 (m, 3H), 6.5 
(d, J = 3.5 Hz, 1H), 5.83 – 5.78 (m, 1H), 5.68 – 5.64 (m, 1H), 5.12 (t, J = 10.0 Hz, 
1H), 5.01 (dd, J = 10.0 Hz, J = 4.0 Hz, 1H), 4.68 (d, J = 4.5 Hz, 2H), 4.27 – 4.18 
(m, 3H), 4.13 – 4.07 (m, 4H), 3.92 (t, J = 10.0 Hz, 1H), 2.07 (s, 3H), 2.02 (s, 3H), 
1.94 (s, 3H). 13C NMR (125 MHz): δ 170.9, 169.9, 169.5, 160.8, 135.7, 133.5, 
133.2, 129.6, 129.3, 128.5, 128.0, 127.9, 126.7, 126.4, 126.2, 125.9, 93.5, 91.1, 
76.5, 72.7, 72.1, 70.7, 69.1, 68.5, 65.8, 61.9, 20.9, 20.9, 20.7. ESIHRMS: calc. 
for C29H32Cl3NO10Na [M+Na]+ 682.0989, found 682.0999. 
Methyl 2,4,6-tri-O-acetyl-3-O-[(Z)-4-(2-napthylmethyloxy)but-2-enyl]-β-D-
glucopyranoside (280).  
Following the general procedure 5, and eluting with 60% EtOAc/hexanes 
the title compound was obtained in 75% yield. [α]23D -14.5 (c =1); 1H NMR (500 
MHz): δ 7.85 -7.83 (m, 3H), 7.79 (s, 1H), 7.49 – 7.46 (m, 3H), 5.81 – 5.76 (m, 
1H), 5.64 – 5.58 (m, 1H) 5.03 (t, J = 10.0 Hz, 1H), 4.94 (dd, J = 9.5 Hz, J = 8.0 
Hz, 1H), 4.68 (s, 3H), 4.27 (d, J = 8.0 Hz, 1H), 4.20 (dd, J = 12.0 Hz, J = 5.0 Hz, 
1H), 4.14 (d, J = 6.0 Hz, 1H), 4.11 (d, J = 3.0 Hz, 1H), 4.09 - 4.08 (m, 2H), 3.55 – 
3.50 (m, 2H), 3.46 (s, 3H), 2.08 (s, 3H), 2.03 (s, 3H), 2.00 (s, 3H). 13C NMR (125 
MHz): δ 171.0, 169.5, 169.4, 135.7, 133.5, 133.2, 129.4, 128.4, 128.1, 127.9, 
126.7, 126.4, 126.2, 125.9, 101.9, 79.8, 72.7 (2C), 72.5, 72.2, 69.7, 67.3, 65.8, 
62.5, 56.9, 21.1, 20.9 (2C). ESIHRMS: calc. for C28H34O10Na [M+Na]+ 553.2050, 
found 528.2064.  
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Methyl 2,4,6-tri-O-acetyl-3-O-[(Z)-4-hydroxybut-2-enyl]-β-D-glucopyranoside 
(281).  
Following the general procedure 6, and eluting with 40% EtOAc/hexanes 
the title compound was obtained in 88% yield. [α]23D -25.4 (c = 1); 1H NMR (500 
MHz): δ 5.77 – 5.72 (m, 1H), 5.55 – 5.51 (m, 1H),  5.06 (t, J = 9.50 Hz, 1H), 4.98 
– 4.95 (m, 1H), 4.34 (d, J = 8.0 Hz, 1H), 4.23 (dd, J = 12.0 Hz, J = 5.0 Hz, 1H), 
4.15 – 4.11 (m, 5H), 3.62 – 3.58 (m, 2H), 3.48 (s, 3H), 2.11 (s, 3H), 2.09 (s, 3H), 
2.08 (s, 3H). 13C NMR (125 MHz): δ 171.1, 169.8 (2C), 132.4, 127.9, 101.9, 79.8, 
72.2 (2C), 69.3, 66.3, 62.5, 58.6, 57.1, 21.2, 21.1, 21.0. ESIHRMS: calc. for 
C17H26O10Na [M+Na]+ 413.1424, found 413.1425. 
Methyl 2,4,6-tri-O-acetyl-3-O-[(2-phenyloxycarbonylthioxy)but-3-enyl]-β-D-
glucopyranoside (282).  
Following the general procedure 7, and eluting with 45% EtOAc/hexanes 
the title compound was obtained in 90% yield. [α]23D -11.5 (c = 1); 1H NMR (500 
MHz): δ 7.45 – 7.42 (m, 2H), 7.32 – 7.29 (m, 1H), 7.12 – 7.10 (m, 2H), 5.84 – 
5.79 (m, 1H), 5.76 – 5.72 (m, 1H), 5.10- 5.06 (m, 3H), 5.01 – 4.97 (m, 1H), 4.35 
(d, J = 7.50 Hz, 1H), 4.26 – 4.24 (m, 2H), 4.22 (d, J = 5.0 Hz, 1H), 4.13 (dd , J = 
12.5 Hz, J = 2.5 Hz, 1H), 3.65 – 3.59 (m, 2H), 3.48 (s. 3H), 2.13 (s, 3H), 2.11 (s, 
3H), 2.08 (s, 3H) 13C NMR (125 MHz): δ 195.1, 171.0, 169.5, 169.5, 153.7, 
131.9, 129.8, 126.9, 125.1, 122.1, 101.9, 80.0, 72.4, 72.2, 69.6, 69.5 (2C), 67.2 
(2C), 62.4, 57.0, 21.2, 21.1, 21.0. ESIHRMS: calc. for C24H30O11SNa [M+Na]+ 
549.1407, found 549.1398. 
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Methyl 2,4,6-tri-O-acetyl-3-O-[(2-phenyloxycarbonylthioxy)but-3-enyl]-β-D-
glucopyranoside (283).  
Following the general procedure 8, and eluting with 45% EtOAc/hexanes 
the title compound was obtained in 90% yield. 1H NMR (500 MHz): δ 7.39 – 7.36 
(m, 2H), 7.26 – 7.23 (m, 1H), 7.15 – 7.14 (m, 2H), 5.93 – 5.85 (m, 1H), 5.33 (d, J 
= 17.0 Hz, 1H), 5.19 (d, J = 10.5 Hz, 1H), 5.10 (t, J = 10.0 Hz, 1H), 5.03 – 4.99 
(m, 1H), 4.33 (dd, J = 8.0 Hz, J = 3.0 Hz, 1H), 4.25 – 4.21 (m, 1H), 4.15 – 4.11 
(m, 1H), 4.09 – 4.05 (m, 1H), 3.86 – 3.80 (m, 2H), 3.62 – 3.58 (m, 2H), 3.48 (s, 
3H, major + minor), 2.12 (s, 3H), 2.10 (s, 3H), 2.09 (s, 3H), 2.08 (s, 3H X 3 
minor). 13C NMR (125 MHz): δ 171.0, 169.6, 169.5, 169.4 (2 C), 151.3, 134.1, 
134.0, 129.7, 126.5, 121.5, 118.7 (2 C), 102.0, 81.0, 73.9, 73.8, 72.2 (2 C), 69.6, 
69.5, 62.4, 57.0, 48.9 (2 C), 21.3, 21.2 (2 C), 21.1, 21.0. ESIHRMS: calc. for 
C24H30O11SNa [M+Na]+ 549.1407, found 549.1385. 
Methyl 3-O-[(2-pyridin-2-yldisulfanyl)but-3-enyl]-β-D-glucopyranoside (284). 
Following the general procedure 9, and eluting with 5% MeOH/CH2Cl2 the title 
compound was obtained in 76% yield. 1H NMR (500 MHz, CD3OD): δ 8.37 – 8.36 
(m, 1H), 7.93 – 7.91 (m, 1H), 7.81 – 7.78 (m, 1H), 7.22 – 7.19 (m, 1H), 5.87 – 
5.79 (m, 1H), 5.24 – 5. 21 (m, 1H), 5.12 (d, J = 10.0 Hz, 1H), 4.17 (dd, J = 7.5 
Hz, J = 1.5 Hz, 1H), 4.13 – 4.09 (m, 1H), 4.07 – 4.06 (m, 1H), 4.04 – 4.01 (m, 
1H), 3.88 -3.85 (m, 1H), 3.81 – 3.77 (m, 1H), 3.69 – 3.65 (m, 1H), 3.53 (s, 3H + 
3H, two isomers), 3.32 (m, 5H), 3.28 – 3.19 (m, 3H). 13C NMR (125 MHz): δ 
160.7, 148.8, 137.8, 134.6, 134.5, 121.0, 120.3, 118.1, 104.2, 85.9, 76.7, 73.8, 
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73.7 (2C), 70.1, 70.0, 61.4, 56.2, 54.9. ESIHRMS: calc. for C15H21NO6S2Na 
[M+Na]+ 398.0708, found 398.0700. 
Methyl 3-O-[4-(1-thio-β-D-glucopyranosyl)but-2E-enyl]-β-D-glucopyranoside 
(285).  
Following the general procedure 10, and eluting with 12% MeOH/CH2Cl2 
the title compound was obtained in 70% yield. [α]23D -45.1 (c = 1); 1H NMR (500 
MHz, CD3OD) δ 5.79 – 5.77 (m, 2H), 4.38 (d, J = 9.5 Hz, 1H), 4.35 – 4.34 (m, 
2H), 4.19 – 4.18 (m, 1H), 3.89 – 3.86 (m, 2H), 3.70 – 3.63 (m, 2H), 3.53 (s, 3H), 
3.50 – 3.46 (m, 1H), 3.32 – 3.31 (m, 3H), 3.29 – 3.27 (m, 2H), 3.26 – 3.22 (m, 
4H). 13C NMR (125 MHz) δ 130.3, 128.9, 104.2, 84.3, 83.9, 80.5, 78.5, 76.6, 
73.9, 73.2, 72.7, 70.5, 70.1, 61.8, 61.5, 56.1, 30.9. ESIHRMS: calc. for 
C17H30O11SNa [M+Na]+ 465.1401, found 465.1407. 
2,4,6-Tri-O-acetyl-3-acetylsulfanyl-3-deoxy-α,β-D-glucopyranose (294).  
To a stirred solution of 1,2,4,6-tetra-O-acetyl-3-S-acetyl-3-deoxy-D-
glucopyranoside 293 (1.0 mmol) in a mixture of EtOAc and CH2Cl2 (20.0 mL + 
10.0 mL) was added TiBr4 (2.5 mmol). The reaction mixture was stirred at room 
temperature for 96 h and diluted with CH2Cl2 (30.0 mL). It was filtered through a 
pad of celite and the filtrate was washed with saturated NaHCO3 (50.0 mL). The 
organic portion was dried over Na2SO4 and the residue was evaporated to 
dryness. The obtained crude bromide was dissolved in acetone/water mixture 
(20.0 mL) and was added Ag2CO3 (1.5 mmol). The reaction mixture was stirred 
at room temperature for 12 h and diluted with EtOAc (30.0 mL). It was filtered 
through a short celite pad and washed with saturated NaHCO3 (50.0 mL). The 
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organic portion was dried over Na2SO4 and concentrated. The residue was 
further purified by column chromatography to give the title product 294 in 86% 
yield as oil.  1H NMR (500 MHz): δ 5.39 (t, J = 4.0 Hz, 1H, major), 5.09 – 5.07 (m, 
1H, major), 5.06 – 5.04 (m, 1H, minor),  4.95 – 4.92 (m, 1H, major), 4.84 (dd, J = 
11.5 Hz, J = 8.0 Hz, 1H, minor), 4.73 (dd, J = 8.5 Hz, J = 8.0 Hz, 1H, minor), 4.28 
– 4.25 (m, 1H, major), 4.23 – 4.15 (m, 2H, major), 4.12 – 4.11 (m, 1H, minor), 
3.97 – 3.95 (m, 1H, minor), 3.85 – 3.83 (m, 1H, minor), 3.81 – 3.80 (m, 1H, 
major), 3.79 – 3.76 (m, 1H, minor), 2.32 (s, 3H, minor), 2.32 (s, 3H, major), 2.07 
(s, 3H X 2), 2.06 (s, 3H X 2), 2.02 (s, 3H, major), 2.01 (s, 3H, minor). 13C NMR 
(125 MHz): δ 193.7 (2C), 171.2, 171.1 (minor), 170.8 (minor), 170.3, 169.7, 
169.6 (minor), 97.1 (minor), 89.9, 75.0, 72.4 (minor), 70.3, 68.7 (minor), 67.6, 
62.6 (minor), 47.7 (minor), 44.4, 30.9, 30.9 (minor), 21.1 (2C), 20.9, 20.8 (2C), 
20.7 (2C), 20.7. ESIHRMS: calc. for C14H20O9SNa [M+Na]+ 387.0726, found 
387.0724. 
2,4,6-tri-O-acetyl-3-S-acetylsulfanyl-3-deoxy-α-D-glucopyranosyl 
trichloroacetimidate (295).  
Following the general procedure 4, and eluting with 45% EtOAc/hexanes 
the title compound was obtained in 80% yield. [α]23D 52.0 (c = 1); 1H NMR (500 
MHz): δ 8.66 (s, 1H), 6.48 (d, J = 3.0 Hz, 1H), 5.21 – 5.13 (m, 2H), 4.23 – 4.16 
(m, 3H), 4.09 – 4.06 (m, 1H), 2.31 (s, 3H), 2.04 (s, 3H), 2.02 (s, 3H), 1.97 (s, 3H). 
13C NMR (125 MHz): δ 193.2, 170.7, 169.8, 169.5, 161.0, 92.8, 91.0, 71.5, 68.9, 
66.6, 61.9, 44.7, 30.9, 20.9, 20.7, 20.6. ESIHRMS: calc. for C16H20Cl3NO9SNa 
[M+Na]+ 529.9822, found 528.9799. 
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Methyl 2,4,6-tri-O-acetyl-3-S-acetylsulfanyl-3-deoxy-β-D-glucopyranoside 
(296). Following the general procedure 5, and eluting with 60% EtOAc/hexanes 
the title compound was obtained in 76% yield. [α]23D -8.7 (c = 1); 1H NMR (500 
MHz): δ 5.06 (dd, J = 11.0 Hz, J = 9.5 Hz, 1H), 4.95 (dd, J = 11.0 Hz, J = 7.5 Hz, 
1H), 4.45 (d, J = 7.5 Hz, 1H), 4.26 (dd, J = 12.0 Hz, J = 4.5 Hz, 1H), 4.12 (dd, J = 
12.0 Hz, J = 3.0 Hz, 1H), 3.85 (t, J = 11.0 Hz, 1H), 3.76 – 3.73 (m, 1H), 3.50 (s, 
3H), 2.33 (s, 3H), 2.09 (s, 3H), 2.05 (s, 3H), 2.02 (s, 3H). 13C NMR (125 MHz): δ 
193.7, 170.9, 169.5 (2C), 103.2, 74.7, 70.3, 67.8, 62.5, 57.1, 47.9, 30.8, 20.9, 
20.9, 20.8. ESIHRMS: calc. for C15H22O9SNa [M+Na]+ 401.0882, found 
401.0878. 
Methyl 3-deoxy-3-[4-(β-D-glucopyranosyloxy)but-2E-enylsulfanyl]-β-D-
glucopyranoside (297).  
Following the general procedure 10, and eluting with 12% MeOH/CH2Cl2 
the title compound was obtained in 65% yield. [α]23D -2.0 (c 0.85); 1H NMR (500 
MHz, CD3OD): δ 5.85 (dt, J = 15.0 Hz, J = 7.5 Hz, 1H), 5.75 (dt, J = 15.5 Hz, J = 
6.5 Hz, 1H), 4.36 (d, J = 8.0 Hz, 1H), 4.32 (dd, J = 12.5 Hz, J = 5.0 Hz, 1H), 4.20 
(d, J = 8.0 Hz, 1H), 4.17 (dd, J = 12.5 Hz, J = 6.5 Hz, 1H), 3.89 – 3.86 (m, 2H), 
3.69 (dd, J = 12.0 Hz, J = 5.0 Hz, 1H), 3.66 (dd, J = 12.5 Hz, J = 5.5 Hz, 1H), 
3.54 (s, 3H), 3.46 – 3.40 (m, 1H), 3.28 – 3.27 (m, 6H), 3.25 – 3.17 (m, 2H), 2.54 
(t, J = 10.0 Hz, 1H). 13C NMR (125 MHz, CD3OD): δ 130.8, 128.7, 105.3, 101.5, 
79.2, 76.8, 76.6, 73.9, 73.1, 70.5, 68.7, 68.6, 61.7, 61.6, 56.0, 54.6, 33.2. 
ESIHRMS: calc. for C17H30O11SNa [M+Na]+ 465.1401, found 465.1407. 
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3-O-{2,4,6-Tri-O-acetyl-3-O-[(Z)-4-(2-naphthylmethyloxy)but-2-enyl]-β-D-
glycopyranosyl}-1,2:5,6-di-O-isopropylidene-α-D-glucofuranose (299). 
Following the general procedure 5, the acceptor 276 was glycosylated with the 
donor 2,4,6-tri-O-acetyl-3-O-[(Z)-4-(2-naphthylmethyloxy)but-2-enyl]-α-D-
glucopyranosyl trichloroacetimidate 279 and after eluting with 70% 
EtOAc/hexanes the title compound was obtained in 60% yield. [α]23D -15.7 (c = 
1); 1H NMR (500 MHz) δ 7.86 – 7.83 (m, 3H), 7.79 (s, 1H), 7.51 – 7.46 (m, 3H), 
5.84 ( d, J = 3.5 Hz, 1H), 5.81 – 5.76 (m, 1H), 5.62 – 5.57 (m, 1H), 5.03 (t, J = 
10.0 Hz, 1H), 4.92 (dd, J = 9.5 Hz, J = 7.5 Hz, 1H), 4.68 (s, 2H), 4.50 (d, J = 8.0 
Hz, 1H), 4.42 (d, J = 4.0 Hz, 1H), 4.35 (dd, J = 12.0 Hz, J = 6.0 Hz, 1H), 4.27 (dd, 
J = 5.5 Hz, J = 3.0 Hz, 1H), 4.25 – 4.24 (m, 1H), 4.18 – 4.11 (m, 3H), 4.08 – 4.03 
(m, 3H), 3.97 (dd, J = 9.0 Hz, J = 6.0 Hz, 1H), 3.53 – 3.49 (m, 2H), 2.08 (s, 3H), 
2.02 (s, 3H), 2.00 (s, 3H), 1.50 (s, 3H), 1.43 (s, 3H), 1.35 (s, 3H), 1.32 (s, 3H). 
13C NMR (125 MHz) δ170.9, 169.4, 168.9, 135.7, 133.5, 133.2, 129.5, 129.3, 
128.5, 128.1, 127.9, 126.7, 126.5, 126.2, 125.9, 112.3, 108.8, 105.3, 99.6, 83.0, 
81.2, 80.8, 79.7, 73.3, 72.7, 72.6, 69.5, 67.3, 66.4, 65.8, 62.4, 27.1, 26.8, 26.6, 
25.5, 20.9. ESIHRMS: calc. for C35H47NO17SNa [M+Na]+ 776.2742, found 
776.2740. 
2,2’,4,4’,6,6’-Hexa-O-acetyl-3’-O-[(Z)-4-(2-naphthylmethyloxy)but-2-enyl]-α-D-
laminarabiosyl trichloroacetimidate (301).  
Following the general procedure 3, the acetonide groups were cleaved 
and the acetate groups were reinstalled to give compound 300 in 82% yield as a 
mixture. Follwing the general procedure 4, and eluting with 70% EtOAc/hexanes 
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the title compound 301 was obtained 68% yield as yellow oil. [α]23D 28.0 (c = 1); 
1H NMR (500 MHz): δ 8.70 (s, 1H), 7.85 -7.82 (m, 3H), 7.77 (s, 1H), 7.50 – 7.45 
(m, 3H), 6.46 (d, J = 4.0 Hz, 1H), 5.79 – 5.74 (m, 1H), 5.59 – 5.54 (m, 1H), 5.12 – 
5.06 (m, 2H), 4.99 (t, J = 9.5 Hz, 1H), 4.89 – 4.85 (m, 1H), 4.66 (s, 2H), 4.54 (d, J 
= 8.5 Hz, 1H), 4.23 (dd, J = 12.0 Hz, J = 5.0 Hz, 1H), 4.19 (dd, J = 12.5 Hz, J = 
4.5 Hz, 1H), 4.16 – 4.03 (m, 8H), 3.55 – 3.49 (m, 2H), 2.08 (s, 3H), 2.08 (s, 3H), 
2.07 (s, 3H), 2.05 (s, 3H), 1.98 (s, 3H), 1.97 (s, 3H). 13C NMR (125 MHz): δ 
170.9, 170.8, 169.7, 169.4, 169.3, 169.1, 160.8, 135.7, 133.5, 133.2, 129.5, 
129.2, 128.5, 128.1, 127.9, 126.7, 126.5, 125.9, 101.4, 93.4, 79.8, 76.3, 72.7, 
72.3, 72.1, 72.0, 70.5, 69.4, 67.5, 66.8, 65.9, 62.3, 61.8, 20.9, 20.9, 20.9, 20.9, 
20.8, 20.8, 20.7. ESIHRMS: calc. for C41H48Cl3NO18Na [M+Na]+ 970.1835, found 
970.1845. 
Methyl 2,2’,4,4’,6,6’-hexa-O-acetyl-3’-O-[(Z)-4-(2-naphthylmethyloxy)but-2-
enyl]-β-D-laminaribioside (302).  
Following the general procedure 5, and eluting with 75% EtOAc/hexanes 
the title compound was obtained in 60% yield. [α]23D -17.0 (c = 1); 1H NMR (500 
MHz): δ 7.85 -7.83 (m, 3H), 7.78 (s, 1H), 7.49 – 7.45 (m, 3H), 5.79 – 5.74 (m, 
1H), 5.59 – 5.55 (m, 1H), 5.03 – 4.91 (m, 3H), 4.86 (t, J = 9.0 Hz, 1H), 4.66 (s, 
2H), 4.46 (d, J = 8.5 Hz, 1H), 4.30 – 4.25 (m, 2H), 4.19 – 4.18 (m, 2H), 4.11 (d, J 
= 6.5 Hz, 2H), 4.07 (d, J = 6.0 Hz, 2H), 4.00 (dd, J = 12.0 Hz, J = 2.5 Hz, 1H), 
3.85 (t, J = 9.0 Hz, 1H), 3.69 – 3.67 (m, 1H), 3.51 – 3.49 (m, 2H), 3.47 (s, 3H), 
2.11 (s, 3H), 2.09 (s, 3H), 2.07 (s, 3H), 2.02 (s, 3H), 2.02 (s, 3H), 1.98 (s, 3H). 
13C NMR (125 MHz): δ 171.1, 170.9, 169.5, 169.4, 169.4, 169.0, 135.7, 133.5, 
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133.2, 129.5, 129.2, 128.5, 128.1, 127.9, 126.7, 126.4, 126.2, 125.9, 101.7, 
101.4, 79.8, 78.8, 72.9, 72.7, 72.1, 72.1, 72.0, 69.3, 68.7, 66.8, 65.9, 62.4, 62.3, 
56.8, 21.2, 21.0, 20.9, 20.9, 20.8, 20.7. ESIHRMS: calc. for C40H50O18Na 
[M+Na]+ 841.2895, found 841.2870. 
Methyl 2,2’,4,4’,6,6’-hexa-O-acetyl-3’-O-[(Z)-4-hydroxybut-2-enyl]-β-D-
laminarabioside (303).  
Following the general procedure 6, and eluting with 90% EtOAc/hexanes 
the title product was obtained in 85% yield. [α]23D -37.0 (c = 1); 1H NMR (500 
MHz): δ 5.75 – 5.69 (m, 1H), 5.50 – 5.45 (m, 1H), 5.02 (t, J = 9.5 Hz, 1H), 4.97 – 
4.90 (m, 2H), 4.86 (dd, J = 9.5 Hz, J = 8.5 Hz, 1H), 4.49 (d, J = 8.0 Hz, 1H), 4.31 
– 4.28 (m, 2H), 4.20 – 4.16 (m, 2H), 4.14 – 4.09 (m, 4H), 4.02 (dd, J = 12.0 Hz, J 
= 2.5 Hz, 1H), 3.85 (t, J = 9.5 Hz, 1H), 3.67 – 3.64 (m, 1H), 3.59 – 3.52 (m, 2H), 
3.45 (s, 3H), 2.13 (s, 3H), 2.07 (s, 3H), 2.06 (s, 3H), 2.06 (s, 3H), 2.06 (s, 3H), 
2.01 (s, 3H). 13C NMR (125 MHz): δ 171.0, 170.8, 169.7, 169.6, 169.5, 169.1, 
132.3, 127.7, 101.7, 101.4, 79.8, 78.9, 72.9, 72.1, 72.0, 71.7, 68.8, 68.6, 65.9, 
62.4, 62.3, 58.5, 56.8,  21.2, 21.0, 21.0, 20.9, 20.9, 20.7. ESIHRMS: calc. for 
C29H42O18Na [M+Na]+ 701.2269, found 701.2289. 
Methyl 2,2’,4,4’,6,6’-hexa-O-acetyl-3’-O-[(Z)-4-
(phenyloxythionocarbonyloxy)but-2-enyl]-β-D-laminaribioside (304).  
Following the general procedure 7, and eluting with 70% EtOAc/hexanes 
the title product was obtained in 90% yield. [α]23D -32.0 (c = 1); 1H NMR (500 
MHz): δ 7.43 – 7.40 (m, 2H), 7.29 (t, J = 7.5 Hz, 1H), 7.09 – 7.07 (m, 2H), 5.80 – 
5.75 (m, 1H), 5.71 – 5.66 (m, 1H), 5.05 – 5.02 (m, 3H), 4.97 – 4.87 (m, 3H), 4.48 
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(d, J = 8.0 Hz, 1H), 4.31 – 4.28 (m, 2H), 4.21 – 4.17 (m, 4H), 4.02 (dd, J = 12.5, J 
= 2.5 Hz, 1H), 3.86 (t, J = 9.5 Hz, 1H), 3.68 – 3.65 (m,1H), 2.12(s, 3H), 2.08 (s, 
3H), 2.07 (s, 3H), 2.07 (s, 3H), 2.06 (s, 3H), 2.02 (s, 3H). 13C NMR (125 MHz) δ 
195.1, 171.0, 170.8, 169.5, 169.4, 169.1, 153.6, 131.8, 129.8 (2C), 126.9, 125.1, 
122.1 (2C), 101.7, 101.4, 80.4, 78.8, 77.0, 72.9, 72.1, 72.0, 71.9, 69.5, 69.2, 
68.6, 66.8, 62.4, 62.2, 56.8, 21.1, 21.1, 21.0, 20.9 (2C), 20.7. ESIHRMS: calc. for 
C36H46O19SNa [M+Na]+ 837.2252, found 837.2239. 
Methyl 2,2’,4,4’,6,6’-hexa-O-acetyl-3’-O-[2-phenyloxycarbonylthioxy]but-3-
enyl]-β-D-laminarabioside (305).  
Following the general procedure 8, and eluting with 70% EtOAc/hexanes 
the title product was obtained in 90% yield. 1H NMR (500 MHz): δ 7.39 – 7.36 (m, 
2H), 7.24 (t, J = 7.5 Hz, 1H), 7.16 – 7.15 (m, 1H), 7.14 – 7.13 (m, 1H), 5.19 (dd, J 
= 10.0 Hz, J = 3.5 Hz, 1H), 4.10 – 5.05 (m, 1H), 4.99 – 4.91 (m, 3H), 4.49 (d, J = 
8.5 Hz, 1H), 4.33 – 4.29 (m, 2H), 4.19 – 4.18 (m, 2H), 4.05 – 4.01 (m, 2H), 3.86 
(t, J = 9.5 Hz, 1H), 382 – 3.77 (m, 2H), 3.47 (s, 3H), 2.13 (s, 3H), 2.11 (s, 3H), 
2.09 (s, 3H x 3), 2.08 (s, 3H x 2), 2.08 (s, 3H), 2.07 (s, 3H), 2.06 (s, 3H), 2.03 (s, 
3H), 2.02 (s, 3H). 13C NMR (125 MHz): δ 171.0, 171.9, 169.5, 169.4 (2C), 169.1, 
151.3, 133.9, 133.8, 129.7, 126.5, 121.5, 118.8, 118.7, 101.7, 101.4, 81.0, 80.8, 
78.8, 73.5, 73.4, 72.9, 72.1, 72.1, 71.9, 71.7, 69.1, 68.9, 68.6, 62.4, 62.2, 56.8, 
48.9, 48.7, 21.2, 21.1, 21.0 (2C), 20.9, 20.9, 20.9 (2C), 20.7 (2C). ESIHRMS: 
calc. for C36H46O19SNa [M+Na]+ 837.2252, found 837.2224. 
Methyl 3’-O-(2-pyridin-2-yldisulfanyl)but-3-enyl-β-D-laminaribioside (306). 
Following the general procedure 9, and eluting with 10% MeOH/CH2Cl2 the title 
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product was obtained in 68% yield. 1H NMR (500 MHz): δ 8.37 – 8.36 (m, 1H), 
7.94 – 7.90 (m, 2H), 7.82 – 7.78 (m, 1H), 7.22 – 7.19 (m, 1H), 5.87 – 5.79 (m, 
1H), 5.25 – 5.21 (m, 1H), 5.14 – 5.12 (m, 1H), 4.55 (dd, J = 7.5 Hz, J = 4.5 Hz, 
1H), 4.23 (dd, J = 7.5 Hz, J = 1.5 Hz, 1H), 4.12 (dd, J = 10.5 Hz, J = 6.0 Hz, 1H, 
minor), 4.08 – 4.07 (m, 1H), 4.03 (dd, J = 10.0 Hz, J = 6.0 Hz, 1H, minor), 3.90 – 
3.86 (m, 2H), 3.80 (dd, J = 15.0 Hz, J = 6.5 Hz, 1H), 3.70 (dd, J = 11.5 Hz, J = 
5.5 Hz, 1H), 3.65 - 361 (m, 1H), 3.54 (s, 3H major + 3H minor), 3.43 – 3.33 (m, 
7H), 3.23 (t, J = 8.5 Hz, 1H). 13C NMR (125 MHz): δ 160.7, 148.8, 137.8, 134.6, 
134.5, 121.0, 120.3, 118.1, 104.1, 103.7, 86.9, 85.7, 85.6, 76.8, 76.4, 74.4, 74.3, 
73.7, 73.2, 69.9, 69.8, 68.8, 61.4, 61.3, 56.2, 54.9, 54.8. ESIHRMS: calc. for 
C22H33NO11S2Na [M+Na]+ 574.1393, found 574.1385. 
1-Bromo hepta-O-acetyl-α-D-laminarabiose (309).  
Following the general experimental procedure 3, the acetonide groups 
were cleaved and acetate groups were installed on the known glycoside 308. 
The peracetyl laminaribioside (1.0 mmol) in CH2Cl2 (4.0 mL) was added 33% HBr 
in AcOH (15.0 mmol) at 0 °C and the reaction mixture was stirred at room 
temperature for 8 h. The reaction mixture was diluted with CH2Cl2 (10.0 mL) and 
washed with saturated NaHCO3 (10.0 mL). The combined organic portion was 
dried over Na2SO4 and evaporated to dryness. The crude bromide was purified 
by column chromatography over silica gel to give the title product as colorless 
liquid in 80% yield. 1H NMR (500 MHz): δ 6.52 (d, J = 4.0 Hz, 1H), 5.17 – 5.06 
(m, 3H), 4.90 (dd, J = 9.5 Hz, J = 8.5 Hz, 1H), 4.81 (dd, J = 10.0 Hz, J = 4.0 Hz, 
1H), 4.69 (d, J = 8.0 Hz, 1H), 4.38 (dd, J = 12.5 Hz, J = 4.5 Hz, 1H), 4.27 – 4.21 
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(m, 2H), 4.18 – 4.14 (m, 2H), 4.09 (dd, J = 12.3 Hz, J = 2.0 Hz, 1H), 3.76 – 3.73 
(m, 1H), 2.19 (s, 3H), 2.09 (s, 3H), 2.08 (s, 3H), 2.06 (s, 3H), 2.04 (s, 3H), 2.01 
(s, 3H), 2.00 (s, 3H), 1.98 (s, 3H), 1.96 (s, 3H). 13C NMR (100 MHz): δ 170.8, 
170.7, 170.6, 169.7, 169.5, 169.3, 169.2, 100.9 (2C), 87.6, 73.1, 72.7, 72.6, 71.9, 
71.6, 68.2, 66.8, 61.2, 61.3, 21.0, 20.9, 20.8, 20.7, 20.7, 20.6, 20.5.  
1-Thio-hepta-O-acetyl-β-D-laminaribiose (310).  
To a stirred solution of 1-bromo hepta-O-acetyl-α-D-laminarabiose 309 
(1.0 mmol) in acetone/water (5.0 mL) was added thiourea (1.5 mmol) and the 
reaction mixture was refluxed for 4-6 h. The reaction mixture was cooled to room 
temperature and solvents were evaporated. To a stirred solution of this residue in 
CH2Cl2/water (10.0 mL) was added sodium metabisulfite (2.0 mmol) and the 
reaction was refluxed under an atmosphere of N2 for 2-4 h. The reaction mixture 
was diluted with CH2Cl2 (10.0 mL) and washed with saturated NaHCO3 (10.0 
mL). The combined organic portion was dried over Na2SO4 and evaporated to 
dryness. The crude thiol was purified by column chromatography over silica gel 
to give the title product as colorless liquid in 65% yield. [α]23D -18.2 (c = 1); 1H 
NMR (500 MHz): δ 5.13 (t, J = 9.5 Hz, 1H), 5.06 (t, J = 9.5 Hz, 1H), 4.99 – 4.94 
(m, 2H), 4.91 – 4.88 (m, 1H), 4.60 (d, J = 7.5 Hz, 1H), 4.42 – 4.36 (m, 2H), 4.19 - 
4.12  ( m, 2H), 4.03 (dd, J = 10.5, J = 2.0 Hz, 1H), 3.85 (t, J = 9.5 Hz, 1H), 3.70 – 
3.66 (m, 2H), 2.29 (d, J = 10.5 Hz, 1H), 2.17 (s, 3H), 2.09 (s, 3H), 2.07 (s, 3H), 
2.03 (s, 3H), 2.01(s, 3H), 2.00 (s, 3H), 1.97 (s, 3H). 13C NMR (125 MHz): δ 170.9, 
170.7, 170.6, 169.6, 169.5, 169.5, 169.4, 101.1, 80.1, 79.0, 76.6, 75.3, 73.2, 
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71.9, 71.3, 68.2, 68.1, 62.5, 61.8, 21.3, 21.0, 20.8, 20.7, 20.7, 20.6, 20.5. 
ESIHRMS: calc. for C26H36O17SNa [M+Na]+ 675.1571, found 675.1541. 
Methyl 3-O-[4-(1-thio-β-D-laminarabiosyl)but-2E-enyl]-β-D-laminaribioside 
(311).  
Following the general procedure 10, the title compound was obtained in 
55% yield. [α]23D -15.0 (c 0.75); 1H NMR (500 MHz, CD3OD): δ 5.79 – 5.77 (m, 
2H), 4.57 (d, J = 7.5 Hz, J = 4.0 Hz, 2H), 4.46 (d, J = 9.5 Hz, 1H), 4.36 – 4.35 (m, 
2H), 4.24 (d, J = 7.5 Hz, 1H), 3.89 (dd, J = 7.0 Hz, J = 2.0 Hz, 4H), 3.72 – 3.67 
(m, 2H), 3.66 – 3.62 (m, 3H), 3.58 – 3.53 (m, 2H), 3.54 (s, 3H), 3.52 – 3.47 (m, 2 
H), 3.45 – 3.21 (m, 18H). 13C NMR (125 MHz, CD3OD): δ 130.3, 129.1, 104.1, 
104.0, 103.7, 88.3, 86.9, 83.6, 83.3, 80.2, 76.9, 76.8, 76.6, 76.4, 74.6, 74.4, 73.2, 
72.5, 72.4, 70.4, 70.0, 69.0, 68.9, 61.7, 61.4, 56.1, 30.8. ESIHRMS: calc. for 
C29H50O21SNa [M+Na]+ 789.2463, found 789.2451. 
(Z)-4-Hydroxybut-2-enyl hepta-O-acetyl-β-D-laminaribioside (312).  
To a stirred solution of 1-bromo hepta-O-acetyl-α-D-laminarabioside 309 
(1.0 mmol) in CH2Cl2 (10.0 mL) was added cis-butene-1,4-diol 244 (20.0 mmol), 
Ag2CO3 (1.5 mmol), CaSO4 (1.0 g) and a catalytic amount of I2. The reaction 
mixture was stirred at room temperature for 12 h without exposing the reaction 
mixture to light. The reaction mixture was diluted with CH2Cl2 (50.0 mL) and 
filtered through a pad of celite. The filtrate was washed with saturated NaHCO3 
(50.0 mL). The combined organic portion was dried over Na2SO4 and evaporated 
to dryness. The crude product was purified by column chromatography over silica 
gel to give the title compound as colorless liquid in 80% yield. [α]23D -43.5 (c = 
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1.5); 1H NMR (500 MHz): δ 5.84 – 5.79 (m, 1H), 5.60 – 5.55 (m, 1H), 5.11 (t, J = 
9.5 Hz, 1H), 5.04 (t, J = 9.5 Hz, 1H), 4.98 (t, J = 8.0 Hz, 1H), 4.93 (t, J = 10.0 Hz, 
1H), 4.87 (t, J = 8.5 Hz, 1H), 4.57 (d, J = 8.0 Hz, 1H), 4.41 (d, J = 8.0 Hz, 1H), 
4.35 (dd, J = 12.5 Hz, J = 4.0 Hz, 1H), 4.31 (dd, J = 12.5 Hz, J = 5.5 Hz, 1H), 
4.21 (dd, J = 13.0 Hz, J = 8.0 Hz, 1H), 4.17 (s, 2H), 4.16 (s, 2H), 4.02 (dd, J = 7.5 
Hz, J = 2.5 Hz, 1H), 3.86 (t, J = 9.5 Hz, 1H), 3.67 – 3.64 (m, 2H), 2.12 (s, 3H), 
2.07 (s, 3H), 2.06 (s, 3H), 2.01 (s, 3H), 1.98 (s, 3H x 2), 196 (s, 3H). 13C NMR 
(125 MHz): δ 171.1, 170.7, 170.6, 169.6, 169.5, 169.4, 169.2, 133.6, 126.9, 
101.2, 99.3, 79.1, 73.2, 72.8, 72.1, 71.9, 71.2, 68.6, 68.3, 64.0, 62.5, 61.9, 58.7, 
21.1, 20.9, 20.8, 20.7, 20.7, 20.6, 20.5. ESIHRMS: calc. for C30H42O19Na 
[M+Na]+ 729.2218, found 729.2210. 
(Z)-4-(Phenyloxythionocarbonyloxy)but-2-enyl hepta-O-acetyl-β-D-
laminaribioside (313).  
Following the general procedure 7, and eluting with 75% EtOAc/hexanes 
the title compound was obtained in 85% yield. [α]23D -11.0 (c = 1); 1H NMR (500 
MHz): δ 7.43 (t, J = 8.0 Hz, 2H), 7.30 (t, J = 7.5 Hz, 1H), 7.11 – 7.09 (m, 2H), 
5.88 – 5.84 (m, 1H), 5.82 – 5.77 (m, 1H), 5.15 – 5.11 (m, 2H), 5.09 – 5.06 (m, 
2H), 5.04 – 4.99 (m, 1H), 4.96 (t, J = 10.0 Hz, 1H), 4.89 (t, J = 9.5 Hz, 1H), 4.58 
(d, J = 8.5 Hz, 1H), 4.44 (d, J = 8.5 Hz, 1H), 4.38 – 4.33 (m, 3H), 4.19 – 4.18 (m, 
2H), 4.03 (dd, J = 12.5 Hz, J = 2.0 Hz, 1H), 3.87 (t, J = 9.5 Hz, 1H), 3.68 – 3.66 
(m, 2H), 2.14 (s, 3H), 2.07 (s, 3H), 2.06 (s, 3H), 2.02 (s, 3H), 2.01 (s, 3H), 2.00 
(s, 3H), 1.98 (s, 3H). 13C NMR (125 MHz): δ 195.1, 170.9, 170.7, 170.6, 169.6, 
169.5, 169.4, 169.1, 153.6, 130.9, 129.8, 126.9, 126.2, 122.1, 101.2, 99.6, 79.2, 
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73.2, 72.7, 72.2, 71.9, 71.3, 69.5, 68.4, 68.3, 64.4, 62.3, 61.9, 21.2., 21.0, 20.8, 
20.8, 20.7, 20.7, 20.6 ESIHRMS: calc. for C37H46O20SNa [M+Na]+ 865.2201, 
found 865.2190. 
2-(Phenyloxycarbonylthioxy)but-3-enyl hepta-O-acetyl-β-D-laminaribioside 
(314).  
Following the general procedure 8, and eluting with 75% EtOAc/hexanes 
the title compound was obtained in 95% yield. 1H NMR (500 MHz): δ 7.39 – 7.36 
(m, 2H), 7.24 – 7.23 (m, 1H), 7.16 – 7.13 (m, 2H), 5.94 – 5.82 (m, 1H), 5.36 (dd, 
J = 17.0 Hz, J = 5.0 Hz, 1H), 5.22 (dd, J = 11.5 Hz, J = 10.5 Hz, 1H), 5.14 – 5.10 
(m, 1H), 5.07 – 4.99 (m, 2H), 4.96 - 4.91 (m, 1H), 4.88 (t, J = 9.0 Hz, 1 H), 4.58 
(dd, J = 8.0 Hz, J = 6.0 Hz, 1H), 4.43 (t, J = 8.0 Hz, 1H), 4.35 (dd, J = 12.5 Hz,  J 
= 4.5 Hz, 1H), 4.20 – 4.16 (m, 3H), 4.14 – 4.09 (m, 1H), 4.07 – 4.02 (m, 1H), 3.89 
– 3.85 (m, 1H), 3.74 (dd, J = 10.5 Hz, J = 6.5 Hz, 1H), 3.68 – 3.65 (m, 2H), 2.14 
(s, 3H), 2.12 (s, 3H), 2.07 (s, 3H X 2), 2.06 (s, 3H), 2.05 (s, 3H), 2.02 (s, 3H), 
2.01 (s, 3H), 2.00 (s, 3H), 1.99 (s, 3H X 3), 1.97 (s, 3H), 1.96 (s, 3H). 13C NMR 
(125 MHz): δ 170.9, 170.7, 170.6, 169.6, 169.5, 169.4, 169.2, 169.0, 168.9, 
151.3, 133.8, 133.5, 129.7, 126.5, 121.4, 119.1, 119.0, 101.5, 101.2 (2C), 100.7, 
79.0, 78.9, 73.2, 72.7, 72.6, 72.2, 71.9, 71.7, 71.3, 70.3, 68.5, 68.4, 68.3, 62.3, 
62.2, 61.9, 48.8, 48.0, 21.2, 21.1, 20.9, 20.8, 20.7, 20.7, 20.6, 20.5. ESIHRMS: 
calc. for C37H46O20SNa [M+Na]+ 865.2201, found 865.2220. 
2-(Pyridin-2-yldisulfanyl)-3-enyl-β-D-laminaribioside (315).  
Following the general procedure 9, and eluting with MeOH/CH2Cl2 the title 
compound was obtained in 70% yield. 1H NMR (500 MHz, CD3OD): δ 8.36 (d, J = 
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7.0 Hz, 1H), 7.95 – 7.92 (m, 1H), 7.79 (t, J = 9.0 Hz, 1H), 7.20 (dd, J = 9.0 Hz, J 
= 6.0 Hz, 1H), 5.88 – 5.78 (m, 1H), 5.27 – 5.20 (m, 1H), 5.16 – 5.13 (m, 1H), 4.55 
(d, J = 10.0 Hz, 1 H), 4.33 (dd, J = 15.0 Hz, J = 10 Hz, 1H), 4.16 – 4.09 (m, 1H), 
3.89 – 3.86 (m, 3H), 3.85 – 3.80 (m, 1H), 3.78 – 3.77 (m, 1H), 3.69 – 3.61 (m, 
2H), 3.56 – 3.51 (m, 1H), 3.42 – 3.36 (m, 4H), 3.33 – 3.25 (m, 6H). 13C NMR (125 
MHz): δ 160.6, 148.8, 137.9, 134.2, 134.1, 121.1, 120.4, 118.5, 118.3, 104.1, 
102.9, 102.9, 86.7, 77.0, 76.6, 76.5, 74.3, 73.2, 70.4, 70.1, 68.8, 68.7, 61.4, 54.2, 
54.1. ESIHRMS: calc. for C21H31NO11S2Na [M+Na]+ 560.1236, found 560.1220. 
Benzyl 2-O-benzoyl–4,6-O-benzylidene-2’,4’,6’-tri-O-acetyl-3’-acetylsulfanyl-
3’-deoxy-β-D-laminarabioside (323).  
Following the general procedure 5, benzyl 2-O-benzoyl–4,6-O-
benzylidene-β-D-glucopyranoside (322) was glycosylated with 2,4,6-tri-O-acetyl-
3-S-acetylsulfanyl-3-deoxy-α-D-glucopyranosyl trichloroacetimidate (295) donor 
and eluting with EtOAc/hexanes the title product was obtained in 25% yield. 
[α]23D -47.7 (c = 1); 1H NMR (400 MHz): δ 7.99 – 7.97 (m, 2H), 7.64 – 7.60 (m, 
1H), 7.51 – 7.45 (m, 4H), 7.35 – 7.33 (m, 3H), 7.21 – 7.16 (m, 1H), 7.14 – 7.12 
(m, 4H), 5.57 (s, 1H), 5.35 (t, J = 10.0 Hz, 1H), 4.97 (t, J = 9.6 Hz, 1H), 4.90 (dd, 
J = 11.2 Hz, J = 7.2 Hz, 1H), 4.84 (d, J = 8.4 Hz, 1H), 4.64 – 4.58 (m, 3H), 4.38 
(dd, J = 10.8 Hz, J = 4.8 Hz, 1H), 4.11 – 4.04 (m, 2H), 3.91 – 3.79 (m, 3H), 3.59 
(t, J = 11.2 Hz, 1H), 3.52 – 3.46 (m, 2H), 2.21 (s, 3H), 1.94 (s, 3H), 1.92 (s, 3H), 
1.68 (s, 3H). 13C NMR (125 MHz): δ 193.7, 169.4, 165.6, 137.4, 136.8, 133.5, 
130.2, 130.0, 129.9, 129.3, 128.7, 128.6, 128.4, 128.1, 128.0, 126.3, 119.2, 
102.1, 101.5, 99.8, 79.3, 79.1, 77.6, 77.3, 76.9, 74.4, 73.6, 70.6, 69.9, 68.8, 67.8, 
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66.8, 62.3, 47.9, 30.7, 20.9, 20.7, 20.2. ESIHRMS: calc. for C41H44O15SNa 
[M+Na]+ 831.2299, found 831.2259. 
Benzyl 2-O-benzoyl–2’,4’,6’-tri-O-acetyl-3’-acetylsulfanyl-3’-deoxy-β-D-
laminaribioside (324).  
The compound 323 was stirred in 50% aqeous AcOH (2.0 mL) at 50 °C for 
4-6 h. Solvents were evaporated completely and purified by column 
chromatography to afford the title product in 90% yield. [α]23D -38.7 (c = 1); 1H 
NMR (400 MHz): δ 7.99 – 7.97 (m, 2H), 7.64 – 7.61 (m, 1H), 7.51 – 7.47 (m, 2H),  
7.19 – 7.14 (m, 1H), 7.12 – 7.11 (m, 4H), 5.25 (t, J = 11.0 Hz, 1H), 4.99 – 4.92 
(m, 2H), 4.82 – 4.79 (m, 1H), 4.63 – 4.59 (m, 1H), 4.53 (d, J = 10.5 Hz, 2H), 4.17 
– 4.08 (m, 2H), 3.99 – 3.94 (m, 1H), 3.83 – 3.75 (m, 4H), 3.73 – 3.71 (m, 1H), 
3.67 – 3.62 (m, 2H), 3.41 – 3.36 (m, 1H), 2.23 (s, 3H), 2.07 (s, 3H X 2), 1.97 (s, 
3H). 13C NMR (125 MHz): δ 193.4, 170.7, 169.4, 169.3, 165.1, 137.0, 133.6, 
130.0, 129.8, 128.7, 128.5, 128.0, 127.9, 102.7, 99.7, 85.7, 75.8, 74.8, 72.5, 
70.7, 69.9, 69.5, 67.8, 63.1, 62.3, 47.9, 30.7, 20.8, 20.6, 20.1. ESIHRMS: calc. 
for C34H40O15SNa [M+Na]+ 831.2299, found 831.2259. 
Benzyl 3-deoxy-3-[4-(β-D-laminaribiosyloxy)but-2E-enylsulfanyl]-β-D-
laminaribioside (325).  
Following the general procedure 10, the title compound was obtained in 
50% yield. [α]23D -16.0 (c 0.75); 1H NMR (500 MHz, CD3OD): δ 7.44 – 7.42 (m, 
2H), 7.36 – 7.32 (m,2H), 7.29 – 7.27 (m, 1H), 5.88 – 5.83 (m, 1H), 5.76 – 5.71 
(m, 1H), 4.94 (d, J = 12.0 Hz, 1H), 4.69 (d, J = 8.5 Hz, 1H), 4.58 (t, J = 8.0 Hz, 
1H), 4.47 – 4.41 (m, 2H), 4.31 (dd, J = 13.0 Hz, J = 5.0 Hz, 1H), 4.20 (dd, J = 
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13.0 Hz, J = 7.5 Hz, 1H), 3.93 – 3.87 (m, 5H), 3.74 – 3.26 (m, 3H), 2.59 (t, J = 
10.0 Hz, 1H). 13C NMR (125 MHz, CD3OD): δ 137.7, 131.2, 128.6, 128.2, 128.1, 
127.6, 105.3, 104.2, 101.6, 100.7, 86.9, 86.8, 79.4, 76.9, 76.5, 76.4, 76.2, 74.4, 
73.8, 73.4, 73.3, 72.6, 70.6, 70.4, 69.0, 68.9, 68.7, 68.4, 63.2, 61.7, 61.5, 61.4, 
53.9, 33.3. ESIHRMS: calc. for C35H54O21SNa [M+Na]+ 865.2776, found 
865.2768. 
4-(1-Thio-β-D-laminarabiosyl)but-2E-enyl β-D-laminarabioside (326). 
Following the general procedure 10, the title compound was obtained in 55% 
yield. [α]23D -11.0 (c 0.75); 1H NMR (500 MHz, CD3OD): δ 5.86 – 5.80 (m, 1H), 
5.77 – 5.71 (m, 1H), 4.59 (d, J = 11.0 Hz, J = 7.5 Hz, 2H), 4.44 – 4.41 (m, 2H), 
4.33 (dd, J = 12.5 Hz, J = 4.5 Hz, 1H), 4.20 (dd, J = 12.0 Hz, J = 7.5 Hz, 1H), 
3.91 – 3.89 (m, 4H), 3.75 – 3.62 (m, 5H), 3.59 – 3.55 (m, 2H), 3.53 – 3.18 (m, 
20H). 13C NMR (125 MHz, CD3OD): δ 130.2, 128.8, 104.1 (2C), 103.9, 100.9, 
88.6, 87.3, 83.1, 80.2, 76.9, 76.8, 76.5, 76.4, 74.4, 74.4, 73.2, 72.4, 70.4, 69.0, 
68.9, 66.5, 61.7, 61.5, 30.6. ESIHRMS: calc. for C28H48O21SNa [M+Na]+ 
775.2306, found 775.2328. 
Phenyl 3-deoxy-3-[4-(β-D-glucopyranosyloxy)but-2E-enylsulfanyl]-1-thio-β-
D-glucopyranoside (327).  
Following the general procedure 10, the title compound was obtained in 
70% yield. [α]23D - 36.0 (c 0.75); 1H NMR (400 MHz, CD3OD): δ 7.57 – 7.54 (m, 
2H), 7.32 – 7.23 (m, 3H), 5.86 – 5.79 (m, 1H), 5.74 – 5.67 (m, 1H), 4.62 (d, J = 
12.0 Hz, 1H), 4.34 (d, J = 10.0 Hz, 1H), 4.30 (dd, J = 16.5 Hz, J = 7.0 Hz, 1H),  
4.14 (dd, J = 16.0 Hz, J = 9.0 Hz, 1H), 3.87 (dd, J = 15.0 Hz, J = 2.0 Hz, 2H),  
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3.69 – 3.62 (m, 2H), 3.46 – 3.26 (m, 8H), 3.18 (t, J = 11.0 Hz, 1H), 2.58 (t, J = 
11.0 Hz, 1H). 13C NMR (100 MHz, CD3OD): δ 133.9, 131.6, 130.8, 128.7, 127.1, 
101.5, 89.6, 82.7, 76.8, 76.6, 73.9, 72.4, 70.5, 68.6, 68.5, 61.8, 61.6, 56.7, 33.6. 
ESIHRMS: calc. for C22H32O10S2Na [M+Na]+ 543.1335, found 543.1346. 
Methyl 3-O-[4-(methyl α-D-glucopyranosid-6-sulfanyl)but-2E-enyl]-β-D-
glucopyranoside (328).  
Following the general procedure 10, the title compound was obtained in 
70% yield. [α]23D - 26.0 (c 0.75); 1H NMR (500 MHz, CD3OD): δ 5.78 – 5.69 (m, 
2H), 4.65 (d, J = 3.5 Hz, 1H), 4.36 – 4.35 (m, 1H), 4.19 – 4.18 (m, 1H), 3.86 (dd, 
J = 12.0 Hz, J = 2.5 Hz, 1H), 3.69 – 3.54 (m, 3H), 3.44 (s, 3H), 3.43 (s, 3H), 3.44 
– 3.37 (m, 1H), 3.32 – 3.31 (m, 2H), 3.29 – 3.19 (m, 6H), 2.94 (dd, J = 14.0 Hz, J 
= 2.0 Hz, 1H), 2.59 (dd, J = 14.6 Hz, J = 8.0 Hz, 1H). 13C NMR (125 MHz, 
CD3OD): δ 130.2, 129.3, 104.2, 99.8, 84.5, 76.6, 73.9, 73.8, 73.5, 72.8, 72.4, 
70.1, 61.5, 56.2, 54.4, 34.1, 32.1. ESIHRMS: calc. for C18H32O11SNa [M+Na]+ 
479.1563, found 479.1550. 
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CONCLUSIONS 
The selenocyanates were shown to be excellent replacements for the 
seleno-Bunte salts employed in the original proof of concept experiments on the 
allylic selenosulfide rearrangement. The permanent modification of simple thiols, 
cysteine thiols and cysteine containing small peptides was achieved using the 
selenosulfide rearrangement. Primary allylic selenosulfides were obtained as 
intermediates by the treatment of allylic selenocyanates with thiols and the 
usefulness of this selenosulfide ligation has been demonstrated by application to 
the synthesis of tertiary allyl sulfides wherein cysteine thiols and cysteine 
containing small peptides were lipidated. 
In response to the need to overcome the requirement for stoichiometric 
phosphine in the allylic disulfide rearrangement, a completely phosphine free 
system was developed employing silver nitrate as the desulfurization reagent. 
This silver mediated variant enabled the attachment of farnesyl-like primary thio 
ether groups to cysteine thiols and cysteine containing small peptides via 
nerolidyl disulfides. The advantages of this silver mediated desulfurative allylic 
rearrangement over the original triphenylphosphine mediated version were 
demonstrated by the lipidation of an electron deficient anomeric thiol under very 
mild reaction conditions and also by the synthesis of an allyl aryl sulfide. The 
protecting group free synthesis of a glycoconjugate further validated the silver 
mediated desulfurative rearrangement in aqueous media. 
The utility of this metal mediated allylic desulfurative rearrangement as a 
chemoselective ligation for the synthesis of complex oligosaccharides was 
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investigated and established. The silver mediated allylic desulfurative 
rearrangement was applied successfully to the synthesis of various β-(1,3)-
glucan mimics enabling the protecting group free synthesis of two distinct types 
of mimic of β-(1,3)-glucan disaccharides and tetrasaccharides. 
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ABSTRACT 
 
DECHALCOGENATIVE ALLYLIC SELENOSULFIDE AND DISULFIDE 
REARRANGEMENTS FOR CYSTEINE MODIFICATION AND 
GLYCOLIGATION 
 
by 
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December 2010 
Advisor:  Professor David Crich 
Major: Chemistry 
Degree: Doctor of Philosophy 
This dissertation describes investigations directed at the development of 
methods for the selenosulfide and disulfide rearrangements for the permanent 
functionalization of thiols, and in particular of cysteine and carbohydrate based 
thiols. Emphasis is placed on the newly invented silver mediated allylic 
desulfurative rearrangement for the primary modification of thiols and the 
synthesis of complex oligosaccharide mimics. 
Chapter one introduces the concept of chemoselective ligations for the 
modification of macromolecules like carbohydrates and proteins. It overviews the 
native and non-native ligation techniques for their modification of such entities 
with a attention focusing on thiol based ligation techniques. The later part of 
chapter one describes the need for a permanent ligation technique for the thiol 
modification and draws attention to a novel method called the selenosulfide 
ligation. 
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The second chapter describes studies focused on the further development 
of the selenosulfide rearrangement through selenocyanate methodology. The 
synthesis of various selenocyanates as convenient synthons for the selenosulfide 
ligation is described. The successful application of this selenosulfide 
methodology to the synthesis of tertiary allyl sulfides in which cysteine containing 
small peptides were modified with lipid units is highlighted. 
In the studies covered in chapter three, with the view to introducing 
farnesyl-like primary thio ether groups to cysteine peptides and electron deficient 
anomeric thiols, the allylic disulfide rearrangement was reassessed with the 
further goal of identifying phosphine-free reagents for the desulfurative 
rearrangement. This led to the invention of silver mediated allylic desulfurative 
rearrangement, which enabled the attachment of lipid groups to cysteine 
peptides and an anomeric thiol under mild reaction conditions. The protecting 
group-free synthesis of a glycoconjugate was accomplished using this 
methodology. 
In chapter four, extending the concept of this novel metal mediated allylic 
desulfurative rearrangement as a chemoselective ligation technique, for the 
synthesis of complex oligosaccharides is described with a focus to the synthesis 
of β-(1,3)-glucan surrogates.  
In chapter five, the experimental procedures and characterization data for 
the synthesized compounds are documented. 
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